submitter_id;icd_10_code;classification_of_tumor;ajcc_pathologic_m;ajcc_pathologic_t;tumor_stage;year_of_diagnosis;synchronous_malignancy;days_to_last_follow_up;primary_diagnosis;ajcc_pathologic_n;diagnosis_id;progression_or_recurrence;days_to_last_known_disease_status;site_of_resection_or_biopsy;prior_treatment;tissue_or_organ_of_origin;state;days_to_diagnosis;age_at_diagnosis;tumor_grade;days_to_recurrence;morphology;prior_malignancy;created_datetime;ajcc_staging_system_edition;ajcc_pathologic_stage;last_known_disease_status;updated_datetime;years_smoked;height;exposure_id;pack_years_smoked;bmi;cigarettes_per_day;weight;alcohol_history;alcohol_intensity;race;demographic_id;gender;age_at_index;ethnicity;vital_status;days_to_birth;year_of_death;year_of_birth;days_to_death;treatments_pharmaceutical_treatment_outcome;treatments_pharmaceutical_treatment_or_therapy;treatments_pharmaceutical_initial_disease_status;treatments_pharmaceutical_treatment_id;treatments_pharmaceutical_treatment_intent_type;treatments_pharmaceutical_therapeutic_agents;treatments_pharmaceutical_regimen_or_line_of_therapy;treatments_pharmaceutical_days_to_treatment_end;treatments_pharmaceutical_treatment_type;treatments_pharmaceutical_days_to_treatment_start;treatments_pharmaceutical_treatment_effect;treatments_pharmaceutical_treatment_anatomic_site;treatments_radiation_treatment_outcome;treatments_radiation_treatment_or_therapy;treatments_radiation_initial_disease_status;treatments_radiation_treatment_id;treatments_radiation_treatment_intent_type;treatments_radiation_therapeutic_agents;treatments_radiation_regimen_or_line_of_therapy;treatments_radiation_days_to_treatment_end;treatments_radiation_treatment_type;treatments_radiation_days_to_treatment_start;treatments_radiation_treatment_effect;treatments_radiation_treatment_anatomic_site;bcr_patient_barcode;disease
TCGA-39-5019;C34.1;not reported;M0;T2a;stage ib;2004;No;3387;Squamous cell carcinoma, NOS;N0;19ea6b5c-77f1-5622-b392-54a44430e575;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25756;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;d7d1e74e-6e79-567b-8777-9486fd49e345;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;1d986f48-e5ea-5f6a-a723-bad62f90bb90;male;70;not hispanic or latino;Alive;-25756;NA;1934;NA;NA;no;NA;f009d41e-425d-54c5-93ed-a4f347774c1d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e4d0cb8b-c3d3-5486-8180-dfdb776a10ad;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5019;LUSC
TCGA-22-1016;C34.9;not reported;M0;T2;stage ib;2001;No;822;Squamous cell carcinoma, NOS;N0;1b1c1d39-fec8-51e5-a723-aa2c8919b983;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;24078;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;30;NA;d74efe4b-2ea5-5a8f-948d-0add93628b4e;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;17c17f28-b561-55fd-9ed7-92ed121b7ad4;male;65;not hispanic or latino;Dead;-24078;2003;1936;822;NA;no;NA;7bd49924-f561-50e5-9713-92505c9a731e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3a65c0f7-863f-5a08-91ed-2c44d5867b1e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-1016;LUSC
TCGA-63-A5MR;C34.1;not reported;M0;T2;stage ib;NA;No;2716;Squamous cell carcinoma, NOS;N0;efa9695e-0b9e-59d2-8bb5-9afc0c6600bf;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;NA;25879;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;40;NA;b7d9fe0e-da6a-5c3f-a75b-312e85ac78e7;120;NA;657.534.246.575.342;NA;Not Reported;NA;not reported;35b9a8a7-c1cf-5ecc-b2ab-d723142ef795;female;70;not reported;Alive;-25879;NA;NA;NA;NA;no;NA;60d765f2-385f-52e1-9a9b-46d1a2169db7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;b352f948-0a09-5536-ab6b-bd7012a55dad;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MR;LUSC
TCGA-J1-A4AH;C34.3;not reported;MX;T2b;stage iia;2012;Yes;581;Squamous cell carcinoma, NOS;N0;0fa43126-94a1-5422-8106-25f3b9d4d09c;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25893;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;a5a92388-cd73-568e-a30c-b8b4fcbaa517;100;NA;547.945.205.479.452;NA;Not Reported;NA;white;9c12ce30-25d9-5c52-a778-ff7085cd73a4;male;70;not hispanic or latino;Alive;-25893;NA;1942;NA;NA;yes;NA;d2b2be8c-6a69-5b76-b820-c434987f37ae;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;af11f2d3-fd9f-575f-b65c-159faacf2d61;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-J1-A4AH;LUSC
TCGA-33-AASJ;C34.1;not reported;MX;T2;stage ib;1999;No;NA;Squamous cell carcinoma, NOS;N0;2bc339bb-e829-5d67-a032-77eabb810433;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22179;not reported;NA;8070/3;no;NA;5th;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;8;NA;33c6b9e6-274a-5286-b4e3-abf56058e650;NA;NA;NA;NA;Not Reported;NA;black or african american;3663ba95-34ed-5149-9c1d-c369b29e8226;male;60;not hispanic or latino;Dead;-22179;2008;1939;3600;NA;no;NA;4e7c7f90-e7f3-51c2-ac4b-295dfa216c2d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;456583b4-bd33-507b-a6c9-ab0315399130;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-AASJ;LUSC
TCGA-56-A5DR;C34.1;not reported;MX;T1a;stage ia;2012;No;4;Squamous cell carcinoma, NOS;N0;655a3b9d-254e-54df-bc2a-817764c0da56;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;29828;not reported;NA;8070/3;yes;NA;7th;Stage IA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;0f343403-5345-58fb-9aba-7e53384aa9ad;NA;NA;NA;NA;Not Reported;NA;white;1b519ec6-a4c5-52a0-b143-1285ce09bc48;male;81;not hispanic or latino;Alive;-29828;NA;1931;NA;NA;no;NA;41d9eb90-a113-5fc2-888e-a9a40fb62303;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4c97b8a0-1057-5963-a07e-356aa75c1a11;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-A5DR;LUSC
TCGA-22-A5C4;C34.3;not reported;M0;T2b;stage iia;2012;No;671;Squamous cell carcinoma, NOS;N0;79b8e80d-7826-523f-9e40-cd828e7ebd45;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25629;not reported;NA;8070/3;yes;NA;7th;Stage IIA;not reported;2019-08-08T17:11:47.463501-05:00;52;NA;6f55f29a-7665-5bd3-a4fa-f63ec7429048;80;NA;438.356.164.383.562;NA;Not Reported;NA;white;1d45bb6b-9b3a-5525-933c-7c060026fbe6;male;70;not hispanic or latino;Alive;-25629;NA;1942;NA;NA;no;NA;61e8a85d-9cb7-5bfc-b563-e6ece4d2587d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;fd4c8b75-b018-57dd-a239-ce3e26a6349c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-A5C4;LUSC
TCGA-70-6722;C34.1;not reported;M0;T3;stage iiia;2010;No;367;Squamous cell carcinoma, NOS;N1;aab41e68-37b0-5776-9dfe-cfa24f127bf6;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;17328;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:13:35.084062-05:00;NA;NA;72924adc-8a02-522d-8405-4f63338bb900;NA;NA;NA;NA;Not Reported;NA;asian;313883f6-1696-5b95-a73b-06732d8dfb3e;male;47;not hispanic or latino;Alive;-17328;NA;1963;NA;NA;no;NA;30096524-d0de-5640-b719-8bb7a2e37200;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;3d542c68-f5af-5009-92ef-52ba94e52a71;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-70-6722;LUSC
TCGA-77-8146;C34.1;not reported;M0;T1;stage ia;2005;No;3189;Squamous cell carcinoma, NOS;N0;2e845360-4cba-5c9c-8e8f-c23ed8fe95c7;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26533;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;404461d3-3ad0-5048-8d59-98c32a350eef;75;NA;410.958.904.109.589;NA;Not Reported;NA;not reported;c7d0782e-acdf-57fc-adb4-f976ad99e1b9;male;72;not reported;Alive;-26533;NA;1933;NA;NA;no;NA;1e1dcb2c-0ca5-584a-9534-a4f682861827;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;bac5504c-26ca-528b-b3f6-1dcdae25dc77;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8146;LUSC
TCGA-94-8491;C34.3;not reported;M0;T2a;stage iia;2012;No;810;Squamous cell carcinoma, NOS;N1;65fa090e-e1be-5631-b968-898ac67b2663;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26698;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:16.559953-05:00;28;NA;98c34d27-ba38-529d-8a81-decd023e8f8a;56;NA;306.849.315.068.493;NA;Not Reported;NA;white;c5d1c661-6745-59bf-a9c2-c98b0b4122b8;male;73;not reported;Alive;-26698;NA;1939;NA;NA;yes;NA;31207941-f29d-5272-9e58-ab8498600959;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;451f42ff-44a9-538f-af14-fb37249ad23e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-94-8491;LUSC
TCGA-18-5595;C34.3;not reported;M0;T2;stage ib;2008;Not Reported;NA;Squamous cell carcinoma, NOS;N0;574371f5-1728-534b-9865-223d98d9ba33;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;18611;not reported;NA;8070/3;yes;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;81a9d3dc-895f-5e80-b1e6-5a1c207a2008;NA;NA;NA;NA;Not Reported;NA;not reported;73e8526a-40ee-526e-bf5f-b0af2b3da9b6;male;50;not reported;Dead;-18611;2010;1958;827;NA;not reported;NA;07c91b70-f0c5-5e51-b88e-aea7d0b364fd;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;016514d6-f7d3-5b0c-ad05-a78405dba731;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-5595;LUSC
TCGA-56-8307;C34.3;not reported;M0;T3;stage iib;2012;No;818;Squamous cell carcinoma, NOS;N0;c4f2e268-6cdc-5891-b33b-b3bec9c24e54;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;20411;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;1a2d240a-d6b0-5fa2-be42-d53ce3b57702;35;NA;191.780.821.917.808;NA;Not Reported;NA;white;a262eed7-1483-5e44-9ff0-abbd0f4e16f1;female;55;not hispanic or latino;Alive;-20411;NA;1957;NA;NA;no;NA;a67b75ef-8694-5f08-80c3-81106b1dc665;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a36684ed-300f-5e0b-bfb9-15783b9aeb4b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8307;LUSC
TCGA-63-A5MI;C34.3;not reported;M0;T2;stage iiia;NA;No;1784;Squamous cell carcinoma, NOS;N2;2ed13c78-24e5-5878-b695-f2fc7bd94b8b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;NA;24040;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;d5c0ef55-96e8-58ed-854a-742f2d224110;50;NA;273.972.602.739.726;NA;Not Reported;NA;not reported;92e93d11-738d-5d29-a24b-8735ad204580;male;65;not reported;Alive;-24040;NA;NA;NA;NA;yes;NA;e34babb6-aae0-5551-9756-40ee1b63ecab;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;37b62682-7039-5bb5-b46e-dcf5df4f1c20;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MI;LUSC
TCGA-77-6843;C34.1;not reported;M0;T1;stage iia;2002;No;NA;Squamous cell carcinoma, NOS;N1;7b397af4-53d1-50bc-9850-1bb90da692f4;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27291;not reported;NA;8070/3;no;NA;6th;Stage IIA;not reported;2019-08-08T17:13:35.084062-05:00;NA;NA;2d2fe6f4-b0ad-5dca-90c5-3540532eed0d;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;3e7e2c21-6c05-5e1e-afea-78ba43bbc7b3;male;74;not reported;Dead;-27291;2008;1928;2224;NA;no;NA;97011e15-b765-54a1-99f1-b64389b436d6;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;52773a21-c233-589b-917b-3e12516d056b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-6843;LUSC
TCGA-46-6026;C34.3;not reported;M0;T2a;stage iib;2010;No;423;Squamous cell carcinoma, NOS;N1;adcb6e30-6878-5f80-bde1-6b92d5ec50db;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;29890;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;f97c5ff0-e0ae-58ae-9ae6-fb4389067e41;NA;NA;NA;NA;Not Reported;NA;white;b7fddd57-d9c7-5abb-a85d-430ec9c38311;male;81;not hispanic or latino;Alive;-29890;NA;1929;NA;NA;yes;NA;767054ae-c477-582e-82e9-2b9bbf714671;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;ae058695-b98b-56a6-b405-a3e59ff52e62;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-46-6026;LUSC
TCGA-63-A5MT;C34.1;not reported;M0;T3;stage iib;NA;No;498;Squamous cell carcinoma, NOS;N0;a2f9890a-f983-5142-9c6f-587413fe1ac8;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;NA;27263;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:13:13.079700-05:00;50;NA;d1c27a0c-55ce-5be4-b0d3-80eeeea7f32d;100;NA;547.945.205.479.452;NA;Not Reported;NA;not reported;53d836e0-4a53-5798-841e-293879763239;male;74;not reported;Alive;-27263;NA;NA;NA;NA;yes;NA;5f4d8c5c-893b-51c2-b2e6-73cd4db1e773;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;8159a2a8-4af2-5782-9f95-93bee40b6f49;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MT;LUSC
TCGA-56-8623;C34.1;not reported;MX;T2a;stage ib;2012;No;6;Squamous cell carcinoma, NOS;N0;8af248fa-1faf-55b1-a02b-d308fce18868;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26231;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;b8e15e12-8d07-5e2d-b389-9ef76432f776;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;d35c64ad-a2a7-5b30-a80f-1f8bdd048b3a;male;71;not hispanic or latino;Dead;-26231;NA;1941;692;NA;no;NA;503db990-ff88-50f5-884e-959622569a84;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;9db5543e-49b5-5c90-9ab2-edb7878aa1df;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8623;LUSC
TCGA-77-8150;C34.9;not reported;M0;T3;stage iiia;2007;No;NA;Squamous cell carcinoma, NOS;N1;f8c582c1-bd01-575a-90e2-e9b77f6a7357;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;23474;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;f40089b0-ac59-521e-9e55-fa6dd5cc627c;46;NA;252.054.794.520.548;NA;Not Reported;NA;not reported;112c1c1c-7e6b-5041-bd46-f1e2c4802f4c;male;64;not reported;Dead;-23474;2011;1943;1655;NA;yes;NA;957c9188-ed5a-5e82-973d-4833b58fdecc;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;492741b0-9e3c-5e0b-9e4f-dc2a40f1328d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8150;LUSC
TCGA-51-4079;C34.1;not reported;NA;T2;stage ib;2009;No;NA;Squamous cell carcinoma, NOS;N0;abc46ff1-fc2a-524c-af51-6275bd493100;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26899;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;1968b4cf-e1f5-5d78-b586-b524dd088cc7;25;NA;136.986.301.369.863;NA;Not Reported;NA;black or african american;4ac59f11-fa27-5aae-8ab9-bc3423786b37;female;73;not hispanic or latino;Dead;-26899;2009;1936;12;NA;no;NA;ad5cf917-a34e-57a1-8cec-8c558f483936;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;55aaeaf0-d395-59e0-a743-15f2749b3821;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-51-4079;LUSC
TCGA-21-5786;C34.1;not reported;M0;T2;stage ib;2009;No;1032;Squamous cell carcinoma, NOS;N0;8f972541-9f16-5bcc-97be-d5527f4e04c6;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23649;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;22b93e05-e7ed-5da8-b656-0a139873798f;75;NA;410.958.904.109.589;NA;Not Reported;NA;white;0f2b6f2e-97bc-59e1-b02f-ee7742620b39;male;64;not hispanic or latino;Alive;-23649;NA;1945;NA;NA;no;NA;4df64e23-1d37-5559-9015-b416041ccf0c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;9d5046fb-241c-5fca-a671-85f50f895c59;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-5786;LUSC
TCGA-56-7222;C34.1;not reported;M0;T2a;stage ib;2011;No;13;Squamous cell carcinoma, NOS;N0;3b91a0f4-8270-5345-82f8-d929902bc6ea;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22097;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;0e97b154-09b7-50b7-af0e-fd606b73f48d;23;NA;126.027.397.260.274;NA;Not Reported;NA;white;8e61721d-e800-50b4-a67f-84f9d515ab86;male;60;not hispanic or latino;Dead;-22097;NA;1951;562;NA;yes;NA;e45e69e4-2ce4-54be-a744-f528f0bf0dd9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ae15f1c9-00f7-5989-b783-05dbc1fc9f3e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-7222;LUSC
TCGA-77-7141;C34.1;not reported;M0;T2;stage ib;2003;No;15;Squamous cell carcinoma, NOS;N0;9d69e4a7-1e85-50ce-93e6-3b510e224820;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23584;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;35;NA;271555e7-6bdd-5b95-a13b-df80ce1da409;70;NA;383.561.643.835.616;NA;Not Reported;NA;white;4b724830-e7e1-5966-864c-7cd0cb9a0057;male;64;not reported;Alive;-23584;NA;1939;NA;NA;no;NA;69271f5c-80d1-53d8-88f8-99d0f8e9b9a8;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e5456d05-bdf0-52fd-bded-89786ec385a4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-7141;LUSC
TCGA-39-5022;C34.1;not reported;M0;T2a;stage ib;2005;No;NA;Squamous cell carcinoma, NOS;N0;bd6c081c-2d74-530f-888c-57d18c16dfad;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27856;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:11.623943-05:00;9;NA;9a7f0b24-0653-5d88-a105-560a95fe837e;35;NA;191.780.821.917.808;NA;Not Reported;NA;white;716f5ea4-8284-54c1-9475-07e9d0b1c848;male;76;not hispanic or latino;Dead;-27856;2009;1929;1679;NA;no;NA;f45d4cd5-21e3-5090-bcb1-6abb23d10e60;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6adfd57b-964b-5a75-bd37-568185f53f02;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5022;LUSC
TCGA-90-A4ED;C34.1;not reported;MX;T2a;stage ib;2012;No;615;Squamous cell carcinoma, NOS;N0;740ffc52-7435-525a-a2ea-38911ce811b8;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25453;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:16.559953-05:00;20;NA;1a71dad8-c5e6-5706-bd60-ad5e7a5770a4;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;8a6ffd75-9ace-51a1-bddc-9a93cfc38d06;male;69;not hispanic or latino;Alive;-25453;NA;1943;NA;NA;no;NA;c2930f69-4fce-5076-826a-059ef39266b1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;59ac9946-3fdf-5e4d-b391-935c041e20fd;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-90-A4ED;LUSC
TCGA-66-2755;C34.1;not reported;M0;T2;stage ib;2007;No;28;Squamous cell carcinoma, NOS;N0;24fe2eee-cec7-580c-8b1f-481668a2e7c3;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23348;not reported;NA;8070/3;no;NA;5th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;20;NA;036c8fec-dd06-505e-a2d7-2e7f8fe24edf;20;NA;10.958.904.109.589;NA;Not Reported;NA;not reported;aa8db254-31e2-59fd-ab4f-3d38140759b1;male;63;not reported;Alive;-23348;NA;1944;NA;NA;not reported;NA;81a0261e-36c6-510f-9a94-a357ce2c0280;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;08a04f71-f561-5a32-a577-234c25b99a4e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2755;LUSC
TCGA-22-5477;C34.3;not reported;M0;T1;stage ia;2004;No;1346;Squamous cell carcinoma, NOS;N0;0b7d8b6b-d111-5d35-a5e3-b24aefb99b51;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24055;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;95c92ebd-dc7e-5d8e-a9e6-8e3afc222e72;100;NA;547.945.205.479.452;NA;Not Reported;NA;white;5ef059c3-25ad-5baa-a634-c87466661922;male;65;not reported;Dead;-24055;2007;1939;1346;NA;no;NA;d031f34c-5b92-579c-858b-c81b12c28994;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;31f01beb-853d-5bee-893f-1d89beec2ff4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5477;LUSC
TCGA-33-4583;C34.3;not reported;M0;T1;stage ia;1999;No;4299;Squamous cell carcinoma, NOS;N0;fb019506-35ac-527a-b9cc-2752362b1551;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26799;not reported;NA;8070/3;no;NA;5th;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;46;NA;25bb6f92-aa0c-5425-bf64-a86255d73a92;46;NA;252.054.794.520.548;NA;Not Reported;NA;white;a4c9f593-d227-518f-835a-5ddc5214ca43;male;73;not hispanic or latino;Dead;-26799;NA;1926;4601;NA;no;NA;63abb964-734a-54fe-9e52-72bc07d24132;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;270a57ea-f387-5aaa-9621-4ed1becb5890;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-4583;LUSC
TCGA-66-2754;C34.1;not reported;M0;T2;stage iiia;2007;No;61;Squamous cell carcinoma, NOS;N2;92fcffa5-1c37-5daa-9d61-191a8cbc4d6d;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24471;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:13:13.079700-05:00;40;NA;7d1a5c74-1c2d-5a92-943c-c8308bca1d08;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;f00f2e89-2d64-5105-b8b3-a3c2d5da7e76;male;67;not reported;Alive;-24471;NA;1940;NA;NA;not reported;NA;f3088a15-a700-50c3-ab7f-e5e18d085a45;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;f42970a0-71fa-5651-9676-855e36b545f0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2754;LUSC
TCGA-66-2793;C34.2;not reported;M0;T4;stage iiib;2008;No;NA;Squamous cell carcinoma, NOS;N1;b9a70e70-97ad-5e9e-91ad-303aececed93;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;25111;not reported;NA;8070/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:35.084062-05:00;56;NA;df43381d-9bac-5b7c-aeb4-1f0ccd1c66c7;112;NA;613.698.630.136.986;NA;Not Reported;NA;not reported;ae76f16b-a92d-51e5-80f6-fa9228d8142b;male;68;not reported;Dead;-25111;2008;1940;306;NA;not reported;NA;efb8a042-0624-594f-aa8b-01167ca9521e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;83c218ea-6687-54d8-9067-ae9bc0aac871;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2793;LUSC
TCGA-85-8276;C34.1;not reported;M0;T1b;stage iia;2011;No;1050;Squamous cell carcinoma, NOS;N1;5ce27f6c-b44a-5037-abe7-e33700b88567;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22707;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;0c192de9-e5a8-5f86-89a5-b7b353ff2c12;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;4c8cae09-5814-5488-8875-dbabf3cc33ed;male;62;not hispanic or latino;Alive;-22707;NA;1949;NA;NA;yes;NA;958ed2f6-5cf4-530f-aed7-d5ca67a83242;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7e536c19-b26d-5c98-a62d-08806b482309;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8276;LUSC
TCGA-94-8035;C34.1;not reported;MX;T3;stage iib;2011;No;122;Squamous cell carcinoma, NOS;N0;6a12d1e9-17b0-58e6-9591-4bce2b611b84;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23399;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;8f51e9fc-9150-514a-9433-6bb89c9519ca;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;5012c747-6192-5e56-bd5e-26c0232424a6;male;64;not hispanic or latino;Alive;-23399;NA;1947;NA;NA;yes;NA;8b682c29-6ae2-5b3f-a24a-fe9512bb759c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e4d40663-1762-5ad9-b432-66baa452c8bf;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-94-8035;LUSC
TCGA-85-A4QR;C34.1;not reported;M0;T2a;stage ib;2012;No;600;Squamous cell carcinoma, NOS;N0;82056187-61de-58e1-b850-b7b15883085e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24756;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:16.559953-05:00;50;NA;f506f812-3ed2-5a67-b95e-641129bb69bb;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;9e75ca22-e479-5e2c-bb06-c1d47f4f54f6;male;67;not hispanic or latino;Alive;-24756;NA;1945;NA;NA;no;NA;726d02b7-01ba-58ab-8efd-2fbbb8eadc80;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;572bac96-86c4-59a9-b5e4-5cfa04d51df6;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A4QR;LUSC
TCGA-92-7340;C34.1;not reported;MX;T2a;stage iia;2011;No;82;Squamous cell carcinoma, NOS;N1;a69abbc3-0df1-5e03-a5ad-41667c43f3ee;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;16447;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:16.559953-05:00;15;NA;ea7855a5-dfcc-5182-9633-c7149acc5598;15;NA;0.821917808219178;NA;Not Reported;NA;white;7694d341-9786-5c07-8f12-6b63e0719e66;female;45;not hispanic or latino;Alive;-16447;NA;1966;NA;NA;yes;NA;0f62816e-d725-5701-93be-a4553a03e311;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;b6719e84-43c0-5c17-be44-bad8053cdfbf;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-92-7340;LUSC
TCGA-79-5596;C34.1;not reported;M0;T3;stage iiia;2006;No;NA;Squamous cell carcinoma, NOS;N1;00d4a2c7-fab2-52a0-91fe-ca6922d66a73;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;NA;NA;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;74d481e0-a1c8-58be-9b9e-2683f238bde4;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;91214489-a081-5bfb-8bbc-12a0e63703e7;male;NA;not reported;Alive;NA;NA;NA;NA;NA;no;NA;1aa7dde9-a76a-5f97-8c92-21ef352c9f34;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;63754292-7718-5607-bdfd-ef7af55818b5;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-79-5596;LUSC
TCGA-60-2704;C34.1;not reported;M0;T2;stage iib;2003;No;NA;Squamous cell carcinoma, NOS;N1;5f4c9dea-a5a4-5f1d-9a1d-24781f174487;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26927;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;da2f3a2e-9788-5cc1-95b4-1aa5a0647147;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;651f6019-7ed4-5912-93c9-3e47f4ff926b;male;73;not hispanic or latino;Dead;-26927;2006;1930;1154;NA;no;NA;f83a3b13-431f-51e2-8136-ee4e346f1856;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;808fd928-5e15-5f5a-9a8f-f6d76a7dfd1e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2704;LUSC
TCGA-92-7341;C34.1;not reported;MX;T2a;stage ib;2011;No;106;Squamous cell carcinoma, NOS;N0;5cec68e5-bc2b-50ed-8bbc-fe379fc50956;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26134;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;081aa985-3a86-5e7c-857d-b72a7246bf96;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;762bf406-d205-5d6b-a18f-2e2ac65590e5;male;71;not hispanic or latino;Alive;-26134;NA;1940;NA;NA;no;NA;65727df0-3c1b-5b37-956d-a5ca1e56beac;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;2044f967-dae5-5609-abf2-8b987cf0c7b4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-92-7341;LUSC
TCGA-56-A62T;C34.1;not reported;MX;T2b;stage iia;2013;No;440;Squamous cell carcinoma, NOS;N0;b2d7db87-9435-510c-a82a-a496cfce5cf9;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28522;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;7642cc4f-cd81-59b1-bd3f-cdc5b71b5222;102;NA;558.904.109.589.041;NA;Not Reported;NA;black or african american;b2b9e6dc-54fb-5d06-b72d-f01a952832ed;male;78;not hispanic or latino;Alive;-28522;NA;1935;NA;NA;yes;NA;b3b8c102-1306-52cf-9d14-a17182cb7d57;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;b4290453-fc18-5cff-bfe3-bfb98a6ddaac;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-A62T;LUSC
TCGA-O2-A5IB;C34.2;not reported;MX;T3;stage iii;2005;No;NA;Squamous cell carcinoma, NOS;N1;f2b7c323-6893-5860-b9aa-e17d653c5711;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;26211;not reported;NA;8070/3;no;NA;6th;Stage III;not reported;2019-08-08T17:14:58.925606-05:00;50;NA;cd649baa-1ffe-523f-8aeb-113dbce5f73c;2.5;NA;0.136986301369863;NA;Not Reported;NA;white;d8ac64c5-dbb8-5398-a2c5-31a5ebe80f75;female;71;not hispanic or latino;Dead;-26211;2005;1934;340;NA;no;NA;1a2d4118-710b-5632-9c70-6e6a0a10a093;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7455a0dd-2efe-5800-94bd-a8d18612f6cf;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-O2-A5IB;LUSC
TCGA-33-4582;C34.3;not reported;M0;T1;stage ia;2000;No;NA;Squamous cell carcinoma, NOS;N0;ca2db36c-ef86-568b-ab91-e567ae56edf3;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;20402;not reported;NA;8070/3;no;NA;5th;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;5ade741c-eedd-5aea-a4dc-c029a1f5296f;86;NA;471.232.876.712.329;NA;Not Reported;NA;white;eba44940-5da5-5551-b656-4daf141ff24f;male;55;not hispanic or latino;Dead;-20402;2008;1945;3149;NA;yes;NA;78c8b33b-6f72-5715-82aa-71fa488cde91;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;6ec26d42-0393-568c-93f6-20dd07b660cd;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-4582;LUSC
TCGA-63-A5MU;C34.3;not reported;M0;T2b;stage iib;NA;No;NA;Squamous cell carcinoma, NOS;N1;85d902a4-9d99-5d63-bdb1-52d3cbf7446b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;NA;17801;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:13:13.079700-05:00;30;NA;dd9b8213-eb42-5daf-a0ef-94914183dae5;15;NA;0.821917808219178;NA;Not Reported;NA;not reported;cbf747e8-106e-5878-97d2-c3ea90babe7a;male;48;not reported;Dead;-17801;NA;NA;NA;NA;yes;NA;48cd68cf-7e6f-50ad-bc63-731a5605062d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3f37f53b-e9a2-561c-95f4-3fcec02ce365;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MU;LUSC
TCGA-33-4589;C34.9;not reported;M0;T2;stage iib;1992;Not Reported;NA;Squamous cell carcinoma, NOS;N1;b0bfa7bc-d4be-559b-8603-4acfe590f11f;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;22754;not reported;NA;8070/3;yes;NA;3rd;Stage IIB;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;df637d64-3d01-5b8f-bc24-961b678f92ef;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;09a524f1-d8fb-5384-a781-34483e9775ef;female;62;hispanic or latino;Dead;-22754;1992;1930;47;NA;no;NA;88b0216f-72c2-5446-8b02-fb38bb304e14;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6158c38c-f408-5dcd-a651-23636cf49ad5;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-4589;LUSC
TCGA-18-3419;C34.3;not reported;M0;T2;stage iib;2007;No;2811;Squamous cell carcinoma, NOS;N1;3c1f21a5-75f0-505f-9227-a59d37337a6c;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26813;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;b4601607-29fc-5c20-9822-d2c712cba0f5;50;NA;273.972.602.739.726;NA;Not Reported;NA;not reported;d86f9d5b-c6a0-56f5-b11c-062aa7323940;male;73;not reported;Alive;-26813;NA;1934;NA;NA;not reported;NA;b12617a7-17f5-5717-97d1-887d710d02b0;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;9668a1f8-c3f2-5163-b35b-d461cc2b9b20;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3419;LUSC
TCGA-43-A475;C34.1;not reported;M0;T3;stage iib;2012;No;296;Squamous cell carcinoma, NOS;N0;fb78f232-869a-59eb-a0aa-73c2294c2774;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24680;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:12:31.795062-05:00;50;NA;a51a482d-6eea-5095-9bc9-7117f15a90bd;100;NA;547.945.205.479.452;NA;Not Reported;NA;white;65a4511c-47d2-5ccf-93f7-8ce13c7048ba;female;67;not hispanic or latino;Alive;-24680;NA;1945;NA;NA;yes;NA;176ffc13-d6da-5da8-bc0e-62d0711d5183;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;9b728647-c64c-5142-86ea-398750dc7de3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-A475;LUSC
TCGA-34-8454;C34.3;not reported;M0;T3;stage iiia;2011;No;1180;Squamous cell carcinoma, NOS;N1;6ee50167-dc61-5655-b01e-c0e62b6cee37;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22913;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;c5f0765f-8380-5973-bedf-197880c91df1;90;NA;493.150.684.931.507;NA;Not Reported;NA;white;2f29af16-407a-5d45-8168-b9f51b414ed1;female;62;not hispanic or latino;Alive;-22913;NA;1949;NA;NA;yes;NA;feb575c9-428b-54e7-8b3a-0bcdf4a36b74;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;8f1ac2c6-ea07-51c1-a37c-09b28ad39b74;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-8454;LUSC
TCGA-39-5027;C34.3;not reported;M0;T2a;stage ib;2006;No;3108;Squamous cell carcinoma, NOS;N0;b23e095d-2bc4-58ef-9a3f-af21545170d0;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26714;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:11.623943-05:00;56;NA;6d45d346-1a41-58c3-beb1-8bab60223f8b;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;4010b2b3-cc53-5aee-8f56-df616773a65a;male;73;not hispanic or latino;Alive;-26714;NA;1933;NA;NA;no;NA;1ac8101b-05fc-542f-a59e-52437a54b7ed;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e42d77f4-a36a-5b86-899e-eb7e8f6b9402;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5027;LUSC
TCGA-56-8624;C34.3;not reported;MX;T3;stage iib;2012;No;420;Squamous cell carcinoma, NOS;N0;bd0b370b-e880-5edb-a1d5-0e097b8fd1cd;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;30798;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;db30bc0a-20a6-5853-bf66-86279b133d35;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;4a5d6c1a-29b0-5016-baca-e7a856972a2a;male;84;not hispanic or latino;Alive;-30798;NA;1928;NA;NA;yes;NA;a86ef0ef-bb11-55c8-b30e-c5d718f1b65a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;074202de-bafe-5c0c-8cbb-f92fa1fede42;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8624;LUSC
TCGA-90-7769;C34.9;not reported;MX;T2b;stage iib;2011;No;358;Squamous cell carcinoma, NOS;N1;ca3d21c6-3dc8-55b5-9bf6-43649613234e;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;20276;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;24;NA;960985fb-e342-5e1f-b2b4-fc351f9b4aac;36;NA;197.260.273.972.603;NA;Not Reported;NA;white;80afdf20-782a-5253-b554-1802d1772003;male;55;not hispanic or latino;Alive;-20276;NA;1956;NA;NA;no;NA;07fcbc92-469c-538e-adbc-8f1814ffc1ff;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;91dbf68a-0484-5d7e-a57a-01575ee38851;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-90-7769;LUSC
TCGA-56-A5DS;C34.3;not reported;MX;T2a;stage ib;2012;No;8;Squamous cell carcinoma, NOS;N0;b0827ced-0dcb-591a-8224-082b329d3b82;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26355;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;ad0fb3bd-6a3e-5ba7-9501-5ae36b00998d;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;3a9a3601-fc16-515b-9728-50d6c1e90e91;female;72;not hispanic or latino;Alive;-26355;NA;1940;NA;NA;not reported;NA;94080640-51c7-520f-b995-221d2a6d4230;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;31668d71-4bf8-5f12-b844-ff4fb19ccc75;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-A5DS;LUSC
TCGA-98-A53D;C34.1;not reported;M0;T3;stage iib;2012;No;22;Squamous cell carcinoma, keratinizing, NOS;N0;f0ccd5d0-4684-5281-90d6-a5b7d9db3e74;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24891;not reported;NA;8071/3;yes;NA;7th;Stage IIB;not reported;2019-08-08T17:14:36.542202-05:00;30;NA;52f5f2c8-17c6-5e11-922a-7998110daf2b;90;NA;493.150.684.931.507;NA;Not Reported;NA;white;1d93da95-abb5-5af4-989f-f9496aaf6c51;male;68;not hispanic or latino;Dead;-24891;NA;1944;645;NA;yes;NA;7462e168-6714-5974-8007-f443787bc8d1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;cd61d238-8a5a-59b0-8ef1-3b995c793d4b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-A53D;LUSC
TCGA-98-8022;C34.1;not reported;M0;T1a;stage ia;2011;No;224;Squamous cell carcinoma, NOS;N0;7a8a34ac-c5e0-5323-b8a9-cad4df417ec0;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22487;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:36.542202-05:00;47;NA;85fa6768-8b77-5fdc-a79a-d6aa8374ab93;117;NA;641.095.890.410.959;NA;Not Reported;NA;white;ae32856b-d027-5895-ae7a-5e445ea72a0e;male;61;not hispanic or latino;Dead;-22487;NA;1950;933;NA;no;NA;311c2390-9969-525c-be26-b64f1b87b0e4;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e1b0ff9c-2a7e-5ae6-81e2-c2ae2665188e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-8022;LUSC
TCGA-33-6738;C34.1;not reported;MX;T1;stage iiia;2009;No;1927;Squamous cell carcinoma, NOS;N2;76efbda1-a002-51f1-8911-da14f5634c29;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;29368;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;82fa8e56-55a4-50a6-8b9a-b028da451662;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;5c3727e6-fc31-5d6b-bcf3-c88fa5c6f9ff;male;80;not reported;Alive;-29368;NA;1929;NA;NA;yes;NA;853a5968-2f92-51f6-989e-27450f36133a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;f94a6234-cb61-538b-958e-2c3b0b821831;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-6738;LUSC
TCGA-66-2737;C34.2;not reported;M0;T2;stage iib;2005;No;61;Squamous cell carcinoma, NOS;N1;9f03c7fd-4458-5ec3-ac79-06572754e95c;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;26390;not reported;NA;8070/3;no;NA;5th;Stage IIB;not reported;2019-08-08T17:13:13.079700-05:00;20;NA;3b44ba99-b9c9-55ca-b5b6-7d8ad0573448;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;9e0e16e0-8536-59b9-9d59-b229cdd499a5;male;72;not reported;Alive;-26390;NA;1933;NA;NA;not reported;NA;c61f27ec-f40b-5030-bd04-e855bb05fc0a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;70482025-f28b-509c-ad59-a7311c8b2628;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2737;LUSC
TCGA-60-2698;C34.3;not reported;M0;T2;stage iib;1993;No;NA;Squamous cell carcinoma, NOS;N1;26947900-07ba-57f3-9a3c-07544f33bfc9;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22800;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;88ae527c-73e2-5a2f-a217-97de52501952;NA;NA;NA;NA;Not Reported;NA;white;d8d7cd2b-ed74-5e76-badc-643645f21bdb;male;62;not reported;Dead;-22800;1993;1931;311;NA;no;NA;0ba17e3e-8054-5f43-b76d-fce471b00cfe;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;fea85a84-8295-5ada-aa58-93eadbf65fb8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2698;LUSC
TCGA-77-8144;C34.1;not reported;M0;T2;stage ib;2004;No;833;Squamous cell carcinoma, NOS;N0;2e5c59c2-5811-51fa-b3e3-a8a7a2179124;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25796;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;9d1b809a-5e2d-5918-81e6-e5448d6d9f8b;59;NA;323.287.671.232.877;NA;Not Reported;NA;not reported;1856e0ce-3fac-58fb-a4f5-bbb48ed9a519;male;70;not reported;Alive;-25796;NA;1934;NA;NA;no;NA;090af034-4b63-5f0f-a150-34e227581e2e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;16cc8f63-5158-547c-a96e-9d8ebbb9e27c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8144;LUSC
TCGA-33-4586;C34.3;not reported;M0;T2;stage iiia;2007;No;NA;Squamous cell carcinoma, NOS;N2;f8517976-6274-50b2-920c-d1816b00f426;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;21148;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:11:47.463501-05:00;43;NA;01a0ae64-9e50-5e32-9b7a-0feeb60de198;108;NA;591.780.821.917.808;NA;Not Reported;NA;white;ef28fef0-e552-570a-b3d5-aa6268485774;male;57;not hispanic or latino;Dead;-21148;2008;1950;428;NA;yes;NA;e454dd90-3ef0-5330-99d7-f8d311f9e4c7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;e987b75b-8577-52d6-8783-a22f3b86b7a8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-4586;LUSC
TCGA-43-2576;C34.1;not reported;M0;T2;stage iiia;2009;No;1223;Squamous cell carcinoma, NOS;N2;71bb9618-525f-5637-a87f-e3b91903d0da;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22805;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:12:11.623943-05:00;35;NA;944b637b-35c8-58da-a47f-d1dd67f9ee6a;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;e8a6a4bd-ddce-5256-8097-bffa9871ad7e;female;62;not hispanic or latino;Alive;-22805;NA;1947;NA;NA;yes;NA;ad12794a-02e4-5bcb-b92e-6dfa714270d9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;bd6abe7c-bbfb-58de-9c79-60fdf3c9d872;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-2576;LUSC
TCGA-18-3415;C34.1;not reported;M0;T2;stage ib;2006;No;1810;Squamous cell carcinoma, NOS;N0;9ebad043-3cf5-5e0e-96de-01786c82886f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28430;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;b48710cb-14ec-575c-ae1b-800cabfb2ab9;30;NA;164.383.561.643.836;NA;Not Reported;NA;not reported;8126d1cd-ac3f-5537-a363-2de892fbe5a6;male;77;not reported;Dead;-28430;NA;1929;2803;NA;yes;NA;0e9f25b2-b49c-5d06-9713-898a349ca897;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c20bbf6b-5b9a-5b88-b3ac-ee1e99eda1d4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3415;LUSC
TCGA-94-7943;C34.3;not reported;MX;T1b;stage ia;2011;Not Reported;559;Squamous cell carcinoma, NOS;NX;2c6bc0ea-a496-5f5a-a9c5-94f42394bff2;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;29282;not reported;NA;8070/3;yes;NA;7th;Stage IA;not reported;2019-08-08T17:14:16.559953-05:00;30;NA;bfaf730a-5194-56ce-928c-35052f87f1da;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;f4c171d2-f15e-55d2-993c-344f838f0858;male;80;not hispanic or latino;Alive;-29282;NA;1931;NA;NA;no;NA;4b671cdf-e119-5b8d-aa24-8f9c70ac0478;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;1bd7b931-a09b-5786-9538-3035eeb7a9ec;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-94-7943;LUSC
TCGA-33-4587;C34.2;not reported;MX;T2;stage ib;2003;No;NA;Squamous cell carcinoma, small cell, nonkeratinizing;N0;94d3669c-4b6c-5362-803f-e596586fa073;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;23062;not reported;NA;8073/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;33;NA;9d652685-551a-58df-ab28-9e6c799af929;NA;NA;NA;NA;Not Reported;NA;white;8417e6f3-f906-55f3-b355-401eb44ca8b6;female;63;not hispanic or latino;Dead;-23062;2007;1940;1656;NA;yes;NA;f663b2b8-f98f-5e0f-b452-c391f45ff0d4;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3e3b71d1-a8ae-532f-a63b-ad22a811ebb8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-4587;LUSC
TCGA-77-8136;C34.3;not reported;M0;T2;stage iib;2002;No;NA;Squamous cell carcinoma, NOS;N1;cd95997b-40fc-5e62-bd41-996bef00c93c;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27193;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;9742d41b-d753-5d4f-80a9-b975e4024065;135;NA;73.972.602.739.726;NA;Not Reported;NA;not reported;414b6217-903b-54b5-a854-b03bd9c71fc2;female;74;not reported;Dead;-27193;2005;1928;1189;NA;no;NA;6f297745-2abb-56a9-9e91-38061afe7543;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;30e6227a-fe54-5db5-b88c-2df18e54e711;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8136;LUSC
TCGA-L3-A524;C34.1;not reported;M0;T3;stage iib;2011;No;449;Squamous cell carcinoma, NOS;N0;1fd4cbed-5c90-5973-9734-2153b5e0ace6;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;16765;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;77f6dd33-2fba-5fd7-80bb-10fe46ade0c7;25.6;NA;14.027.397.260.274;NA;Not Reported;NA;white;64ec4215-fa6f-57b4-8eb6-514b9db1ebbb;female;45;not hispanic or latino;Dead;-16765;NA;1966;490;NA;yes;NA;a093debc-06a9-5d18-b0d8-ae57e504eee6;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;43670e95-f464-50a4-b6e4-a671d73300ee;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-L3-A524;LUSC
TCGA-34-5234;C34.1;not reported;M0;T1;stage ia;2007;No;2271;Squamous cell carcinoma, NOS;N0;2dce1683-ad7d-5b9a-a734-28c8c383eae0;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26072;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:12:11.623943-05:00;40;NA;6ebe9bfa-e281-5abd-a962-a9065c17fc70;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;0f38f0aa-1bde-5835-8261-4eaaab3aa61c;female;71;not hispanic or latino;Alive;-26072;NA;1936;NA;NA;no;NA;c8464aa2-3d39-57c6-9fea-867e96ff2aa1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3501a1f5-2861-571a-b86e-81502304516a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-5234;LUSC
TCGA-77-7338;C34.1;not reported;M0;T2;stage ib;1995;No;NA;Squamous cell carcinoma, NOS;N0;112ad8e5-8855-5619-b28a-435ab6914f63;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23480;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;NA;NA;dc30bd9f-5025-5df1-87e1-6b0bc60d2d4f;41.25;NA;226.027.397.260.274;NA;Not Reported;NA;white;9d22cc81-376c-59c2-95ca-d3db34e95b49;male;64;not reported;Dead;-23480;1995;1931;5;NA;no;NA;d70b1258-6f15-581b-bea5-a12d41c1eb0c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;47e39043-d253-5064-8ac6-037599b289e7;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-7338;LUSC
TCGA-56-A4BW;C34.1;not reported;M0;T2a;stage iia;2012;No;585;Squamous cell carcinoma, NOS;N1;bd3a33be-f038-593b-b449-57430202d557;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20301;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:53.407315-05:00;30;NA;190395ac-51a3-540b-9831-b16ca5c6212b;120;NA;657.534.246.575.342;NA;Not Reported;NA;white;b80e8078-0b89-5c2f-af76-b584ca908afb;male;55;not hispanic or latino;Alive;-20301;NA;1957;NA;NA;yes;NA;c9cbaa33-c102-512a-9fe2-412fd14d5326;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;11aea894-e623-503d-ad4c-189472e3cece;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-A4BW;LUSC
TCGA-22-4591;C34.3;not reported;M0;T3;stage iiia;2001;No;623;Squamous cell carcinoma, NOS;N2;62677635-3e19-57e0-ace8-f1d456754edc;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;29250;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;dc47d720-e99a-5edb-bcec-5d95305ccdef;NA;NA;NA;NA;Not Reported;NA;white;73485643-3c73-5d58-ba03-5537c3a8854d;male;80;not reported;Dead;-29250;2002;1921;623;NA;no;NA;fa08b622-3467-5339-964d-47b631bd7899;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;558be8ef-d0a5-5758-b6f0-388db8e38573;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-4591;LUSC
TCGA-33-AAS8;C34.1;not reported;MX;T1;stage ia;1998;No;NA;Squamous cell carcinoma, NOS;N0;6dcbd705-5d17-508c-8adb-355983c1bc08;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21675;not reported;NA;8070/3;no;NA;5th;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;20;NA;4db1cd7b-a1d4-559c-899f-b3b1eb5fb97d;60;NA;328.767.123.287.671;NA;Not Reported;NA;black or african american;53c71f8d-fabd-5298-b85d-6b83b7863858;female;59;not hispanic or latino;Dead;-21675;2001;1939;1114;NA;yes;NA;b9d67cb4-7dfe-529d-b85f-e0343160d76e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ed0ed6ad-50e4-5424-a33c-16deef1a2f65;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-AAS8;LUSC
TCGA-22-5481;C34.3;not reported;M0;T2;stage iib;2002;No;NA;Squamous cell carcinoma, NOS;N1;6c3addc9-ce7d-5b96-9fb5-ed6335dd102b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26419;not reported;NA;8070/3;no;NA;5th;Stage IIB;not reported;2019-08-08T17:11:47.463501-05:00;50;NA;079c997b-9c8b-59a1-bc0e-4dbc4b2c2732;75;NA;410.958.904.109.589;NA;Not Reported;NA;white;4f227eee-27fc-59d6-81f8-3b38fab0dca0;female;72;not reported;Dead;-26419;2008;1930;2409;NA;no;NA;f997314c-16c5-5ef0-b51c-5e0aae9f139c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;470f8bc3-3673-59c6-8d44-f1975faf715d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5481;LUSC
TCGA-39-5035;C34.3;not reported;M0;T1b;stage ia;2007;No;2080;Squamous cell carcinoma, NOS;N0;cc7eeea0-4568-591f-a5a3-7c40b6420d3c;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26383;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:12:11.623943-05:00;47;NA;975b8a3b-1052-51a7-9123-97301b4cba8b;47;NA;257.534.246.575.342;NA;Not Reported;NA;white;47755018-aac9-5ae5-ba56-ad4ff6367e07;female;72;not hispanic or latino;Alive;-26383;NA;1935;NA;NA;no;NA;8276c002-d06e-5ee9-853b-fb83bb9c35c3;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;be8acbdb-95e2-50b7-b37f-1c3f4d57eee2;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5035;LUSC
TCGA-22-5492;C34.1;not reported;M0;T2a;stage iiia;2003;No;506;Squamous cell carcinoma, NOS;N2;8a3e3e16-90a2-51e6-864b-986f06f479d3;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26838;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:11:47.463501-05:00;50;NA;d95f44ed-b940-5d16-a9d6-8a726041cd10;50;NA;273.972.602.739.726;NA;Not Reported;NA;not reported;cbba5e5b-a616-5263-b681-ad24c7f1ba9b;female;73;not reported;Dead;-26838;2004;1930;506;NA;no;NA;25eded38-0205-5a88-8a20-2b6cd2b60fa9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;4a730c6a-9f06-5ca0-9ad3-ee0d717e8913;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5492;LUSC
TCGA-85-A4PA;C34.3;not reported;M0;T2a;stage ib;2012;No;741;Squamous cell carcinoma, large cell, nonkeratinizing, NOS;N0;b1d0bc06-91d1-50a6-925c-3532aafdbf91;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22614;not reported;NA;8072/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:16.559953-05:00;40;NA;7003dc65-748e-5bb9-99b7-2f8da2d36210;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;e4dfab48-c01f-5179-bb9a-6bed3bd38f5a;male;61;not hispanic or latino;Alive;-22614;NA;1951;NA;NA;no;NA;e4d4dcb3-188d-597d-a2f8-088acda86505;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e1c3c7f2-47dc-5c1a-b9d9-afae7ddd8ca9;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A4PA;LUSC
TCGA-LA-A446;C34.3;not reported;MX;T1b;stage ia;2012;No;401;Squamous cell carcinoma, NOS;N0;24e70149-0e0f-562f-a7f0-cb825888afef;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25199;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;bc5c879a-37a3-5536-8e72-212b39a4149b;26;NA;142.465.753.424.658;NA;Not Reported;NA;white;24d81e40-43a2-5776-a1df-1cd5e6f696f2;male;68;not hispanic or latino;Alive;-25199;NA;1944;NA;NA;no;NA;fe97be99-8d00-591d-bba2-b6945c5408d0;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;653ea15c-12ce-5ae5-adb1-8de486e6fd5a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-LA-A446;LUSC
TCGA-63-A5MH;C34.3;not reported;M0;T1;stage ia;NA;Yes;2026;Squamous cell carcinoma, NOS;N0;f66b0b16-86d3-5d48-8b86-6d0e10daba54;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;NA;25159;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;972af369-7e5b-5f0c-a09b-e51d9bdaa4b2;35;NA;191.780.821.917.808;NA;Not Reported;NA;not reported;cc83c9b8-d6fc-5770-8ce5-6168aa5e137f;male;68;not reported;Alive;-25159;NA;NA;NA;NA;no;NA;a4daecb6-6970-51e8-a24f-3d613b274595;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;f9c7302a-8fd8-5b0a-99b9-246067ce81b4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MH;LUSC
TCGA-18-4721;C34.3;not reported;M0;T1;stage ia;2002;No;4694;Squamous cell carcinoma, NOS;N0;15f765c2-8ae3-581d-9ff9-17cf964e5fbc;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27076;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;451beaa6-021c-581b-b813-9844b809bc82;NA;NA;NA;NA;Not Reported;NA;white;fecf2a08-e46b-5af9-915b-b97e3b3d8dd9;male;74;not hispanic or latino;Alive;-27076;NA;1928;NA;NA;no;NA;384b786b-7b4d-56c8-a3c2-6d8bea3ee3ee;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6104078b-b80e-5c60-b036-1e8f0e8c277a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-4721;LUSC
TCGA-43-8115;C34.3;not reported;MX;T2a;stage iia;2011;No;407;Squamous cell carcinoma, NOS;N1;fd19e47b-cbaa-5a26-aef7-0ba6758500b0;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26406;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:31.795062-05:00;56;NA;7997388a-4c30-5a8f-8bdd-61c287b13b4d;55.83;NA;305.917.808.219.178;NA;Not Reported;NA;white;fda05807-a571-53c8-a66e-003032aeac97;female;72;not hispanic or latino;Alive;-26406;NA;1939;NA;NA;yes;NA;cd0131f6-4aef-56b7-a11b-1c72b07578c8;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;255f8276-d709-52d1-aa3c-227538ad6b80;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-8115;LUSC
TCGA-66-2778;C34.3;not reported;M0;T2;stage iiib;2007;No;578;Squamous cell carcinoma, NOS;N3;ff662d1d-b04e-5950-9268-4661916c025a;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25080;not reported;NA;8070/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:35.084062-05:00;37;NA;860cfd55-b79a-523f-a3bf-fc6738ae00a3;37;NA;202.739.726.027.397;NA;Not Reported;NA;not reported;3a636fe9-79b4-5aba-a0c0-73c30260788d;female;68;not reported;Alive;-25080;NA;1939;NA;NA;yes;NA;879fcb37-53b3-537b-bef0-a7712a9f0185;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;5f5b0a86-7387-5818-bc97-23ac83d6610c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2778;LUSC
TCGA-63-A5M9;C34.3;not reported;M0;T2;stage iib;NA;Not Reported;0;Squamous cell carcinoma, NOS;N1;59550f42-de50-5dff-9fcc-5a28228800e4;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;NA;NA;not reported;NA;8070/3;not reported;NA;6th;Stage IIB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;0c09797e-d1f6-5ad0-90a1-cacf9f164ba1;25;NA;136.986.301.369.863;NA;Not Reported;NA;not reported;d71afd00-a98f-59a7-a42c-c98ced97b640;female;NA;not reported;Alive;NA;NA;NA;NA;NA;not reported;NA;1db58078-f51f-5b31-a8ff-64e7ce1c9898;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;1d792539-f196-5b37-b54c-6399ee98e839;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5M9;LUSC
TCGA-NK-A7XE;C34.1;not reported;M0;T4;stage iiib;2013;No;13;Squamous cell carcinoma, NOS;N2;3f3c031b-8c6c-5a3a-b357-64e6d7f6875d;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24319;not reported;NA;8070/3;yes;NA;7th;Stage IIIB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;a21844a9-fd41-5ff0-b94c-da0cb3b4a9c2;80;NA;438.356.164.383.562;NA;Not Reported;NA;black or african american;99668e49-42e7-5aec-95d9-3a7b42e20041;male;66;not hispanic or latino;Alive;-24319;NA;1947;NA;NA;no;NA;eea60719-a32d-5c62-b6f4-d01e0199155b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;b419df8f-c856-5c96-bb89-cfa9a919655d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NK-A7XE;LUSC
TCGA-66-2771;C34.1;not reported;M0;T2;stage iib;2007;No;578;Squamous cell carcinoma, NOS;N1;614054dc-e662-5c94-9797-6ed29a9642f0;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22219;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:35.084062-05:00;35;NA;1537f690-5913-5092-b7e4-b64c4ac361f4;70;NA;383.561.643.835.616;NA;Not Reported;NA;not reported;671fdcf5-4177-55f2-8ab0-3e0df76375fd;male;60;not reported;Alive;-22219;NA;1947;NA;NA;yes;NA;92a40c23-72b5-5199-a580-726e1611157a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;95a6a66d-54d6-5266-8409-54d00cc88650;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2771;LUSC
TCGA-77-7465;C34.1;not reported;M0;T2a;stage iia;2010;No;990;Squamous cell carcinoma, NOS;N1;fa355f31-7182-58a3-b846-dbad904837b0;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21548;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:13:35.084062-05:00;NA;NA;b41c2db6-3f1f-540e-9e9f-1308b3344155;120;NA;657.534.246.575.342;NA;Not Reported;NA;white;9016370b-7159-53fd-aa4a-fcaaee4f461f;male;58;not reported;Alive;-21548;NA;1952;NA;NA;not reported;NA;624c866c-33e1-5709-8dc6-046a7a0c0eea;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;1f7ee0d6-0e20-5baf-b649-f09dfa81641e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-7465;LUSC
TCGA-68-7757;C34.1;not reported;MX;T1b;stage ia;2011;No;211;Squamous cell carcinoma, NOS;N0;1c28b1e6-f939-5a68-899c-38436b98a313;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27272;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:13:35.084062-05:00;50;NA;15428a6c-0b72-53ba-8547-61a575503512;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;240a323d-0734-5e27-882a-bca5e158e45e;male;74;not hispanic or latino;Alive;-27272;NA;1937;NA;NA;no;NA;d2eca9da-bbb4-5323-9c57-f940cf0b2244;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;81819b82-5b15-53c9-835b-498e323916de;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-68-7757;LUSC
TCGA-46-3769;C34.1;not reported;M0;T4;not reported;2009;No;135;Squamous cell carcinoma, NOS;N0;7b47ddc8-b2de-5e2a-b51d-4ea860fa129d;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20941;not reported;NA;8070/3;no;NA;NA;NA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;c622ac6d-2bf3-5760-b5ba-e3144702bcb5;NA;NA;NA;NA;Not Reported;NA;white;93e90fd3-5481-5311-8ac6-bde1d94a667d;male;57;not hispanic or latino;Alive;-20941;NA;1952;NA;NA;yes;NA;4dcfde44-617f-5d4b-952b-8b2683a40924;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;4224b47f-d646-5281-9c4f-1dc2b7f85e8a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-46-3769;LUSC
TCGA-56-8625;C34.3;not reported;MX;T3;stage iiia;2012;No;63;Squamous cell carcinoma, NOS;N1;83d7116c-eff1-5b1d-8006-e7e942209a7d;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24188;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;21acedbb-c9b6-562e-8d06-42199c3382d2;NA;NA;NA;NA;Not Reported;NA;white;03263f5d-72d6-516c-951c-02fb587d49f4;female;66;not hispanic or latino;Dead;-24188;NA;1946;315;NA;yes;NA;10bc82ba-3883-5bb2-aeba-96f90cbab0e6;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4e686c10-1d91-5fde-8ebe-6c86ce7811c8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8625;LUSC
TCGA-85-A4QQ;C34.3;not reported;M0;T2a;stage ib;2012;No;553;Squamous cell carcinoma, keratinizing, NOS;N0;4272bad9-eb50-5658-9d9d-32fd7b2026a4;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25065;not reported;NA;8071/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;0107d3dd-8088-5c38-8bb2-c5f29cf177d4;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;c7d850b0-8d05-5a74-9229-bb8dc091d82e;male;68;not hispanic or latino;Dead;-25065;NA;1944;927;NA;no;NA;5b1f5c49-fe0d-51b3-9ae5-c5c108d8826e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;87e560d9-e3cc-552f-be6e-f87798147f93;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A4QQ;LUSC
TCGA-66-2758;C34.1;not reported;M0;T2;stage ib;2007;No;639;Squamous cell carcinoma, NOS;N0;3e7cdc11-2178-5b0a-a49b-5270eba2083f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26209;not reported;NA;8070/3;no;NA;5th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;56;NA;3f6b228a-35f1-5dc8-8414-73adbfd26a31;56;NA;306.849.315.068.493;NA;Not Reported;NA;not reported;8aec85a0-a8c9-5afc-abde-88851ded76f3;male;71;not reported;Alive;-26209;NA;1936;NA;NA;yes;NA;94e8ce7a-8a54-5b05-ab56-db78eac5c0ad;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4daee2f0-4abd-58a9-82af-9ffefc561544;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2758;LUSC
TCGA-56-7823;C34.1;not reported;M0;T1b;stage iia;2011;No;1011;Squamous cell carcinoma, NOS;N1;545e9c25-8eff-58c9-b916-3d7c8f11de65;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21344;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:31.795062-05:00;40;NA;9b88a2fb-8624-55a8-9341-16e4689e4077;80;NA;438.356.164.383.562;NA;Not Reported;NA;white;30c42810-bb0b-5462-ba74-7779b593d3fb;female;58;not hispanic or latino;Alive;-21344;NA;1953;NA;NA;yes;NA;1130269f-6e23-548b-959e-fc7c53443424;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;2323d9eb-933d-5f98-95d9-add144c40b8c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-7823;LUSC
TCGA-O2-A52S;C34.3;not reported;MX;T4;stage iii;2006;No;NA;Squamous cell carcinoma, NOS;N2;4360f821-2d30-59c7-988f-a606eae4a343;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;21182;not reported;NA;8070/3;no;NA;6th;Stage III;not reported;2019-08-08T17:14:36.542202-05:00;30;NA;f4d53df3-7075-5050-ab82-8e8ecf00aced;3;NA;0.164383561643836;NA;Not Reported;NA;white;09ff46f9-fcb5-5fb3-ba5f-0f1a8f5037db;female;57;not hispanic or latino;Dead;-21182;2007;1949;387;NA;no;NA;d449d8ef-557e-5249-83a6-9a6f1c73a382;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;942a2594-0067-583c-85a3-a1edef4f65fb;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-O2-A52S;LUSC
TCGA-85-8580;C34.3;not reported;M0;T2a;stage ib;2012;No;1113;Squamous cell carcinoma, NOS;N0;a07e2b72-5b40-5410-9d82-246489ec3fd3;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;19301;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:16.559953-05:00;38;NA;da72bb1f-cd30-5724-89e4-5fe3e11639f0;38;NA;208.219.178.082.192;NA;Not Reported;NA;white;167d15c4-875d-553f-b135-80e59fd38cb2;female;52;not hispanic or latino;Alive;-19301;NA;1960;NA;NA;no;NA;0ca43506-9cc8-54f5-9a8c-0bab237a31e8;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3d9daa3b-7cb5-534d-8ca8-25f111957fdc;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8580;LUSC
TCGA-22-4593;C34.3;not reported;M0;T2b;stage iia;2002;No;1067;Squamous cell carcinoma, NOS;N0;73a5a5e2-ea29-588f-b7de-c1f118e8097f;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28385;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:11:26.507214-05:00;60;NA;5c6a2785-1d0a-5c79-aeec-80a1c647664f;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;b2b18d4b-89ad-5f17-a0e6-51b1d6304a12;male;77;not reported;Dead;-28385;2004;1925;1067;NA;no;NA;8132b7ad-c589-5d96-8811-f8191c39a793;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e100b915-5778-527b-8f5f-e5a7704a4a0e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-4593;LUSC
TCGA-85-A5B5;C34.1;not reported;M0;T1b;stage ia;2012;No;111;Squamous cell carcinoma, NOS;N0;c0962f16-4e45-5ff9-a007-b3d255527e62;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21450;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:16.559953-05:00;29;NA;59fe301a-e19d-5459-bccf-eed77f7f9a8c;15;NA;0.821917808219178;NA;Not Reported;NA;white;9d7dc9c1-65eb-595f-921b-38cc17b28e7b;male;58;not hispanic or latino;Alive;-21450;NA;1954;NA;NA;no;NA;4ca3de9c-006d-5b00-ad4c-686f8c206f3e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;63abfbe4-c78f-5eb3-8ba3-9fa784f3b13c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A5B5;LUSC
TCGA-68-A59I;C34.3;not reported;M0;T3;stage iiia;2012;No;492;Squamous cell carcinoma, NOS;N1;cad1ccea-ae07-5bce-9de9-7d8c82b37f02;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26839;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:13:35.084062-05:00;50;NA;10c433b9-fbfb-5943-8efa-bb34a7bf8538;50;NA;273.972.602.739.726;NA;Not Reported;NA;black or african american;1924f650-4d73-5254-a600-ebe8a77b1852;female;73;not hispanic or latino;Alive;-26839;NA;1939;NA;NA;yes;NA;948f85a5-534e-5716-9b21-30fd1875ab63;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;48023027-c925-5fc5-804a-dc0c7620b14c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-68-A59I;LUSC
TCGA-77-A5FZ;C34.1;not reported;M0;T4;stage iiib;2001;No;NA;Papillary squamous cell carcinoma;N0;c7a86218-a3d5-5a78-90f1-c1ed2c6249a7;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23436;not reported;NA;8052/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:55.903240-05:00;47;NA;24055f3f-85b8-5de7-a5da-621e91b91dc3;141;NA;772.602.739.726.027;NA;Not Reported;NA;not reported;ae5a7a5c-562c-5d9d-b80c-e4c6d361399a;male;64;not reported;Dead;-23436;2011;1937;3838;NA;no;NA;86114932-36f5-52c9-98c3-122194e390f1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;d8bd53eb-706e-5c01-a1e9-bd02e656574e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-A5FZ;LUSC
TCGA-22-4609;C34.1;not reported;M0;T1;stage ia;2003;No;NA;Squamous cell carcinoma, NOS;N0;ab2eb087-1ecb-5ae1-8a74-0153e0bcee67;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;29844;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;0f2ff356-ad13-55cf-b28b-aa255a75c699;77;NA;421.917.808.219.178;NA;Not Reported;NA;white;4def81fe-8908-5bb9-8b9f-8d7a79d352c8;male;81;not reported;Dead;-29844;2003;1922;291;NA;no;NA;2bbd3082-5a38-5528-9cd4-2cc07f3dc37e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;5da38572-0abd-5e7c-96e9-f01097ba58bb;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-4609;LUSC
TCGA-77-8008;C34.3;not reported;M0;T2;stage ib;2001;No;NA;Squamous cell carcinoma, keratinizing, NOS;N0;ba5ef89e-a461-5f7b-bc44-2ce6d2df39e4;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24948;not reported;NA;8071/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;41;NA;6c9f716c-2b69-5690-8600-142dd73acc73;61.5;NA;336.986.301.369.863;NA;Not Reported;NA;not reported;0670e81e-8954-5b41-b1d4-14212f988701;male;68;not reported;Dead;-24948;2008;1933;2639;NA;no;NA;4c8381a0-ebf9-5133-b61d-ea2c90c5f5ee;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;8fda720b-c192-53b6-9283-e5993b03ef53;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8008;LUSC
TCGA-34-8455;C34.1;not reported;M1a;T4;stage iv;2011;No;NA;Squamous cell carcinoma, NOS;N0;71ea19d1-44d9-5669-93e8-9be2095acfa0;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24624;not reported;NA;8070/3;no;NA;7th;Stage IV;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;a5874956-94c1-5bac-8e71-d4d9903b9ced;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;13bb929a-cc17-5ffd-9340-732eda8428a9;male;67;not hispanic or latino;Dead;-24624;2011;1944;123;NA;no;NA;0f4199e6-458d-5ff5-ba0b-c5ec2d90e45e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;43d15e9a-6204-5666-9e62-21e9449b3e4f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-8455;LUSC
TCGA-NC-A5HL;C34.1;not reported;M0;T2b;stage iia;2010;No;NA;Squamous cell carcinoma, NOS;N0;b544e371-a6af-50ef-997b-c9852301a792;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26977;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;46ff27a2-13f4-5297-a25b-4bd0a8ca6156;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;4e71f121-8080-5f6a-80dd-143e229e23ff;male;73;not reported;Dead;-26977;2010;1937;88;NA;no;NA;58c3d10c-1e94-5578-b8b9-a28d74c2fbce;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;d64de9a9-4bfc-5235-bb5c-a0fa9894f1c3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HL;LUSC
TCGA-22-5478;C34.3;not reported;M0;T2a;stage ib;2004;No;24;Squamous cell carcinoma, NOS;N0;00595bd0-e968-554d-bfaa-dafdd251817c;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28978;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;effc37e1-b796-532c-a9eb-06981426b30c;NA;NA;NA;NA;Not Reported;NA;not reported;56cc1755-ce4f-597a-b7fe-2ddaf98483f9;male;79;not reported;Dead;-28978;2004;1925;24;NA;no;NA;cd2b5ec4-9fff-5669-8f79-78690e697f52;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;731cbd8c-748b-5827-b41d-89b68d0e5c61;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5478;LUSC
TCGA-63-5128;C34.1;not reported;M0;T2;stage ib;2007;No;NA;Squamous cell carcinoma, NOS;N0;d8a912d7-b0f4-5ced-aea3-918612ce08ae;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;NA;NA;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;501a1415-388a-5add-bc06-cc632ef38889;NA;NA;NA;NA;Not Reported;NA;not reported;caa741a0-c240-5191-8b69-0995e8aaa266;male;NA;not reported;Dead;NA;NA;NA;NA;NA;no;NA;1d097e88-9180-5a8e-ad13-fef8b1edc551;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;0ac6649c-74b7-544d-9c34-b53fb8edd441;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-5128;LUSC
TCGA-66-2777;C34.2;not reported;M0;T2;stage ib;2007;No;61;Squamous cell carcinoma, NOS;N0;bee5c4fc-70bf-52bc-818b-4cf6ff9dc055;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;26085;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;35;NA;241d0ba4-27de-52d4-b6d0-28ed3f284f7f;12;NA;0.657534246575342;NA;Not Reported;NA;not reported;d57fe963-543c-5aae-97af-bbfca5c20789;male;71;not reported;Alive;-26085;NA;1936;NA;NA;not reported;NA;0e13df1b-9a83-5514-9a39-d19303500e91;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;c29ab64b-d7ed-599a-a3fe-e41fa1120b1a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2777;LUSC
TCGA-56-8083;C34.1;not reported;MX;T2a;stage ib;2011;No;150;Squamous cell carcinoma, NOS;N0;6a8bafed-00b7-51b0-8915-73bb15e64bd9;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20696;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;31d7697a-1e2f-55eb-a9d9-6286f98a45ab;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;9f28bc52-61f6-52c2-a094-83a6740ec9fe;male;56;not hispanic or latino;Alive;-20696;NA;1955;NA;NA;not reported;NA;9830f9de-9864-5098-bee3-b499e8bab0c2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;250d5ffc-3dcb-580d-a570-2b415d40952e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8083;LUSC
TCGA-90-A4EE;C34.9;not reported;MX;T2a;stage iia;2012;No;688;Squamous cell carcinoma, NOS;N1;3d56f356-d625-5e55-89d0-7549f80e5d44;not reported;NA;Main bronchus;No;Main bronchus;released;0;19676;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;6eab1e62-9f4d-5615-a6a6-7f3674236196;68;NA;372.602.739.726.027;NA;Not Reported;NA;white;3c81b480-b920-5387-81a2-540652d4f82d;male;53;not hispanic or latino;Alive;-19676;NA;1959;NA;NA;yes;NA;a4c01a6e-4b83-59fb-ac4c-0b7d09b147cb;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6d4452dd-53fa-5eee-a340-66591c77c0f1;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-90-A4EE;LUSC
TCGA-56-A49D;C34.1;not reported;MX;T2a;stage iiia;2012;No;637;Squamous cell carcinoma, NOS;N2;af0d5d46-8154-5cf1-bdc6-a148f157b8f1;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24745;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:12:53.407315-05:00;52;NA;fdaff2c5-8cde-54ac-8849-73f6c81de3f8;53;NA;29.041.095.890.411;NA;Not Reported;NA;white;0a1a4577-5c7a-5988-a4be-65d6faee2795;male;67;not reported;Alive;-24745;NA;1945;NA;NA;no;NA;b973126c-1f1a-59c6-87d8-4d5597527590;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7c09fe7a-1ac8-5e95-9e13-2fdb7b50e5e0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-A49D;LUSC
TCGA-77-8139;C34.1;not reported;M0;T3;stage iib;2003;No;3166;Squamous cell carcinoma, NOS;N0;e4330dbf-7aeb-5abd-9089-d8766f9833e5;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26464;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;27225279-659c-5fd3-ba3f-0bc4d335cb18;52;NA;284.931.506.849.315;NA;Not Reported;NA;not reported;67ea9b3d-d6b7-5684-8589-25f33f2682a8;male;72;not reported;Alive;-26464;NA;1931;NA;NA;no;NA;422da418-19d8-5774-9977-68f45d13c431;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;5d3b6bfc-27eb-58bf-8d89-54241d967577;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8139;LUSC
TCGA-94-A5I4;C34.0;not reported;MX;T2a;stage iia;2012;No;491;Squamous cell carcinoma, NOS;N1;09ff90b7-fba1-5557-a9df-cfe6fa35e40d;not reported;NA;Main bronchus;No;Main bronchus;released;0;22299;not reported;NA;8070/3;yes;NA;7th;Stage IIA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;5bb69f05-71ab-5260-bd21-1ec4a58464de;80;NA;438.356.164.383.562;NA;Not Reported;NA;white;09cfd2fd-b852-5a54-abcb-9501ffddf5f1;male;61;not hispanic or latino;Alive;-22299;NA;1951;NA;NA;no;NA;8b9ad6ef-8aad-572c-8e20-20a434d94ce6;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;ff8a84b6-7839-5dd6-b41b-1bc333c03032;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-94-A5I4;LUSC
TCGA-66-2786;C34.1;not reported;M0;T1;stage ia;2008;No;790;Squamous cell carcinoma, NOS;N0;1f133963-a2d7-561b-be90-fcc375bea386;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25051;not reported;NA;8070/3;no;NA;5th;Stage IA;not reported;2019-08-08T17:13:35.084062-05:00;48;NA;6cb27160-aab7-5db3-8985-597f3d9e6c2b;74;NA;405.479.452.054.795;NA;Not Reported;NA;not reported;ef309a15-bc83-5284-bbf5-e468e97cfbf0;female;68;not reported;Alive;-25051;NA;1940;NA;NA;no;NA;ab31f1a0-bd08-5adf-9bc2-01185175b63d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;1ca8bfcd-0f1a-5925-a4f4-73aa6c6e9ebf;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2786;LUSC
TCGA-22-5480;C34.1;not reported;M0;T1b;stage ia;2002;No;2170;Squamous cell carcinoma, NOS;N0;118e8073-4d57-51c5-a522-88e5d8b02635;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24245;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;50;NA;3c065efa-21c1-5be2-b18f-24279e25c5aa;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;c28877b3-b071-5bac-9618-024a6d2d9d40;female;66;not hispanic or latino;Dead;-24245;2007;1936;2170;NA;no;NA;105173a6-1a15-5b61-ad4d-9df3e3b3bdc2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;5094f82a-5fb5-5dd0-97ed-2aa412d60824;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5480;LUSC
TCGA-43-A474;C34.1;not reported;M0;T2b;stage iia;2012;No;353;Squamous cell carcinoma, NOS;N0;0df6081a-11ee-5b9d-9d9d-44deb730d748;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24286;not reported;NA;8070/3;yes;NA;7th;Stage IIA;not reported;2019-08-08T17:12:31.795062-05:00;47;NA;1aa45868-518a-5f31-b349-19538b2fd829;47;NA;257.534.246.575.342;NA;Not Reported;NA;white;865d6059-0809-564d-ae1e-91e6da18b618;male;66;not hispanic or latino;Alive;-24286;NA;1946;NA;NA;yes;NA;116cd20a-69be-5809-bee7-41e3b0c46fce;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c1205826-4e16-5928-98cf-384ff233d6f3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-A474;LUSC
TCGA-22-5473;C34.3;not reported;M0;T3;not reported;2005;No;NA;Squamous cell carcinoma, NOS;N0;6f743793-a9ee-5bd6-8c70-fa0b7f82a2ac;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28826;not reported;NA;8070/3;no;NA;NA;NA;not reported;2019-08-08T17:11:47.463501-05:00;45;NA;2480d5be-6f47-51ed-bdc0-b1dd05b985da;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;306c4a39-c386-5f04-8869-c3ef8cbf3189;male;78;not hispanic or latino;Dead;-28826;2010;1927;1933;NA;yes;NA;38e9195b-c642-56e2-8fa2-c525adbf9dd1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;19b5b346-eea0-5843-851b-78ad882ea06d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5473;LUSC
TCGA-21-5784;C34.1;not reported;M0;T2;stage ib;2008;No;1268;Squamous cell carcinoma, NOS;N0;90f07351-923a-5fb4-ba2e-fd00021ede40;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;29362;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;534e182c-464a-5baf-8b66-f1b66e429aa6;14;NA;0.767123287671233;NA;Not Reported;NA;white;6497a284-5113-5fc8-a14c-560e1ce8831d;female;80;not hispanic or latino;Alive;-29362;NA;1928;NA;NA;no;NA;06746923-04f8-50da-ad14-4649adefdc6a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c8fecc1e-fa39-5517-9cef-4bed5d37cc03;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-5784;LUSC
TCGA-58-8390;C34.3;not reported;M0;T2b;stage iia;2010;No;911;Squamous cell carcinoma, NOS;N0;fe617915-e6d6-5ae3-b62a-cb492f1dc227;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25827;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;0d6dba6f-bd89-5b68-88ba-b43113956958;120;NA;657.534.246.575.342;NA;Not Reported;NA;white;e8da6734-7604-5df9-9165-c795808d3632;male;70;not hispanic or latino;Alive;-25827;NA;1940;NA;NA;no;NA;805feb2e-60c3-5b9a-a617-eef6e1c96b8d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;55f8b030-af77-5a2d-8b44-63c0a0277f92;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-58-8390;LUSC
TCGA-34-5232;C34.1;not reported;M0;T1;stage iia;2006;No;2471;Squamous cell carcinoma, NOS;N1;365f57df-7a81-5a39-9f0b-b7c516764a6f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27633;not reported;NA;8070/3;no;NA;6th;Stage IIA;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;d8cb9970-2414-5082-86fd-7631c87481c8;NA;NA;NA;NA;Not Reported;NA;black or african american;50f3a838-e986-58da-9001-4741d47b2b47;female;75;not hispanic or latino;Alive;-27633;NA;1931;NA;NA;no;NA;8ace722e-ba54-5919-80f7-f4ca57eb8418;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;638f06c9-c120-51e2-ab98-bc8759f976cc;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-5232;LUSC
TCGA-39-5016;C34.3;not reported;M0;T2a;stage iia;2003;No;3850;Basaloid squamous cell carcinoma;N1;c6917aaf-0fe9-52f7-bf3e-17f62e649fa4;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;16306;not reported;NA;8083/3;no;NA;6th;Stage IIA;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;87ed167c-c3a2-5681-b176-b71358eabb8b;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;5d6dc168-7e84-5614-9691-e4293098dc26;male;44;not reported;Alive;-16306;NA;1959;NA;NA;no;NA;f90a34e1-dea2-5917-b902-cde59dd49d42;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;dd3edcce-827c-522c-84fc-086c3086faaf;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5016;LUSC
TCGA-MF-A522;C34.1;not reported;MX;T2a;stage ib;2012;No;83;Squamous cell carcinoma, keratinizing, NOS;N0;412aaa0a-e19d-51c6-b826-9ad26d43b4e4;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20051;not reported;NA;8071/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:36.542202-05:00;43;NA;2b760390-9d14-550c-a606-06f58dd3e873;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;4e3242f1-4faf-5a75-b13b-773b02774cce;male;54;not reported;Dead;-20051;NA;1958;360;NA;yes;NA;8d5481e3-5df0-569b-b33a-c8c6dd972c7d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;76bd0193-3564-5235-9924-9c2d85f287bc;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-MF-A522;LUSC
TCGA-66-2781;C34.1;not reported;M0;T2;stage ib;2007;No;121;Squamous cell carcinoma, NOS;N0;c224396e-ee1f-5284-8151-9179baa3627e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24471;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;53;NA;e57c346e-4cf4-5e5d-9f77-05a0965b7c49;80;NA;438.356.164.383.562;NA;Not Reported;NA;not reported;5e20ab4a-e952-5da4-92a8-b523f2754897;male;67;not reported;Alive;-24471;NA;1940;NA;NA;not reported;NA;cde587d6-7fd7-5dfa-9b65-d884779a0846;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;df5d9ce5-da97-5633-8336-2c953ab1a3eb;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2781;LUSC
TCGA-63-A5ML;C34.3;not reported;M0;T2;stage ib;NA;No;1386;Squamous cell carcinoma, NOS;N0;412ae5a0-2dae-5ebb-8d57-31a51f972a40;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;NA;24947;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;e64c3855-755c-5410-8d15-2661192ee1de;60;NA;328.767.123.287.671;NA;Not Reported;NA;not reported;a5f452e4-3958-57d1-8077-f9d352170fbc;male;68;not reported;Alive;-24947;NA;NA;NA;NA;yes;NA;ee6f1145-f940-5142-9cf3-ec0274144c34;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;03f2320a-c30e-567b-a2b0-d71b02620a41;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5ML;LUSC
TCGA-66-2791;C34.3;not reported;M0;T2;stage iiib;2008;No;NA;Squamous cell carcinoma, NOS;N3;d68ccb46-a8a6-5d95-a87f-8b9cbb5c7428;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24138;not reported;NA;8070/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:35.084062-05:00;25;NA;e5adaf88-7daa-51d8-8a9e-29d63e03d842;25;NA;136.986.301.369.863;NA;Not Reported;NA;not reported;b4e1964d-03ab-51c7-83ca-a9ed53d8bde4;male;66;not reported;Dead;-24138;2008;1942;153;NA;not reported;NA;f3786742-5b10-54cb-ba59-9cbf4187f38f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;254a90a4-c9f6-5fde-be18-9b415e7af61c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2791;LUSC
TCGA-56-8629;C34.3;not reported;MX;T2b;stage iia;2012;No;481;Squamous cell carcinoma, NOS;N0;9bf24c24-8b39-549c-8bee-0b50e71d8d9b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;23346;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:53.407315-05:00;33;NA;27703e20-0a89-5803-a551-788ea985953a;66;NA;361.643.835.616.438;NA;Not Reported;NA;white;52fdd115-b2fa-5ce8-b271-a14f5a302ece;male;63;not hispanic or latino;Alive;-23346;NA;1949;NA;NA;yes;NA;ac6485d9-9354-5155-8a61-b6bab30576b9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;41e95b52-1266-50f3-93dc-c2a28ef2c7c9;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8629;LUSC
TCGA-66-2790;C34.1;not reported;M0;T2;stage iib;2008;No;699;Squamous cell carcinoma, NOS;N1;096dd573-80a3-5b33-a402-075f8ce5461f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26420;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:35.084062-05:00;57;NA;2cdf666d-8338-5e27-9844-e67120fc4093;57;NA;312.328.767.123.288;NA;Not Reported;NA;not reported;61e768c6-1025-5409-85b8-39cf223bcaf1;male;72;not reported;Alive;-26420;NA;1936;NA;NA;yes;NA;793e52cf-54fb-5905-a681-060a5cb3960b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;96d5e4b8-3495-536c-854d-937994faaa0b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2790;LUSC
TCGA-63-A5MS;C34.1;not reported;M0;T2;stage ib;NA;No;2381;Squamous cell carcinoma, NOS;N0;590b2e1b-c158-510e-9f5f-e956f2850f65;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;NA;28827;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;a9001105-c9df-5c43-b973-d70132069c06;6;NA;0.328767123287671;NA;Not Reported;NA;not reported;7bcf9a2a-c497-5a51-8820-1f84234e9f1a;male;78;not reported;Alive;-28827;NA;NA;NA;NA;no;NA;9b8997e6-b4fd-576d-b9ce-313857da5475;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;d0ad4446-6bb9-58e9-934b-98e0beb9d6d9;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MS;LUSC
TCGA-58-A46K;C34.3;not reported;M0;T2;stage iiia;2008;No;NA;Basaloid squamous cell carcinoma;N2;ef4a0879-4110-5f61-a7d1-33c616ce86e5;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;21867;not reported;NA;8083/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;f1c13809-4327-5537-9cc8-afaed1e74b4d;10;NA;0.547945205479452;NA;Not Reported;NA;white;30a7b930-0d27-5c8a-b8a6-67150f6bbbe3;male;59;not hispanic or latino;Dead;-21867;2010;1949;1045;NA;yes;NA;6f72468c-5275-524c-99dc-bc167a9a411d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;86fe8d05-5e5e-5578-b00e-85421198eecf;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-58-A46K;LUSC
TCGA-18-3410;C34.3;not reported;M0;T3;stage iib;2004;Not Reported;NA;Squamous cell carcinoma, NOS;N0;60b4a692-0777-54b9-9e86-ad3fe991dc0d;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;29827;not reported;NA;8070/3;yes;NA;NA;Stage IIB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;1c2c75c3-c291-5985-9683-da9550eaa259;NA;NA;NA;NA;Not Reported;NA;not reported;dcc0fd1a-fc18-5ee1-9099-4269836692d4;male;81;not reported;Dead;-29827;2004;1923;146;NA;no;NA;65a877fa-d2c3-5bd7-991a-7ae371b08db2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3257f71c-a349-5e9c-a760-a6722e4f22f8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3410;LUSC
TCGA-22-1012;C34.9;not reported;M0;T2;stage ib;2001;No;NA;Squamous cell carcinoma, NOS;N0;789d4ff1-4257-59e1-bc30-ff046dbb8614;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;29273;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;61;NA;15c315fb-32b3-547b-afdc-365d13ac0448;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;9e56467c-1397-5755-aa21-88ca61b0ccdc;female;80;not hispanic or latino;Dead;-29273;2002;1921;429;NA;not reported;NA;8fa417c5-8bda-5961-ba7e-4584efdef2e7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;2deb950b-db89-54b5-8805-d69c6ce8b989;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-1012;LUSC
TCGA-63-A5MP;C34.3;not reported;M0;T2;stage iib;NA;No;769;Squamous cell carcinoma, NOS;N1;b295d4e0-c1de-5b8b-8fdf-e6074066eec7;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;NA;20818;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:13.079700-05:00;41;NA;5b95ed01-6bf4-5207-9539-3e8b76a4ed02;41;NA;224.657.534.246.575;NA;Not Reported;NA;not reported;6ce0d634-1f5d-5bd7-9dbc-8fe9f97692dc;male;56;not reported;Alive;-20818;NA;NA;NA;NA;yes;NA;054091c3-34b3-5812-a82a-092e924dcfe4;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;20dade68-11bb-5a54-873a-6b2d1a024b35;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MP;LUSC
TCGA-22-1005;C34.9;not reported;M0;T1;stage ia;2001;No;1953;Squamous cell carcinoma, NOS;N0;53543be1-92d4-53ed-983e-b394e448d3c3;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;23322;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:11:26.507214-05:00;45;NA;a40c51e9-2ba3-5bda-8bd9-b63766e9f0b1;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;ee68e5a4-005d-5af4-80a3-0e2a633ac1f7;male;63;not hispanic or latino;Dead;-23322;2006;1938;1953;NA;no;NA;42ddaa4f-43df-569c-9edc-83d3101bfa77;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;196e2912-c56e-5714-b50c-de32a6e9b51e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-1005;LUSC
TCGA-85-8353;C34.3;not reported;M0;T3;stage iiia;2011;No;54;Squamous cell carcinoma, NOS;N1;7e76dc81-64f4-573e-9400-42ea984101b8;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26549;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;df9a04a5-cff3-5624-886d-128bdf705181;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;1193d1d5-de16-58b2-88bf-14273f5bb7c3;male;72;not hispanic or latino;Dead;-26549;NA;1939;94;NA;no;NA;b71d85f2-388a-5047-a462-1b003031689f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;44db5d56-7645-57e1-8c6e-8e4dbc94d746;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8353;LUSC
TCGA-85-6560;C34.1;not reported;M0;T1b;stage iia;2011;No;1259;Squamous cell carcinoma, NOS;N1;3e9a5889-20c9-539b-8f55-4a9b2b696b5f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21768;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:13:55.903240-05:00;41;NA;deedee1b-4753-5da6-b787-9afaa6fc06d1;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;9fd6ef7a-f6b9-5000-87a4-e131187d1ee3;male;59;not hispanic or latino;Alive;-21768;NA;1952;NA;NA;yes;NA;2f79a2da-3276-5782-95dd-dd6d3bf46cb9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;f12b8df5-a1da-53df-ac20-2073feddfcb8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-6560;LUSC
TCGA-22-5471;C34.3;not reported;M0;T2;stage ib;2005;Not Reported;1845;Squamous cell carcinoma, NOS;N0;9d80e071-ebce-5c6d-95dc-916228892db1;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27749;not reported;NA;8070/3;yes;NA;6th;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;7cb0c8c2-f64f-57ce-b63c-6c2cf3f9926f;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;37d9726a-54f9-5d8a-bc2f-018a1c5305cb;male;75;not reported;Alive;-27749;NA;1930;NA;NA;no;NA;bd572d4f-f183-51d0-b387-6882177c4f6f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;8d49424e-f2b7-5e75-95df-bc425ebfea73;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5471;LUSC
TCGA-85-8664;C34.1;not reported;M0;T2b;stage iib;2011;No;434;Squamous cell carcinoma, NOS;N1;757054b3-1809-53fb-9cf4-3b5b95db0ecd;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26954;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;173d4730-d4c9-5bfa-bc62-20a33b464ca8;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;e96d0867-96a9-58d0-8553-6e3054365d9c;male;73;not hispanic or latino;Dead;-26954;NA;1938;550;NA;yes;NA;7d30f4e1-50e9-5776-b42d-623e3ecd4609;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;cf2ffb35-e3f3-5178-9324-72116f6240e2;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8664;LUSC
TCGA-98-A53B;C34.1;not reported;M0;T2a;stage ib;2012;No;NA;Squamous cell carcinoma, NOS;N0;d68b68a0-8fa0-51c1-aa77-31db5414312d;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25390;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;697b1ff4-036c-57f2-ab47-c42d214553ff;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;faa17738-818b-5a07-b68e-a1836899af04;male;69;not hispanic or latino;Dead;-25390;2012;1943;61;NA;no;NA;edc9380c-5f68-53ed-8012-f6a194412d79;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e3cabefc-969f-540a-8766-356c45185771;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-A53B;LUSC
TCGA-85-7950;C34.1;not reported;M0;T2a;stage ib;2011;No;576;Squamous cell carcinoma, NOS;N0;eaa87bdb-a1ff-50ec-a9d2-2d56c8004de8;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;16975;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;160147e8-5da4-597d-b686-dd8dc0b1f105;27;NA;147.945.205.479.452;NA;Not Reported;NA;white;23f35290-5ec5-5461-9967-fea27558c327;male;46;not hispanic or latino;Alive;-16975;NA;1965;NA;NA;no;NA;d46d3a94-5247-59fd-80d9-2454c3b76f64;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;fbd05c6e-ba12-5f52-af5e-dcf3f04fb169;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-7950;LUSC
TCGA-NC-A5HO;C34.1;not reported;M0;T3;stage iiia;2011;No;1336;Squamous cell carcinoma, keratinizing, NOS;N1;8b29d6b2-bbd4-5367-a0e1-96f3efd89f73;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25694;not reported;NA;8071/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;c4fc9eee-d346-51fd-b6c8-29b390bc9dc6;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;bcb516f5-8c50-5887-9dea-cb2a9a33b82e;female;70;not reported;Alive;-25694;NA;1941;NA;NA;yes;NA;56ecc776-3d28-5511-9a87-75afd5aea585;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;5f549822-52d6-5bf8-aeda-f7a66cc29928;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HO;LUSC
TCGA-21-1080;C34.3;not reported;M0;T2;stage ib;1996;No;3724;Squamous cell carcinoma, NOS;N0;72cc8194-9174-5b6e-882c-c6e14c6e322d;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24253;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;3be96690-be6d-54ad-8314-7d742ea2fdb0;100;NA;547.945.205.479.452;NA;Not Reported;NA;white;e97dee83-d879-5505-a820-72e3b35f9afc;male;66;not hispanic or latino;Alive;-24253;NA;1930;NA;NA;no;NA;e0805781-660c-5f5d-bd26-d29dc591853c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;b513bd8d-e606-5756-80c3-b1f645424c9f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-1080;LUSC
TCGA-77-8140;C34.3;not reported;M0;T2;stage iib;2003;No;NA;Squamous cell carcinoma, NOS;N1;314f40ca-e0cb-5e83-a34c-8949422d71b8;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24415;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:55.903240-05:00;39;NA;12973f73-9fd3-5887-a6a1-0305b16982b2;78;NA;427.397.260.273.973;NA;Not Reported;NA;not reported;039d8e12-0522-5866-a9f0-5e09eeac62bd;female;66;not reported;Dead;-24415;2003;1937;351;NA;no;NA;c8dde3a5-601d-531c-a69e-dabf2b0f2f87;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;260796b0-e4e7-52ca-99d6-0092061e04d3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8140;LUSC
TCGA-33-4538;C34.1;not reported;M0;T2;stage iiia;2002;No;NA;Squamous cell carcinoma, NOS;N2;0c29e5f9-e43e-517e-bb7f-e8cbd356e333;not reported;NA;Upper lobe, lung;Yes;Upper lobe, lung;released;0;24174;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;5205a7a1-2251-52d4-898a-22f6a9bfcc4e;51;NA;279.452.054.794.521;NA;Not Reported;NA;white;6eb100db-2525-5ebd-b2e9-22414a0fb308;male;66;hispanic or latino;Dead;-24174;2010;1936;2979;NA;yes;NA;feff13d4-53a0-5201-97d3-4086ebed283f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ec387163-c99c-5b18-96f3-f4866db6f170;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-4538;LUSC
TCGA-22-4605;C34.10;not reported;M0;T2;stage ib;2003;No;NA;Squamous cell carcinoma, large cell, nonkeratinizing, NOS;N0;9dff09fe-82b1-5112-8601-153288ec7c5f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28623;not reported;NA;8072/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;50;NA;2b98ff6a-f999-54ea-8eda-1a9954b6aea2;75;NA;410.958.904.109.589;NA;Not Reported;NA;not reported;5c4506bd-0b0f-53ae-a9a9-ee8d849a48db;female;78;not reported;Dead;-28623;2005;1925;974;NA;no;NA;e6eb66fc-0aa9-5f0d-9384-336c9fabf08c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;3fadce3c-7162-5c14-9bbb-8db9f57d1bd4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-4605;LUSC
TCGA-22-4595;C34.3;not reported;NA;T3;stage iiia;2002;No;734;Squamous cell carcinoma, NOS;N2;a03219db-eb06-5c0b-a876-2876fb77a424;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;21146;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;fd8c99c5-2c7a-57ff-9409-9872aa7bed21;37;NA;202.739.726.027.397;NA;Not Reported;NA;white;d8533fa0-8302-5603-af4c-e1fb0e4d5941;male;57;not reported;Dead;-21146;2004;1945;734;NA;no;NA;393b821c-a683-56cf-a2bc-f97ff37d474c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;a33cb1eb-66a6-546b-85ce-ae202fab3525;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-4595;LUSC
TCGA-77-8009;C34.9;not reported;M0;T2;stage iib;2007;No;1641;Squamous cell carcinoma, NOS;N1;3f277214-cfdd-5161-bcd3-c4c60d806035;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;25037;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:35.084062-05:00;39;NA;009aadd9-13c8-593c-a526-e04025afe4f6;97.5;NA;534.246.575.342.466;NA;Not Reported;NA;not reported;49fe57eb-4e0f-5e68-bd01-40d2f50190c4;male;68;not reported;Dead;-25037;NA;1939;1695;NA;yes;NA;32468ab9-13ff-5324-b5c4-f62028eaed7e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c4a5b03b-d856-5fe5-9212-17962bcc7d63;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8009;LUSC
TCGA-39-5040;C34.1;not reported;M0;T2a;stage iiia;2008;No;NA;Squamous cell carcinoma, NOS;N2;de73c6d6-fdec-536f-acaf-3d04c4a78b1e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21790;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:12:11.623943-05:00;41;NA;d1105975-1613-598a-9f8e-406fc72aac9f;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;ff920986-0541-5f06-a330-f257dea31c1c;male;59;not hispanic or latino;Dead;-21790;2009;1949;519;NA;yes;NA;25ea4961-3170-55ce-8ad3-4ca17f9353cf;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;ed0c4b50-1dca-5ffa-9f9b-162bfa045069;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5040;LUSC
TCGA-34-2596;C34.9;not reported;M0;T2;stage iib;2004;No;80;Squamous cell carcinoma, NOS;N1;c9896899-3885-5ebf-a0f0-a74cf2cd2a75;not reported;NA;Main bronchus;No;Main bronchus;released;0;25574;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;0f35aaf8-0d01-548e-9059-df72d4321864;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;cc3a5452-fb06-5f7e-b80d-c5c9cfa8b424;male;70;not hispanic or latino;Dead;-25574;2004;1934;80;NA;no;NA;6df32578-de85-523f-866c-c68b4a234490;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;aee79200-3b94-5ebf-bff6-d9e9259fe72b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-2596;LUSC
TCGA-56-8082;C34.3;not reported;MX;T2b;stage iia;2011;No;455;Squamous cell carcinoma, NOS;N0;503a0cec-359f-51cc-8378-986a01fdb47e;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;29440;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;e1dd0250-6e41-5830-862a-90c014b8f4c6;NA;NA;NA;NA;Not Reported;NA;white;ad55db1f-7f3e-5115-9968-78ac9d2883c6;female;80;not hispanic or latino;Alive;-29440;NA;1931;NA;NA;no;NA;e3d4be91-3165-56b4-941e-865d60ab1929;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a9f777c0-4bba-54bc-82ec-2dc0f16288f1;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8082;LUSC
TCGA-37-4135;C34.3;not reported;M0;T2a;stage ib;2010;No;207;Squamous cell carcinoma, NOS;N0;410f6432-9931-55e8-a131-5765fca39635;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25041;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:11.623943-05:00;45;NA;ab5783a8-1bb7-578a-bf34-da1299bae968;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;36399ec2-b066-5692-a626-baa7edc350c3;male;68;not hispanic or latino;Alive;-25041;NA;1942;NA;NA;not reported;NA;ca73e886-bc67-5d60-8143-9706e163f574;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;b5e1226d-fd2a-5493-b87f-e069fd47e252;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-4135;LUSC
TCGA-34-2605;C34.1;not reported;M0;T4;stage iiib;2006;Not Reported;881;Squamous cell carcinoma, NOS;N1;97696688-9c01-572e-b116-567f2d5d87a5;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27833;not reported;NA;8070/3;yes;NA;NA;Stage IIIB;not reported;2019-08-08T17:11:47.463501-05:00;60;NA;32d691fc-a93d-5576-b045-744255e9b577;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;439c31b2-662b-544f-a5b3-a7e795146849;male;76;not hispanic or latino;Dead;-27833;2008;1930;881;NA;yes;NA;e17911c1-462c-579a-a082-ad14b71f4d8d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;d6e554f1-e85b-5f5c-ba33-07aa3a915279;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-2605;LUSC
TCGA-85-7710;C34.1;not reported;M0;T1b;stage ia;2011;No;42;Squamous cell carcinoma, NOS;N0;48428d22-12af-519a-9def-71f454eb9a62;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21790;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;5016baaa-ec79-5d62-8a5c-01b180144070;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;b0ab4d12-5462-5675-a5f7-3375f69f76f5;female;59;not hispanic or latino;Alive;-21790;NA;1952;NA;NA;no;NA;66aa7b23-c817-5885-afbd-90a49087375e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;5bdbc21e-c99b-59f9-b16b-506a5cfe29ad;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-7710;LUSC
TCGA-56-6545;C34.1;not reported;M0;T2a;stage ib;2010;No;666;Squamous cell carcinoma, NOS;N0;b54345a6-921f-59bc-88e6-f1540782a5e0;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28400;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;44;NA;382ba4eb-e588-58d9-893f-2277ff584df2;NA;NA;NA;NA;Not Reported;NA;white;b6825b0b-c05f-59bc-b388-a5be1336e628;female;77;not reported;Alive;-28400;NA;1933;NA;NA;no;NA;5912148a-8474-5504-8150-f992cb0ce523;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;11e01504-5711-5dbc-a161-57681a6dfd88;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-6545;LUSC
TCGA-92-8065;C34.3;not reported;MX;T3;stage iib;2012;No;70;Squamous cell carcinoma, keratinizing, NOS;N0;92112ad2-b597-596f-ba3e-90c4f87a54cf;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27049;not reported;NA;8071/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;27;NA;6d84aad6-1c79-5853-91aa-fe4da2e0c6fd;14;NA;0.767123287671233;NA;Not Reported;NA;white;4d269ddc-b7a7-53b6-a5ba-4f7e80283ddd;female;74;not hispanic or latino;Alive;-27049;NA;1938;NA;NA;no;NA;477b26ef-da01-561b-bb9b-7d3de28c9ddd;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;bc8d7820-95cd-5eb4-a820-9f6beab82012;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-92-8065;LUSC
TCGA-22-4604;C34.1;not reported;M0;T2a;stage iia;2003;No;NA;Squamous cell carcinoma, NOS;N1;7df158d7-d609-5dac-b147-97b449c5da4e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26952;not reported;NA;8070/3;no;NA;NA;Stage IIA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;ab15803e-1f83-5446-86b2-4a26658920a3;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;010cf7a4-b6fd-5c9d-a396-eee929ca5f1d;male;73;not reported;Dead;-26952;2004;1930;399;NA;yes;NA;83d1cf40-3647-5f57-882b-829604398471;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;05e2a60d-f76b-52c7-88a7-8eef372921ad;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-4604;LUSC
TCGA-98-8023;C34.9;not reported;M0;T3;stage iiia;2011;No;649;Squamous cell carcinoma, NOS;N1;b1c7edaf-2b7d-557e-b64c-b32a1a0a30aa;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;25732;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;3f427a8b-c792-5c7e-82ff-58f46610a28a;75;NA;410.958.904.109.589;NA;Not Reported;NA;white;424e0597-0b33-5aa5-b77d-299ce39ef9ef;male;70;not hispanic or latino;Alive;-25732;NA;1941;NA;NA;no;NA;18399a43-3f28-5ef7-838c-a641a5cc7e98;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;1aefe9fa-de20-50ee-b0df-063f6f9130e2;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-8023;LUSC
TCGA-85-A513;C34.1;not reported;M0;T1a;stage ia;2012;No;910;Squamous cell carcinoma, NOS;NX;5a89ecaa-e251-5161-a7bc-b1d6653d9506;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21967;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;230e5b33-4269-5794-b526-5acd6c003e64;NA;NA;NA;NA;Not Reported;NA;asian;79d743ce-831f-535f-ab11-54565e954774;female;60;not hispanic or latino;Alive;-21967;NA;1952;NA;NA;not reported;NA;c8562727-f0c2-54d8-8872-c811942c5a4d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;57c79062-a3f6-559b-b4a4-f0753facd0c0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A513;LUSC
TCGA-22-4607;C34.3;not reported;M0;T2a;stage ib;2003;No;587;Squamous cell carcinoma, NOS;N0;ae74f478-eb58-5fc6-a839-b6a6d7e8e2b8;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27601;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;20;NA;489039c7-4a3b-5345-a6b2-58142d26884e;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;7f7d2341-1dbc-5105-99b3-69287dfa17f1;male;75;not reported;Dead;-27601;2004;1928;587;NA;no;NA;fbe009ab-2bfd-5efc-a4a1-f74907ef1435;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3d4b5e18-b97b-53ab-baa4-f4d8c3fd3a0a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-4607;LUSC
TCGA-39-5031;C34.1;not reported;M0;T1a;stage ia;2007;No;833;Squamous cell carcinoma, NOS;N0;f8d53f8f-460d-5039-b858-2733d4552438;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28106;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:12:11.623943-05:00;51;NA;0629d822-de45-5e4d-bec6-5bad816f91db;60;NA;328.767.123.287.671;NA;Not Reported;NA;not reported;c87377fc-bdb9-5098-88da-9eb925ae3bc2;female;76;not reported;Dead;-28106;NA;1931;1841;NA;no;NA;ecc10a73-af97-5489-84de-4ddf2b036356;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6f615ab4-75cc-5cb7-911b-de5400ce4fbc;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5031;LUSC
TCGA-34-5236;C34.1;not reported;M0;T3;stage iib;2007;No;NA;Squamous cell carcinoma, NOS;N0;686c09b5-000c-5be9-83bf-e4580a1b59ab;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21935;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;eaa8eac6-6fc0-58fc-88b5-817a31cd1304;NA;NA;NA;NA;Not Reported;NA;white;a5b53154-6a3e-58f5-9b65-52caf8a78dbb;male;60;not hispanic or latino;Dead;-21935;2007;1947;276;NA;yes;NA;232716a6-15ae-58db-9ddc-bd62d23f5c21;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;2320fe37-59b5-5adb-b32c-caab74eb865f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-5236;LUSC
TCGA-52-7812;C34.9;not reported;M0;T2;not reported;2009;No;NA;Squamous cell carcinoma, NOS;N2;7a26b30d-3ead-582a-846a-46a0d37628a5;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;24887;not reported;NA;8070/3;no;NA;6th;NA;not reported;2019-08-08T17:12:31.795062-05:00;30;NA;ae0db803-6696-5ee6-9d1b-e11cadd5604f;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;262a49d2-0de7-5189-9328-871e36e29e2d;male;68;hispanic or latino;Dead;-24887;2011;1941;835;NA;yes;NA;4d53cb71-6f3c-5262-9b78-7238f0edeb24;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;d2b3d29f-699b-5da4-8a74-a0cbe249a816;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-52-7812;LUSC
TCGA-18-3407;C34.1;not reported;M0;T2;stage ib;2003;Not Reported;NA;Squamous cell carcinoma, NOS;N0;36237e82-1f15-5450-8d54-1b393f54a033;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26615;not reported;NA;8070/3;yes;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;5aa5109d-bfe7-5eac-8bdc-d9b1afd6399e;40;NA;219.178.082.191.781;NA;Not Reported;NA;asian;c04ece07-0b07-5d9d-ab95-ea089a6287c3;male;72;not hispanic or latino;Dead;-26615;2003;1931;136;NA;no;NA;1eb09a1e-6f64-56ef-bac0-0729078ae5a1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;d25cc2b2-54c8-5dff-98eb-38738bb94327;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3407;LUSC
TCGA-NC-A5HT;C34.8;not reported;M0;T3;stage iiia;2012;No;804;Squamous cell carcinoma, NOS;N1;e04fc7e1-ac93-58bf-8016-aa705ac1044b;not reported;NA;Overlapping lesion of lung;No;Overlapping lesion of lung;released;0;25466;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;894d1825-c04f-51e8-80fe-8ead8e4e76b1;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;17f72a2b-0ebe-5350-a7ba-eeb7942dba63;male;69;not reported;Alive;-25466;NA;1943;NA;NA;yes;NA;c0b2ff70-6e75-5e69-bb1c-79fce4dc826c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;f17f5c3a-68f5-5e30-93af-c4a1d57ab00e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HT;LUSC
TCGA-66-2792;C34.3;not reported;M0;T2;stage iib;2008;No;913;Squamous cell carcinoma, NOS;N1;484e5682-2bb2-5058-86fa-f1b1854658bb;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;21428;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:35.084062-05:00;40;NA;1adbe354-f7cd-5524-a3f7-a9f9922c79d1;10;NA;0.547945205479452;NA;Not Reported;NA;not reported;4e3352a5-8421-5eda-98e9-9680c6751f6c;male;58;not reported;Alive;-21428;NA;1950;NA;NA;yes;NA;be77a736-ada3-5226-bbd0-1ccc9dfaa9cf;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;1b7f531f-e124-54c8-9fee-9ee40ac82732;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2792;LUSC
TCGA-96-A4JK;C34.1;not reported;M0;T2a;stage iia;2012;No;589;Squamous cell carcinoma, NOS;N1;733ffa59-4134-57ef-aaa9-e4ca0c25fb64;not reported;NA;Upper lobe, lung;Yes;Upper lobe, lung;released;0;23974;not reported;NA;8070/3;yes;NA;7th;Stage IIA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;1c844e64-1789-58dd-8b09-0d89acaff4eb;110;NA;602.739.726.027.397;NA;Not Reported;NA;white;8c41e28b-32fd-5777-8863-783b9be39747;male;65;not hispanic or latino;Alive;-23974;NA;1947;NA;NA;yes;NA;825bf29e-7bed-5dc5-9895-77442851cb38;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;2bd7e2e0-9817-56b0-8e78-830cc76f7e39;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-96-A4JK;LUSC
TCGA-56-A4BX;C34.3;not reported;MX;T2b;stage iia;2012;No;405;Squamous cell carcinoma, NOS;N0;1d309dde-6d1a-5e07-a0b5-b634272deeee;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25745;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:53.407315-05:00;55;NA;58d22aa9-389f-5ba3-bd03-9f095bca20d8;83;NA;454.794.520.547.945;NA;Not Reported;NA;white;dded7d30-5cf0-5ccd-bdb2-dc277b8f9422;male;70;not hispanic or latino;Alive;-25745;NA;1942;NA;NA;yes;NA;cbe81a70-c8c8-5693-9871-5ef6fb603866;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;21f49206-d21c-55b2-ad68-2ea07749e689;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-A4BX;LUSC
TCGA-77-8133;C34.9;not reported;M0;T1;stage iia;2001;No;NA;Squamous cell carcinoma, NOS;N1;ce1d9dae-d09a-5cfc-9f08-23b08f507af4;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;27139;not reported;NA;8070/3;no;NA;6th;Stage IIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;fb3a586a-ecff-58c5-86c1-e2edfd4ad729;22;NA;120.547.945.205.479;NA;Not Reported;NA;not reported;38613561-a533-54e7-84da-3a7b78e2a5ff;male;74;not reported;Dead;-27139;2005;1927;1640;NA;no;NA;26c4d4b4-4797-51de-b1ff-59fcf036d1a2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e5beada2-7773-51f8-992f-f0b1acebc18d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8133;LUSC
TCGA-56-8504;C34.1;not reported;MX;T2a;stage ib;2012;No;510;Squamous cell carcinoma, NOS;N0;72305e89-9cef-599d-a033-eb433a8f7791;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27210;not reported;NA;8070/3;yes;NA;7th;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;2f6046ce-b3d2-56f4-a4e9-d059fd4e3d10;NA;NA;NA;NA;Not Reported;NA;white;d100d657-216a-5da6-a8d8-7219a46591f6;male;74;not hispanic or latino;Alive;-27210;NA;1938;NA;NA;no;NA;9f21cf50-495c-5cfc-b6d8-594db234ee5c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;0add8204-7c91-5824-b3b6-870abc586ff0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8504;LUSC
TCGA-85-A50M;C34.1;not reported;M0;T2b;stage iia;2012;No;382;Squamous cell carcinoma, NOS;N0;70662c28-4356-5f9c-98e6-191bfe2b5c7c;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;17429;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:16.559953-05:00;15;NA;6fdaaf23-6110-51c8-b3d8-5e486bb8fe58;15;NA;0.821917808219178;NA;Not Reported;NA;asian;20bf79b5-c3d0-520e-a83e-9de551a66a1e;male;47;not hispanic or latino;Dead;-17429;NA;1965;826;NA;no;NA;9649b38b-0f1f-559d-836c-2c217f3817d1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6c79b814-c935-5d9c-8e68-f84e0bcb92fd;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A50M;LUSC
TCGA-60-2697;C34.9;not reported;M0;T2;stage iia;1992;No;NA;Squamous cell carcinoma, NOS;N2;a318274e-a4d8-5891-bff2-77f019c4ec6a;not reported;NA;Lung, NOS;Yes;Lung, NOS;released;0;14984;not reported;NA;8070/3;no;NA;3rd;Stage IIA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;cd36133f-bec3-5cd7-8194-095c1908d011;NA;NA;NA;NA;Not Reported;NA;white;4bc6f7ba-79e7-59d6-8cb6-f5b3d0360d06;male;41;not reported;Dead;-14984;1993;1951;372;NA;no;NA;626b891e-a3d9-5470-8c96-3264101310b1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4d3296c9-0ee0-5fd3-ab5f-5016c60c3cb4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2697;LUSC
TCGA-96-7545;C34.3;not reported;MX;T1;stage ia;2008;Not Reported;1344;Squamous cell carcinoma, NOS;N0;5d97ccec-1a91-541d-834c-b7844a59949b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26729;not reported;NA;8070/3;yes;NA;6th;Stage IA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;b5a9a656-c7de-516a-b6c7-d6c7c099f9e2;116;NA;635.616.438.356.164;NA;Not Reported;NA;white;75c171f1-bb60-542b-a719-b9c0db0fa85d;male;73;not hispanic or latino;Dead;-26729;NA;1935;1736;NA;no;NA;cd1c2fa3-123d-59a5-9c25-dc8dd57d97f4;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;73d423a8-29a9-5b49-80b0-298b34dcae54;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-96-7545;LUSC
TCGA-77-8154;C34.3;not reported;M0;T1;stage ia;2008;No;1841;Squamous cell carcinoma, NOS;N0;9734c0e3-b0cf-53af-9fdf-f32c403c1152;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24640;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:13:55.903240-05:00;40;NA;c1e9f713-7904-5eeb-9f19-27ac5deea22e;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;49ca50f6-44c6-5d4c-9277-0da0a5367475;male;67;not reported;Alive;-24640;NA;1941;NA;NA;no;NA;e489b763-4a48-5630-8010-89618f2670e5;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;1e4ca66d-b542-5e92-9abd-023c6216b6ef;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8154;LUSC
TCGA-39-5034;C34.1;not reported;M0;T3;stage iib;2007;No;1107;Squamous cell carcinoma, NOS;N0;0d4274a6-5bec-59be-8664-085244be4b37;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26682;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:12:11.623943-05:00;57;NA;9bc6c6b3-b06a-591b-b813-e39a54a355c8;84;NA;46.027.397.260.274;NA;Not Reported;NA;white;b1eb54c0-cee5-5cb8-b36e-31d12c13bb22;female;73;not hispanic or latino;Dead;-26682;2010;1934;1107;NA;no;NA;cda216f2-70a7-5564-9767-c17574d0688b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;9ccdfac4-0c7c-5d1b-a93f-5178edcbd9b5;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5034;LUSC
TCGA-34-7107;C34.3;not reported;M0;T2a;stage ii;2011;No;NA;Squamous cell carcinoma, NOS;N0;56dd9e2c-4532-5472-8b48-7213de0117c5;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25677;not reported;NA;8070/3;no;NA;7th;Stage II;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;d496caac-0b95-59cd-b9c1-85f3bf91819e;NA;NA;NA;NA;Not Reported;NA;white;1d27c597-fadd-5586-bacb-5f52d10d0e11;male;70;not hispanic or latino;Dead;-25677;2011;1941;34;NA;not reported;NA;c1db9d64-5925-5a2a-801b-3d11dcb8d146;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;17e23ebf-6df5-5133-a38d-4cf9ecbaca48;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-7107;LUSC
TCGA-43-6771;C34.1;not reported;MX;T2;stage ib;2006;No;NA;Squamous cell carcinoma, NOS;N0;bfca0fa2-b940-555f-bf84-75277d70e2cd;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;31052;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;40;NA;dab685ec-cc37-5c23-ac21-8cd0a9878ff6;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;0fe9bddf-b62b-5005-8a19-8f1c2017711e;male;85;not reported;Dead;-31052;2006;1921;166;NA;no;NA;9c43e0f4-4360-5d19-8bfa-78c0db7d84c2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;1bf636d3-c6ee-5449-b1d9-2f79a8a44dcc;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-6771;LUSC
TCGA-98-A53J;C34.1;not reported;M0;T2a;stage ib;2012;No;630;Squamous cell carcinoma, NOS;N0;0e98ca2f-9894-58c0-a90b-6b68226cc3c7;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28485;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:36.542202-05:00;25;NA;71004b81-dc5f-5ad8-ba40-028238a8df0d;100;NA;547.945.205.479.452;NA;Not Reported;NA;white;b6244933-f4a8-5d85-8178-8ef65c25e9c2;male;77;not hispanic or latino;Alive;-28485;NA;1935;NA;NA;no;NA;7e19cfb1-b980-5a98-b83c-39fde95e06a7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a0469beb-63d5-5216-910a-1fce8876d326;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-A53J;LUSC
TCGA-21-1078;C34.3;not reported;M0;T2;stage ib;2006;Not Reported;474;Squamous cell carcinoma, NOS;N0;91107a5e-1043-59aa-9f75-f58f6422b9cf;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28125;not reported;NA;8070/3;yes;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;59;NA;8b64a766-62dc-5fea-9a6d-4f818aa2c83e;9;NA;0.493150684931507;NA;Not Reported;NA;white;f5dbe2d2-a5fe-5b97-bef1-87114acd6486;male;77;not hispanic or latino;Dead;-28125;2007;1929;474;NA;no;NA;4664bc7b-bb2e-5927-9027-3d33885cb6f2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;0cf4e2d9-f4c4-53d2-b4a5-1f5b78ec56a0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-1078;LUSC
TCGA-43-6773;C34.2;not reported;MX;T2;stage iib;2008;No;NA;Squamous cell carcinoma, NOS;N1;1177e989-e856-5054-8a15-dbebaa55c515;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;28036;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;f635007c-a9e3-5c56-a738-6cc3d1eec16d;NA;NA;NA;NA;Not Reported;NA;white;d92b508e-e2ae-5f31-b339-f2698f6b0b44;male;76;not reported;Dead;-28036;2008;1932;116;NA;no;NA;1565a774-96b5-57a9-946b-7e16abf19625;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;f935955b-0225-5ce6-a38c-ee2ef8bff2bb;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-6773;LUSC
TCGA-96-7544;C34.3;not reported;MX;T2;stage iib;2008;No;1517;Squamous cell carcinoma, NOS;N1;5c7bc17a-2b28-50c7-81fa-1c68db626867;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;30548;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;402b6249-4b43-590a-847f-dd67601d074b;65;NA;356.164.383.561.644;NA;Not Reported;NA;white;8002a97f-11cb-5aa2-9352-348698fded71;male;83;not hispanic or latino;Dead;-30548;NA;1925;2160;NA;no;NA;0a20de12-1e9f-518a-a017-dff0d66f23d9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;aa09ad83-86bf-56f2-ade5-9dd2582f700a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-96-7544;LUSC
TCGA-77-A5G1;C34.3;not reported;M0;T3;stage iiia;2002;No;4026;Squamous cell carcinoma, NOS;N1;0fc5d9b0-fe87-519b-8c2f-4b290a8693f4;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27555;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:13:55.903240-05:00;53;NA;58b2d8ea-d107-506e-8d9e-e04b7d710a56;53;NA;29.041.095.890.411;NA;Not Reported;NA;not reported;831d0781-fe70-57d7-89f9-f6d08be5d842;male;75;not reported;Alive;-27555;NA;1927;NA;NA;no;NA;c72eb4d9-ff76-59e8-a0c1-32750f104a3f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ad003a71-ec99-5175-9ff7-83021987cafb;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-A5G1;LUSC
TCGA-77-A5GF;C34.3;not reported;M0;T2a;stage iia;2011;No;839;Squamous cell carcinoma, NOS;N1;0d7b0c18-913f-5cf8-89aa-f7f758ab7fda;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25654;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:13:55.903240-05:00;40;NA;45c78284-297d-5289-aa01-8c89f428d913;60;NA;328.767.123.287.671;NA;Not Reported;NA;not reported;6ed6aede-1183-5b9c-ae3c-8a7d7d30e127;male;70;not reported;Dead;-25654;NA;1941;840;NA;no;NA;551c8e5e-a9fa-5535-ad36-feebeb563530;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;86086bdd-1f53-5d80-9748-ea6a4ddfabd3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-A5GF;LUSC
TCGA-85-8355;C34.1;not reported;M0;T1a;stage ia;2011;No;61;Squamous cell carcinoma, NOS;N0;e32a61ad-ed2f-59a4-b4af-db80bb81352b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23227;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;21364fc6-1a48-5875-a587-3c8cab231e8a;NA;NA;NA;NA;Not Reported;NA;white;d4482966-a09e-5536-8177-8187243f52b6;male;63;not hispanic or latino;Alive;-23227;NA;1948;NA;NA;no;NA;f04c82d7-1818-5d3c-a72a-8d89fd31402b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a5150c34-c22c-5f89-b926-547d1372ac08;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8355;LUSC
TCGA-L3-A4E7;C34.3;not reported;M0;T2a;stage ib;2012;No;392;Squamous cell carcinoma, NOS;N0;cc64075e-3863-52ea-af07-9e7c7e05960b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26232;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;709cfe5b-00a0-560c-b9b7-bd70b73924ae;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;16588e72-508e-5731-9a05-0e643280edb3;male;71;not hispanic or latino;Alive;-26232;NA;1941;NA;NA;no;NA;2ae91299-1b82-5e40-9a2d-78bd13128b5f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;56fcd350-a0d0-5e14-af83-d9958b670f45;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-L3-A4E7;LUSC
TCGA-77-8148;C34.9;not reported;M0;T3;stage iiia;2006;No;2023;Squamous cell carcinoma, NOS;N1;f45ee1e9-796d-59b8-a4bc-100d5db9dd43;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;24918;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;144f69b8-4f76-5666-817c-f56b6d75c282;60;NA;328.767.123.287.671;NA;Not Reported;NA;not reported;51c6b0d2-0a7c-5b60-974f-5bccfa95f567;male;68;not reported;Alive;-24918;NA;1938;NA;NA;no;NA;9f05e193-5a95-51ea-b299-194b823cec49;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c91d467d-0a95-58b1-a4e3-4537a71cbed5;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8148;LUSC
TCGA-85-6561;C34.1;not reported;M0;T2a;stage ib;2011;No;1224;Squamous cell carcinoma, NOS;NX;8da10a06-aec4-5176-b172-1015cae25c99;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24234;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;25;NA;a2fda261-2bde-502a-b399-40677728a953;35;NA;191.780.821.917.808;NA;Not Reported;NA;white;5e26ac37-86ba-56f1-af98-a7a9a772d891;male;66;not hispanic or latino;Alive;-24234;NA;1945;NA;NA;yes;NA;08b5fe46-dbba-532b-96cc-cd14d4c164ef;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;96a46d5a-94d9-593c-ae4f-131145e0c546;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-6561;LUSC
TCGA-39-5011;C34.9;not reported;M0;T1b;stage ia;2002;No;4053;Squamous cell carcinoma, NOS;N0;b108aea9-e709-59d4-9e9c-efbd2929b107;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;25788;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;9a6931fb-ab4e-51b5-bd6d-d425bc5342e6;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;153616ff-8f49-51a9-9378-a730309e60a5;female;70;not hispanic or latino;Alive;-25788;NA;1932;NA;NA;no;NA;bcfc05af-91ec-509a-89f3-3dbc21b1eed2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;18c7e863-e997-5a7f-8510-d34196db285c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5011;LUSC
TCGA-37-5819;C34.1;not reported;M0;T2;stage iiia;2010;No;103;Squamous cell carcinoma, NOS;N2;3cb5f16c-59d7-5a5d-b393-64282c144c7b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23726;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:12:11.623943-05:00;45;NA;bcfc205c-ce52-5958-b9c8-55244750c173;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;7d32c8e8-4bb1-5fc7-9111-1aba7f09a166;male;64;not hispanic or latino;Alive;-23726;NA;1946;NA;NA;not reported;NA;1411fd28-a983-54de-bddf-ab141bd46571;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;f913e922-1244-5e27-900b-156ad0f48b74;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-5819;LUSC
TCGA-39-5024;C34.9;not reported;M0;T2a;stage iiia;2005;No;2510;Squamous cell carcinoma, NOS;N2;341ed22e-1a33-546f-b954-27167a24ca40;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;23975;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:12:11.623943-05:00;41;NA;2290250b-7c0d-5153-a20e-35044dd47195;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;ed292500-b390-5a77-ab3d-aa7cf4857ac4;female;65;not hispanic or latino;Alive;-23975;NA;1940;NA;NA;yes;NA;3cb759d2-7d6a-576b-9fc1-27d0c80300cf;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6bb44bfb-cc35-53c0-a425-ea796faabda7;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5024;LUSC
TCGA-66-2727;C34.3;not reported;M0;T2;stage ib;2004;No;NA;Squamous cell carcinoma, NOS;N0;614cf3cd-6dc2-57b9-9d26-09c8153e5e34;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;20150;not reported;NA;8070/3;no;NA;5th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;37;NA;712cc81e-cde8-5560-8163-3663df2e64bb;56;NA;306.849.315.068.493;NA;Not Reported;NA;not reported;f91f06b6-33a6-53bd-9300-dcfa7fb04bf8;female;55;not reported;Dead;-20150;2005;1949;516;NA;not reported;NA;70fd72ad-2c1b-5397-8edc-495673a56fef;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;ee5e135c-39e8-5595-b66e-21dcff1ea2ee;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2727;LUSC
TCGA-77-7335;C34.9;not reported;M0;T4;stage iiib;1996;No;NA;Squamous cell carcinoma, keratinizing, NOS;N2;057ae056-aa58-50db-890f-619649cef918;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;22863;not reported;NA;8071/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:35.084062-05:00;26;NA;260c4cb7-059a-5f36-bec3-113bc22b1780;52;NA;284.931.506.849.315;NA;Not Reported;NA;white;de28d9c0-88d7-5326-a561-02e916971b45;female;62;not reported;Dead;-22863;2001;1934;2133;NA;no;NA;2331bf65-583e-5283-a0b5-f85a06aacc95;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a945a98c-1417-55ea-a2b3-b8786d109cb3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-7335;LUSC
TCGA-98-A539;C34.1;not reported;M0;T3;stage iib;2011;No;173;Squamous cell carcinoma, NOS;N0;2fde0e38-0916-50cc-9d1a-948ad1c2a7bc;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23098;not reported;NA;8070/3;yes;NA;7th;Stage IIB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;b8768321-6bee-5b2e-a148-98577021ca98;75;NA;410.958.904.109.589;NA;Not Reported;NA;white;2a01c980-e88c-5d54-8986-70a80e0b4c62;male;63;not hispanic or latino;Alive;-23098;NA;1948;NA;NA;no;NA;1fad07f6-164f-5e3f-a7f9-9d170049d92a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3c079e41-ee22-52cb-a136-636cf7a8dca3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-A539;LUSC
TCGA-66-2756;C34.1;not reported;M0;T4;stage iiib;2007;No;30;Squamous cell carcinoma, NOS;N0;a3b590af-f335-5f0a-b037-f3a37b1f93f1;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24929;not reported;NA;8070/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:13.079700-05:00;40;NA;85e250a3-ebef-5580-8a6a-9041c5dc7a90;NA;NA;NA;NA;Not Reported;NA;not reported;34165af8-b79a-5961-a1da-c2439221d37a;male;68;not reported;Alive;-24929;NA;1939;NA;NA;not reported;NA;70cca796-fb69-5cf0-8fec-d56f06f2e791;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;e354680d-d900-5848-8753-63e5a0eb190a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2756;LUSC
TCGA-85-8354;C34.3;not reported;M0;T2a;stage ib;2011;No;995;Squamous cell carcinoma, NOS;N0;8e2db96f-ac95-59db-a6d2-5c79e375417b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;19692;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;ec4de6bd-3631-5a41-b791-a75134bb1ed5;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;cb6e0080-53c3-52c9-a186-a5d1e58683f2;male;53;not hispanic or latino;Alive;-19692;NA;1958;NA;NA;no;NA;19fccc96-85bb-526b-a8eb-0326c00d4bee;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;2f2937da-e040-508e-ae87-703756b7532b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8354;LUSC
TCGA-77-A5G7;C34.1;not reported;M0;T1;stage ia;2009;No;NA;Squamous cell carcinoma, NOS;N0;8da5f710-3e65-54ef-92a2-4089db63a602;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23090;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;dd647962-8ed5-5d97-b97a-a7d182d445f5;69;NA;378.082.191.780.822;NA;Not Reported;NA;not reported;f006362c-eaf5-59e5-a1fb-f428a12e0c53;male;63;not reported;Dead;-23090;2009;1946;180;NA;no;NA;f06e6ca5-b1ce-5f63-ae40-096fb03bf582;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ae89910f-2cb2-5b0c-ac35-c6599a461a31;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-A5G7;LUSC
TCGA-34-8456;C34.3;not reported;M0;T2a;stage iia;2011;No;804;Squamous cell carcinoma, NOS;N1;366cdaae-3aea-55a7-9283-74f8d96c20c3;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26183;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;5892af12-1556-5e63-bc0c-b03b6cf5cd66;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;6ee28f3d-8e17-5022-af61-a9571dee8da1;female;71;not hispanic or latino;Alive;-26183;NA;1940;NA;NA;no;NA;5b0448dc-36b5-567a-bd1c-9557e53ca2e5;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c9237968-437b-5fc6-b418-f18b74f8814d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-8456;LUSC
TCGA-66-2780;C34.1;not reported;M0;T2;stage ib;2007;No;NA;Squamous cell carcinoma, NOS;N0;288ac11f-385b-53bc-b6a5-71b49ef17897;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23955;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;14;NA;66f1a7e8-005e-56bb-ad89-70ae938f2985;28;NA;153.424.657.534.247;NA;Not Reported;NA;not reported;99636601-b5f8-599c-a12c-b3d6189b55af;male;65;not reported;Dead;-23955;2008;1942;366;NA;not reported;NA;e9c645d5-83ed-5702-93a8-6579ed7bd8d0;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;e3ea4514-96bf-5aa2-95fc-572fd5719a4f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2780;LUSC
TCGA-66-2789;C34.3;not reported;M0;T1;stage iiib;2008;No;NA;Squamous cell carcinoma, NOS;N3;47ff7229-af8f-5325-9a62-da6c18228a3e;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26753;not reported;NA;8070/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:35.084062-05:00;40;NA;da2fd851-cb1d-5270-9d80-577a619aa181;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;a48a13c8-b37f-5e8c-8568-09957fdeca97;male;73;not reported;Dead;-26753;2008;1935;123;NA;not reported;NA;525069fd-14bd-531e-9b36-972c98660027;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;926f1fe5-a1cf-5600-b048-b5dcf9228218;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2789;LUSC
TCGA-85-A50Z;C34.1;not reported;M0;T2b;stage iia;2012;No;493;Squamous cell carcinoma, NOS;N0;1d2f2fc1-bde1-5af6-875b-f9f82f52aaa9;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20941;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;e9e3adde-2694-5639-88f2-3aa66583e300;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;231df915-1f37-53d9-b4b5-c6ed54522757;male;57;not hispanic or latino;Alive;-20941;NA;1955;NA;NA;yes;NA;9ec0ae75-e83f-56e2-bee7-e154354ee846;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;bc0d7754-23c2-5041-b93d-26902609d18e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A50Z;LUSC
TCGA-39-5028;C34.1;not reported;M0;T4;stage iiia;2006;No;52;Squamous cell carcinoma, NOS;N1;1cbf4084-5844-512d-a2b7-1e37930dd4b5;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27707;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:12:11.623943-05:00;35;NA;349a3f5e-42f8-5541-a5ab-5d404a5a523d;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;c315ed6f-7fad-5c47-b24a-897a122ad679;male;75;not hispanic or latino;Dead;-27707;2006;1931;52;NA;no;NA;fc7b67c2-b5cb-5ad9-8d91-ad85061ce7e3;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;072e1383-d485-5f5e-9fa0-850a438b40de;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5028;LUSC
TCGA-43-A56U;C34.1;not reported;MX;T1b;stage ia;2012;No;432;Squamous cell carcinoma, NOS;N0;b896db7f-41fc-5020-b30a-3509a5b2145e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27847;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:31.795062-05:00;41;NA;cbfdddde-8533-5100-867f-07d21e172342;20.5;NA;112.328.767.123.288;NA;Not Reported;NA;white;58888863-f745-5055-9203-8897890bc5f6;female;76;not hispanic or latino;Alive;-27847;NA;1936;NA;NA;no;NA;0b7b0898-8b41-59b7-b2ee-3482491ae2c4;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4f453ffb-bf8b-5e6d-a190-b452b2f41a6c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-A56U;LUSC
TCGA-58-A46L;C34.1;not reported;M0;T2;stage iiia;2008;No;1723;Basaloid squamous cell carcinoma;N2;3dd22f5e-594c-537f-a58d-aec12722a228;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26685;not reported;NA;8083/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;468aef79-046e-55fb-9fb4-f36a6ed454cb;NA;NA;NA;NA;Not Reported;NA;white;fe17c667-c9da-5ef0-aa3d-663e66309bc2;male;73;not hispanic or latino;Alive;-26685;NA;1935;NA;NA;yes;NA;6eb8e5f6-0ce7-517b-bb31-62241dc33405;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3b585115-0f8f-51e1-ba30-6d9a614b72fe;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-58-A46L;LUSC
TCGA-63-A5MM;C34.8;not reported;M0;T2;stage iib;NA;No;NA;Squamous cell carcinoma, NOS;N1;45526f72-185d-5d9e-a5a3-3c5eec4c4398;not reported;NA;Overlapping lesion of lung;No;Overlapping lesion of lung;released;NA;25348;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;070e43e7-e9b8-5e19-b787-f932219af66c;30;NA;164.383.561.643.836;NA;Not Reported;NA;not reported;19370788-e83a-5328-be20-e86a21e8226b;female;69;not reported;Dead;-25348;NA;NA;456;NA;yes;NA;05aac3cf-edd7-5c5f-bb20-a970223bc815;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;22b7585e-11bd-5827-b709-274d862f3339;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MM;LUSC
TCGA-66-2785;C34.1;not reported;M0;T2;stage ib;2008;No;60;Squamous cell carcinoma, NOS;N0;5df96bf8-a9df-5380-ba3d-14ebe6be661a;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23772;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;NA;NA;691cc17b-0f81-5573-83fb-419d32b6b86f;70;NA;383.561.643.835.616;NA;Not Reported;NA;not reported;2f38d852-88e4-5175-b6a4-febd493000db;male;65;not reported;Alive;-23772;NA;1943;NA;NA;not reported;NA;bb298ed9-15ce-5d66-b878-d29964f1c2af;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;6847066c-8311-58a3-883e-a4d30b83a9bf;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2785;LUSC
TCGA-43-7657;C34.1;not reported;MX;T1;stage ia;2011;Not Reported;236;Squamous cell carcinoma, NOS;N0;5883fd80-898d-520b-9499-5ae859adbc1f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25042;not reported;NA;8070/3;yes;NA;7th;Stage IA;not reported;2019-08-08T17:12:31.795062-05:00;45;NA;4a1eeb74-5370-52e5-8b43-25a535fb872c;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;ef99209f-e2ed-5a06-b87d-67758c907da6;female;68;not hispanic or latino;Alive;-25042;NA;1943;NA;NA;no;NA;81ecff60-da43-586f-a00c-6a6fcff15dad;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;bf74fa95-1d0d-5bb0-90e1-f23042e575f8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-7657;LUSC
TCGA-60-2720;C34.3;not reported;M0;T2;stage ib;2007;No;97;Squamous cell carcinoma, NOS;N0;8f37d045-e27e-5dd8-980f-8c912e63bcc9;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22238;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;40;NA;f57f52f0-6b9e-5895-9f91-1f911225417a;110;NA;602.739.726.027.397;NA;Not Reported;NA;white;52d9a7f6-d81f-5cf2-8f0e-0ed5603c1ce3;female;60;not hispanic or latino;Alive;-22238;NA;1947;NA;NA;yes;NA;53fbb353-65ba-51f7-9d9c-147b6541ddf0;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;866ae3ff-4e1d-53e4-8d29-4c0a021b0c3f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2720;LUSC
TCGA-O2-A52W;C34.2;not reported;MX;T2;stage i;2006;No;NA;Squamous cell carcinoma, NOS;N0;01c8bb5f-c5fd-5c68-802d-7b39d26ce9fe;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;23156;not reported;NA;8070/3;yes;NA;6th;Stage I;not reported;2019-08-08T17:14:58.925606-05:00;50;NA;e13cb0dc-ff50-5c7c-aa98-ef0e8d3cc9bf;2.5;NA;0.136986301369863;NA;Not Reported;NA;black or african american;4972623f-557c-56f3-9f0b-6643663056c9;male;63;not hispanic or latino;Dead;-23156;2006;1943;261;NA;no;NA;b94724a1-675c-5bc3-9c45-a0619ce76d3b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;53c3e9f8-8f6f-59db-8a7c-9af652f6fbb7;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-O2-A52W;LUSC
TCGA-60-2696;C34.1;not reported;M0;T2;stage iia;2009;Not Reported;109;Squamous cell carcinoma, NOS;N0;b2c46277-2959-512d-85df-9fd55cba0975;not reported;NA;Upper lobe, lung;Yes;Upper lobe, lung;released;0;27991;not reported;NA;8070/3;yes;NA;NA;Stage IIA;not reported;2019-08-08T17:12:53.407315-05:00;30;NA;19c64bd9-45aa-5e56-a2ce-c41c24bd1174;15;NA;0.821917808219178;NA;Not Reported;NA;black or african american;f86e6e1f-35ca-500a-88c0-dfa492a336c3;female;76;not hispanic or latino;Dead;-27991;2009;1933;109;NA;no;NA;9f6fb870-afed-598c-b9f7-3e6a014a78f7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a79346d2-a09c-5d37-b689-24f7b9463e7e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2696;LUSC
TCGA-92-8063;C34.1;not reported;MX;T2b;stage iiia;2011;No;122;Squamous cell carcinoma, NOS;N2;1318ac51-464a-58d9-92b5-203bbd118a87;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;19193;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;ee8eecc8-d3e9-58be-b1fe-23bce2aef67d;74;NA;405.479.452.054.795;NA;Not Reported;NA;white;eaa95d18-861b-5e7d-b9fe-7d93052125b1;male;52;not hispanic or latino;Alive;-19193;NA;1959;NA;NA;yes;NA;f848c894-66a6-5c82-b276-171b8fe6be06;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;ffef1386-2395-53cf-895c-d1590bfc90e5;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-92-8063;LUSC
TCGA-21-1076;C34.3;not reported;M0;T2;stage ib;2005;No;1852;Squamous cell carcinoma, NOS;N0;fec0fec5-2cec-58bd-a031-3006d5ff5a64;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;19863;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;8910a0b3-5203-5b4e-9d71-6b7b3b1a6e89;35;NA;191.780.821.917.808;NA;Not Reported;NA;white;dc5047c3-5ba3-5537-931b-316cb71237cb;female;54;not hispanic or latino;Alive;-19863;NA;1951;NA;NA;no;NA;7b9a26f0-bac2-5e84-a8ab-658603a105be;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7a57d29e-d99c-5adf-93cc-75bfa42676b1;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-1076;LUSC
TCGA-77-7463;C34.1;not reported;M0;T2;stage ib;2001;No;NA;Squamous cell carcinoma, NOS;N0;cb731b52-a693-51a7-b521-8e288cb582d4;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27520;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;42;NA;e059948f-af6d-5807-a525-9f2c914419cb;42;NA;23.013.698.630.137;NA;Not Reported;NA;white;9420df0a-250c-5f22-8253-1caad122cb59;male;75;not reported;Dead;-27520;2004;1926;1423;NA;no;NA;2a5f4e98-dac3-5045-98f3-9843e1f5aca5;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;f0734370-d7fa-5d0b-9f85-2386196d8d6f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-7463;LUSC
TCGA-6A-AB49;C34.3;not reported;MX;T2;stage ib;2009;No;NA;Squamous cell carcinoma, NOS;N0;dc068fbf-8cb3-53a8-88ef-5313998b9c0e;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;NA;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;NA;NA;b20436c1-200e-5828-ac04-d394718d71dc;50;NA;273.972.602.739.726;NA;Not Reported;NA;black or african american;24b11492-8a7a-504e-9e2b-dceff46cd606;female;73;not hispanic or latino;Dead;NA;NA;1936;NA;NA;no;NA;225debe5-803f-56fb-9d89-43d772776136;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;816b4225-f002-5fb0-bd5d-70e89ae9ee60;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-6A-AB49;LUSC
TCGA-66-2769;C34.1;not reported;M0;T4;stage iiib;2007;No;NA;Squamous cell carcinoma, NOS;N0;4dce428e-ad0e-502b-a545-b307f7565c3f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27515;not reported;NA;8070/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:35.084062-05:00;33;NA;fd12e39e-8be2-575d-8f0d-d0a27caf1621;33;NA;180.821.917.808.219;NA;Not Reported;NA;not reported;20b7beaf-3060-50bc-acf1-163542642e5d;male;75;not reported;Dead;-27515;2007;1932;215;NA;not reported;NA;b6d0d01d-aa4c-5341-9041-0b9986439801;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;0e12fccd-20cf-544a-ad59-25ccfc84fbb4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2769;LUSC
TCGA-63-A5MV;C34.3;not reported;M0;T2b;stage iia;NA;No;1100;Squamous cell carcinoma, NOS;N0;685b9dbc-5883-5c87-94b0-2ef1ceda959c;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;NA;25505;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:13:13.079700-05:00;50;NA;f8018960-9912-5ce3-b878-ea763f8bb5f4;50;NA;273.972.602.739.726;NA;Not Reported;NA;not reported;431efb51-dbbd-53d0-9f4d-166478e6e82e;male;69;not reported;Alive;-25505;NA;NA;NA;NA;yes;NA;87e8bfc2-5297-504e-b8f3-a522504f5fd6;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4dcdfebe-ae74-58a5-91ae-f8454459fde7;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MV;LUSC
TCGA-85-7698;C34.1;not reported;M0;T1b;stage ia;2011;No;952;Squamous cell carcinoma, NOS;N0;9802e7cf-3e1c-5ee5-a5d9-9ba06aeba9c0;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;17651;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;8646f77c-4974-506e-acea-5b9f24284c43;44;NA;241.095.890.410.959;NA;Not Reported;NA;white;991f9613-476d-5c7c-8056-99d579d20a18;male;48;not hispanic or latino;Alive;-17651;NA;1963;NA;NA;yes;NA;d04f9214-0613-5367-b1c1-8e1d21e62be6;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c6b719a8-4205-5073-af38-8e8c8b8c499f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-7698;LUSC
TCGA-63-A5MJ;C34.9;not reported;M0;T2;stage iib;NA;No;1824;Squamous cell carcinoma, NOS;N1;c0358f2d-8318-5fff-b7da-cfdd461ebc68;not reported;NA;Lung, NOS;No;Lung, NOS;released;NA;20018;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;94e0019e-27ac-5da0-89bc-896d61ea7a0c;NA;NA;NA;NA;Not Reported;NA;not reported;33b985d7-4d72-5bd6-89ba-018b25f2fd97;male;54;not reported;Alive;-20018;NA;NA;NA;NA;yes;NA;939a223f-1721-5632-8bee-5184f83526c1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;d87bb382-dee3-56cd-9ca5-cdb21015811c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MJ;LUSC
TCGA-46-3768;C34.1;not reported;M0;T3;stage iiia;2010;No;4;Squamous cell carcinoma, NOS;N1;0c392dce-589c-5e09-90ff-5bbfd8781e3b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21307;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;ba3ed5b6-b67c-5a7b-88bf-c18a39373446;NA;NA;NA;NA;Not Reported;NA;white;c6427ba1-f2a8-51d3-8b9e-f35b9253bf9f;male;58;not hispanic or latino;Dead;-21307;2010;1952;299;NA;yes;NA;8d353e0f-b5dc-57d2-be66-7b9f1b29c523;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;d3fc46ca-c1a9-5427-8ec0-1cad3648d110;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-46-3768;LUSC
TCGA-34-2600;C34.3;not reported;M0;T1;stage ia;2000;No;1874;Squamous cell carcinoma, NOS;N0;0b59171e-159e-5e21-bc60-c9c7228bdd47;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28072;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;097cfd2c-fbfd-5013-b24e-72411e4a92a0;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;e5dc1d61-aa66-548f-8143-283b9eec36d1;female;76;not hispanic or latino;Dead;-28072;2005;1924;1874;NA;no;NA;b30f8b2a-03a9-56c6-b82d-721f92d1286a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c44a7ff2-6c7a-5a09-8bc6-a65c122f9586;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-2600;LUSC
TCGA-34-2604;C34.3;not reported;M0;T2;stage ib;1999;Not Reported;958;Squamous cell carcinoma, NOS;N0;56c474cc-f039-55d1-b890-a8d7ad7985d7;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;29827;not reported;NA;8070/3;yes;NA;NA;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;7397fb77-bd11-50fb-93a3-052dcbc6dc34;132;NA;723.287.671.232.877;NA;Not Reported;NA;white;fe71603a-f786-5b41-aed9-0e55cc0faf43;female;81;not hispanic or latino;Dead;-29827;2001;1918;958;NA;no;NA;509a66a1-57c9-595d-a315-482625a14db8;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;82d14758-7675-5bf8-bd14-4060c1b4c1db;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-2604;LUSC
TCGA-77-7139;C34.3;not reported;M0;T2;stage iib;2002;No;4261;Squamous cell carcinoma, NOS;N1;ff2c3e22-a4ab-527e-b1b1-2f9f453bc772;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;20632;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:35.084062-05:00;23;NA;ca19a319-d390-5eec-82e6-69ea4d674a00;2;NA;0.10958904109589;NA;Not Reported;NA;white;5bf682ac-bf9e-574b-979d-4b4e69ed266d;male;56;not reported;Alive;-20632;NA;1946;NA;NA;no;NA;bd875bca-4791-56d8-91a6-61d11e9b4fac;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;f4067b81-080a-5cab-b662-5a1dab9a6087;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-7139;LUSC
TCGA-98-A538;C34.1;not reported;M0;T3;stage iib;2012;No;826;Squamous cell carcinoma, NOS;N0;b83a0686-447b-5892-a86f-e51b206be013;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24698;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:36.542202-05:00;35;NA;a0f88ae5-955b-5562-b5c2-37930c53d53c;35;NA;191.780.821.917.808;NA;Not Reported;NA;white;dac9c151-ccf5-5517-b276-726bab36596a;male;67;not hispanic or latino;Alive;-24698;NA;1945;NA;NA;no;NA;c97fd428-dd2a-5781-83e3-78baea00a2b1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c28c1e8a-f2a9-53c7-b4a9-371174e88798;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-A538;LUSC
TCGA-37-A5EN;C34.2;not reported;M0;T4;stage iiib;2011;No;660;Squamous cell carcinoma, NOS;N2;a6ec44d0-59d6-5db7-83a6-e2fdfb6144d9;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;21600;not reported;NA;8070/3;no;NA;7th;Stage IIIB;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;0e777836-fa66-5195-8204-22d211cd47d6;NA;NA;NA;NA;Not Reported;NA;white;bfdab608-0c38-56e1-9f3a-131b9ddfe0e3;male;59;not hispanic or latino;Alive;-21600;NA;1952;NA;NA;no;NA;2fdc32b3-fd45-528f-b3d9-b6cf309b3763;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;8d637985-d6a3-542d-9544-3c24f3f45ad5;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-A5EN;LUSC
TCGA-60-2722;C34.1;not reported;M0;T2;stage iib;2008;No;908;Squamous cell carcinoma, NOS;N1;f88fd772-ee03-58e5-ac6f-8ccb66fedf47;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24267;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;6adcc685-87af-543c-95cc-605490be8162;90;NA;493.150.684.931.507;NA;Not Reported;NA;white;9658a41a-8f9a-56be-8b12-23dc818af6dd;male;66;not hispanic or latino;Alive;-24267;NA;1942;NA;NA;yes;NA;e33052bb-f84e-5ed6-b16b-dbdbfc10ec63;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;252ad946-4c4c-5e76-9bb4-b6df540ee111;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2722;LUSC
TCGA-60-2703;C34.9;not reported;M0;T2;stage iib;2002;No;NA;Squamous cell carcinoma, NOS;N1;d9d9a124-f289-5196-bccf-d1932cfa5fc8;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;27003;not reported;NA;8070/3;no;NA;5th;Stage IIB;not reported;2019-08-08T17:12:53.407315-05:00;50;NA;83c81ccd-4e91-5256-ba72-bb99713688ea;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;8adf35fc-4aad-5b7a-8140-f951a6ec5f7d;male;73;not hispanic or latino;Dead;-27003;2010;1929;2945;NA;no;NA;6439b826-11d1-502f-b8dd-b6c3b80ae0cc;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4f35735c-aa10-511d-a808-30703bb1ab6a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2703;LUSC
TCGA-NC-A5HR;C34.3;not reported;M0;T2a;stage iia;2011;No;1244;Basaloid squamous cell carcinoma;N1;dcbcf455-e9fa-5ed6-aae1-18483e22338f;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27629;not reported;NA;8083/3;yes;NA;7th;Stage IIA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;67cfd256-d252-56ed-9fcc-229ff563f259;35;NA;191.780.821.917.808;NA;Not Reported;NA;white;b5aec87b-f5b6-5a53-8b39-b1b68750c666;female;75;not reported;Alive;-27629;NA;1936;NA;NA;yes;NA;ebbf5624-0403-5c93-a9af-99175fd21fb2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;983882f5-8eae-578a-b24c-b9e2aeddb38b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HR;LUSC
TCGA-60-2706;C34.9;not reported;M0;T1;stage ia;2003;No;2820;Squamous cell carcinoma, NOS;N0;3a3fb50f-080d-5fc3-ba2b-2e028a47d1f5;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;21477;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;30692a14-ff3f-5f7f-bab4-6b99ee81a22a;51;NA;279.452.054.794.521;NA;Not Reported;NA;white;0b29380a-6392-5098-ba55-ba6492b5e5d0;male;58;not hispanic or latino;Alive;-21477;NA;1945;NA;NA;no;NA;3af87651-dcd6-5bd0-b7fb-1af12d727708;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;88223200-7bfe-53a4-a8ae-6e2f6a843c7b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2706;LUSC
TCGA-85-8582;C34.1;not reported;M0;T1a;stage ia;2012;No;1160;Squamous cell carcinoma, keratinizing, NOS;N0;cc3a645f-f4d7-5d3b-8f22-69fba81844b8;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;18168;not reported;NA;8071/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;e96725c2-bbc2-5bc8-9cf5-cc6098649eb3;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;6cecd50c-3805-5055-9899-45d355e4bcea;male;49;not hispanic or latino;Alive;-18168;NA;1963;NA;NA;no;NA;76e301c2-0aa1-5828-8ffe-990b31b0dccd;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;68e71e30-10eb-592f-b202-0fbb5f6e0508;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8582;LUSC
TCGA-46-6025;C34.3;not reported;M0;T2b;stage iib;2010;No;324;Squamous cell carcinoma, NOS;N1;9a229056-7b85-508c-8bc5-064651d7cc60;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26168;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;ccbd83cf-fd43-5ae0-99cb-2c12f34d9c8a;NA;NA;NA;NA;Not Reported;NA;white;3d82843a-da01-5fee-a38e-06cf266f448e;male;71;not hispanic or latino;Alive;-26168;NA;1939;NA;NA;yes;NA;5afa56a2-1195-520c-bd61-c2e64b9b345e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;8e00a0cd-97c9-56e3-8250-54f7398e2629;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-46-6025;LUSC
TCGA-43-5670;C34.3;not reported;M0;T2b;stage iia;2010;No;849;Squamous cell carcinoma, NOS;N0;c6bf3849-3dc9-548d-a2d5-d7a07010793d;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25652;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:31.795062-05:00;10;NA;af96d2b2-d1c3-54a0-b6e8-818dafd60244;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;2a0d06ff-0829-513d-85dc-3547b246b42a;male;70;not hispanic or latino;Alive;-25652;NA;1940;NA;NA;yes;NA;c64adfca-46f1-5e29-ac47-70b3fd390a5d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;0d18ac3c-981f-504a-9b1e-9f6dd74dd5af;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-5670;LUSC
TCGA-63-A5MN;C34.1;not reported;M0;T3;stage iib;NA;No;NA;Squamous cell carcinoma, NOS;N0;73155c78-a974-5e03-8aad-b42a8386b124;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;NA;28677;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;096e98c0-0ba9-529b-ab50-e0ec0ccf5049;NA;NA;NA;NA;Not Reported;NA;not reported;e7752e4f-e2f3-5c2b-be72-bb0a590af542;female;78;not reported;Dead;-28677;NA;NA;345;NA;no;NA;74504a74-3391-5197-802f-c33546b7ff7d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;11f7ab0a-4efb-5380-9c79-834e66858376;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MN;LUSC
TCGA-34-5239;C34.1;not reported;M0;T4;stage iiia;2010;No;1834;Squamous cell carcinoma, NOS;N0;c983d81e-671f-594a-b940-2009575cb454;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27528;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;3f56336b-98b5-54bd-91f5-1dfb5e52432f;NA;NA;NA;NA;Not Reported;NA;white;b41457b7-18ee-5bf7-aa18-b76e454a7f88;male;75;not hispanic or latino;Alive;-27528;NA;1935;NA;NA;yes;NA;72c2edf4-51bb-59e2-9281-e6350a06989f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;95779c48-33c6-5621-bfeb-49d84eda804c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-5239;LUSC
TCGA-90-6837;C34.8;not reported;MX;T3;stage iib;2011;No;758;Squamous cell carcinoma, NOS;N0;8613e60f-298c-5875-b2be-26eeac35ceb7;not reported;NA;Overlapping lesion of lung;No;Overlapping lesion of lung;released;0;23511;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;7967999d-5d36-5fa0-848b-cb7b8465a905;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;91ca1eda-e9bc-5c7e-a4c6-ca3d98c4bffd;male;64;not hispanic or latino;Alive;-23511;NA;1947;NA;NA;yes;NA;0bbf9bc1-21c4-5744-80c9-b02ff72d2461;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;0f4cd035-6253-5d8f-8e24-e686905e2c4b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-90-6837;LUSC
TCGA-68-A59J;C34.3;not reported;MX;T2a;stage ib;2012;No;448;Squamous cell carcinoma, NOS;N0;6c8cdcda-4dbd-58c1-b88a-ad2e5d991e42;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27031;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;45;NA;d7a89697-450c-5f3c-873f-18f9aa16b439;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;7b7f987c-9a34-5ce6-a4f5-e1f011b4b1d1;female;74;not hispanic or latino;Alive;-27031;NA;1938;NA;NA;no;NA;07e44056-1c16-5b18-8db4-cf6f6860570a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;00a1feab-f7f7-5a61-9816-0a5d1d0d1913;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-68-A59J;LUSC
TCGA-85-8048;C34.3;not reported;M0;T1;stage ia;2011;No;765;Squamous cell carcinoma, NOS;N0;c6b5cffc-34b9-5ce8-ad4d-6b4b9cedc737;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22907;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;411fc2db-bb64-59c5-bb8a-d0bf2e6aabbd;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;48c4d9ef-bb90-5cec-af29-f39397aaef09;male;62;not hispanic or latino;Alive;-22907;NA;1949;NA;NA;no;NA;30f6248f-8ec3-5919-b1cb-8a10c08f2a66;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;1c70aa2f-fccd-550a-ac7f-2cdd4f1d0551;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8048;LUSC
TCGA-98-8020;C34.1;not reported;M0;T2;stage iiia;2011;No;NA;Squamous cell carcinoma, NOS;N2;84348425-75e6-5849-9ed4-b9466f10a98e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20509;not reported;NA;8070/3;yes;NA;7th;Stage IIIA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;d2c0d487-06b6-5c8d-aa58-7dfaebce50a8;NA;NA;NA;NA;Not Reported;NA;black or african american;18d18d09-02f3-55bc-9986-2c7eeeea2f00;female;56;not hispanic or latino;Dead;-20509;2011;1955;84;NA;no;NA;a904573b-3377-516b-9d8d-6f3caaca7d6a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;1300cb5f-890b-5b09-8277-b29f14bd7070;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-8020;LUSC
TCGA-NK-A5CX;C34.3;not reported;MX;T2b;stage iia;2011;No;111;Squamous cell carcinoma, NOS;N0;85152716-e0f3-5baf-91a9-8f08a075f6b8;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26879;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;1852e3a3-bb1c-59e1-a347-a3adfa279a10;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;b89ffd7e-c0ac-596f-926f-9ee7545002dd;male;73;not hispanic or latino;Alive;-26879;NA;1938;NA;NA;no;NA;731b052e-e5e9-5f53-9122-9b3efc7afefb;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7ed01262-ad9a-5f6d-a053-6a630af94344;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NK-A5CX;LUSC
TCGA-21-1071;C34.1;not reported;M0;T2;stage ib;2001;No;1426;Squamous cell carcinoma, NOS;N0;ebe4cc0e-c835-5f20-a57f-c06f3aa8f9cf;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24515;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;fcc10cc3-6d9a-5368-8aa0-92635a708f0b;90;NA;493.150.684.931.507;NA;Not Reported;NA;white;76c7b196-37ec-5486-8e67-1890e41e6c92;male;67;not hispanic or latino;Dead;-24515;2004;1934;1426;NA;no;NA;8e4fdd00-4ce9-513c-9d3e-bb65b9a9340a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;0b91adff-1ce2-5ddb-a769-58f1bcdb8f50;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-1071;LUSC
TCGA-77-8143;C34.1;not reported;M0;T2;stage iiia;2004;No;NA;Squamous cell carcinoma, NOS;N2;2fa2d3e8-10a8-5de4-8657-dc8c3a40fc2d;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27772;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;108f4bcd-069f-5fcb-b22f-076da2213f82;30;NA;164.383.561.643.836;NA;Not Reported;NA;not reported;da2e5b25-1391-5425-b6d3-1443511b31a8;male;76;not reported;Dead;-27772;2006;1928;803;NA;no;NA;d13e25c7-a328-509f-9f5b-1b07ed417752;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;9e8850f6-23af-557c-8568-cb63841cf140;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8143;LUSC
TCGA-22-5485;C34.1;not reported;M0;T1a;stage ia;2001;No;916;Squamous cell carcinoma, NOS;N0;944b6499-e0df-5432-9da2-ce5a055de453;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21488;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;62949f58-7604-5124-86eb-1f238c4fa372;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;5d7aafcd-69d9-5fbf-9d1b-7f8dd30a4f23;female;58;not reported;Dead;-21488;2003;1943;916;NA;no;NA;2e1c36f5-48ce-51ac-bee9-30aea283cc44;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ee119d8f-1c46-5be5-9f5e-aeb73b3afb57;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5485;LUSC
TCGA-39-5037;C34.3;not reported;M0;T1b;stage iia;2007;No;1690;Squamous cell carcinoma, NOS;N1;fe4439ad-295b-5169-b89c-4dc7930dddb8;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;23868;not reported;NA;8070/3;no;NA;6th;Stage IIA;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;35989433-93da-53d8-81ce-51a7018ba1b8;26;NA;142.465.753.424.658;NA;Not Reported;NA;white;82721aef-15a1-5c10-8876-9d92c7fa8100;male;65;not hispanic or latino;Alive;-23868;NA;1942;NA;NA;yes;NA;89d1a5ba-83bc-531d-ae6a-2c14427e6fbf;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a0908725-7c74-5714-9a16-5c253c1f05e4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5037;LUSC
TCGA-22-5489;C34.1;not reported;M0;T1b;stage ia;2003;No;1912;Squamous cell carcinoma, NOS;N0;51aa12d8-ab07-5d0e-9d38-264f026b46b3;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23618;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;e228b3cb-d36d-5157-983f-1059e5d3f264;70;NA;383.561.643.835.616;NA;Not Reported;NA;white;f1dcd73e-24fd-5eef-85d6-f7826d7595d9;male;64;not reported;Dead;-23618;2008;1939;1912;NA;no;NA;28e0fa51-69b0-5d4e-b1b5-4714193726a0;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;73855de0-deb2-59c2-a013-f09e2e7baf1a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5489;LUSC
TCGA-37-A5EL;C34.1;not reported;M0;T3;stage iib;2011;No;454;Squamous cell carcinoma, NOS;N0;78f20850-cf65-518e-9ba4-0eff560c9750;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;19371;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;cfb59a25-fe72-5442-9906-8800739b348c;NA;NA;NA;NA;Not Reported;NA;white;32ad138f-caad-5308-904c-e2da484c21ee;male;53;not hispanic or latino;Dead;-19371;NA;1958;1143;NA;yes;NA;bbf9ee0a-b5b7-512f-aebc-c94d207fbb60;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;a2f1a0cc-8c4e-5745-b2cb-5e692b153391;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-A5EL;LUSC
TCGA-21-1081;C34.3;not reported;M0;T2;stage iib;1996;No;284;Squamous cell carcinoma, NOS;N1;7ce703db-8d1a-5dee-9540-d2069d67fc74;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25440;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;bb29c94f-395e-5509-9490-10e2cfcc2b62;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;1f0bbbef-b4ce-5866-bd3d-e6e54a754b9b;male;69;not hispanic or latino;Dead;-25440;1996;1927;284;NA;no;NA;dabb27a6-7217-5d61-b653-8956c7622182;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;0d57f783-7171-5f5d-907d-ad868f62f56b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-1081;LUSC
TCGA-43-7658;C34.1;not reported;M0;T1;stage ia;2006;Not Reported;2023;Squamous cell carcinoma, NOS;N0;64b8312b-1ddb-59b7-b5d3-23d6ee327a8b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27734;not reported;NA;8070/3;yes;NA;6th;Stage IA;not reported;2019-08-08T17:12:31.795062-05:00;25;NA;30659e73-3e34-5e73-82d0-a16af57f81ed;12;NA;0.657534246575342;NA;Not Reported;NA;white;1cc2fb57-cbc3-58ed-a743-c6959480ae2a;female;75;not reported;Dead;-27734;NA;1931;2378;NA;no;NA;6cdbf4ac-69ef-5f81-89b3-50abf8cf3be9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;b48ac6ed-aca8-5242-a557-c64e4a194413;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-7658;LUSC
TCGA-66-2734;C34.3;not reported;M0;T2;stage ib;2005;No;1311;Squamous cell carcinoma, NOS;N0;a3155ecb-0524-5a0c-a4ef-c7d4bbe38c08;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22919;not reported;NA;8070/3;no;NA;5th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;40;NA;2a8e9182-66ee-52b9-9d11-2263f9aef96b;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;ea48d26d-0d1d-58dd-81cc-d4d10954f76d;female;62;not reported;Alive;-22919;NA;1943;NA;NA;no;NA;350d6097-26ca-5b8d-98e2-983d27a6ebb3;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;600d43fa-57d9-587b-8321-4b482b6a2e6f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2734;LUSC
TCGA-56-8626;C34.1;not reported;MX;T1a;stage ia;2012;No;17;Squamous cell carcinoma, NOS;N0;f75f9eaf-484c-5cc5-9f89-28825e8647e2;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21908;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;cbfcd999-4d95-543f-ab37-47a75ab9c621;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;c8bcafcd-b637-55f6-ad52-b36425b11f52;male;59;not hispanic or latino;Dead;-21908;NA;1953;302;NA;no;NA;8527719b-5c6b-5f92-832f-b7f2bfbc952a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e5c6f01d-7463-5919-8d1a-75ef7caad2b5;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8626;LUSC
TCGA-66-2766;C34.1;not reported;M0;T2;stage iiia;2007;No;31;Squamous cell carcinoma, NOS;N2;86379302-1ef9-598e-a929-6a7252958a27;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;19814;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:13:13.079700-05:00;40;NA;e4e61e43-881e-57e1-98df-63a0e4ee2ac9;80;NA;438.356.164.383.562;NA;Not Reported;NA;not reported;330ad5ce-c6ba-5424-be3c-1d5e9a24041d;male;54;not reported;Alive;-19814;NA;1953;NA;NA;not reported;NA;2f56c318-d757-57e5-80bb-1b591078dda1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;adb5c785-0b90-5015-b826-0fa87a5cdbd0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2766;LUSC
TCGA-85-8277;C34.1;not reported;M0;T3;stage iiia;2011;No;11;Squamous cell carcinoma, NOS;N1;09ae61e3-5a89-51bb-8efe-30f554eda743;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25793;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;7b47ad34-c454-5714-a9d4-eb8ade211bf9;NA;NA;NA;NA;Not Reported;NA;white;f666a056-bb12-5ae7-ae38-8faf253827d0;male;70;not hispanic or latino;Dead;-25793;NA;1941;307;NA;no;NA;ffbb8e6e-417b-54c9-b07a-d9754b5fc231;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c54bbe90-90fa-557e-aae1-4315d1f17a7b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8277;LUSC
TCGA-43-8116;C34.1;not reported;M0;T1b;stage ia;2011;No;358;Squamous cell carcinoma, NOS;N0;d74c4e6f-4d48-5828-94b5-f010ca412158;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26790;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;ba722629-8fcb-5df8-b954-7bc19be49160;35;NA;191.780.821.917.808;NA;Not Reported;NA;white;b2c421b0-248e-5474-a954-bdbe84cd52ed;male;73;not hispanic or latino;Alive;-26790;NA;1938;NA;NA;no;NA;0845e7b8-40d8-5040-a589-2626423898eb;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c7c73ca5-8d60-5951-876e-506885081ac8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-8116;LUSC
TCGA-21-1077;C34.1;not reported;M0;T2;stage iib;2006;Not Reported;1058;Squamous cell carcinoma, NOS;N1;633bca3f-8180-5a01-87c6-39f7bc6d2ce8;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23523;not reported;NA;8070/3;yes;NA;NA;Stage IIB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;e76fcba5-b5d5-536e-a547-4ea938acd760;56;NA;306.849.315.068.493;NA;Not Reported;NA;white;2b7c5d75-9067-514a-a16b-6cb9e45eaa4e;male;64;not hispanic or latino;Dead;-23523;2008;1942;1058;NA;no;NA;a7b83b40-fbe4-56b8-83e5-efd49a33c85c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ea213c55-07e5-5161-8e89-0de9048cfde0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-1077;LUSC
TCGA-60-2724;C34.9;not reported;M0;T3;stage iiia;2008;No;717;Squamous cell carcinoma, NOS;N1;9fa8337e-2de4-5621-a393-9be3e502d27c;not reported;NA;Main bronchus;No;Main bronchus;released;0;17462;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:13:13.079700-05:00;30;NA;2084f379-6ee2-5879-abd3-a593f1ee0781;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;908dd777-ac28-56ba-83e7-1f3c791989ff;male;47;not hispanic or latino;Alive;-17462;NA;1961;NA;NA;yes;NA;110b2cfb-0164-5a11-9070-0502e959a7c9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ee4bae49-d303-5624-922d-09663bcb4c8e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2724;LUSC
TCGA-NC-A5HF;C34.3;not reported;MX;T4;stage iiib;2008;No;NA;Squamous cell carcinoma, keratinizing, NOS;N0;26fed697-6e0d-52ec-8ae6-664d81f91cba;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27038;not reported;NA;8071/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;4e9e4af2-3ca6-5825-8c91-71b58f40c4e1;NA;NA;NA;NA;Not Reported;NA;white;25c3a919-d1d4-5575-b5b8-29a01a2661f5;male;74;not reported;Dead;-27038;2008;1934;138;NA;no;NA;d46b4479-abcb-503e-9f1f-f51cb54e1182;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;ec54910d-851b-563d-b9f3-c03e9676710e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HF;LUSC
TCGA-92-8064;C34.1;not reported;MX;T2b;not reported;2011;No;160;Squamous cell carcinoma, NOS;N0;91a4f989-6a0c-58e9-8204-8b94d0f7511e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21417;not reported;NA;8070/3;no;NA;7th;NA;not reported;2019-08-08T17:14:16.559953-05:00;30;NA;81393bea-ec31-5251-914d-5b3c93e4e7ab;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;dadc2178-7a75-59f4-bcec-54400c98f21c;male;58;not hispanic or latino;Alive;-21417;NA;1953;NA;NA;yes;NA;0035e97b-cf28-50d4-9001-d7ba2fa9cbc8;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a6132466-0329-5ed0-964b-0223a0306ab2;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-92-8064;LUSC
TCGA-60-2719;C34.9;not reported;M0;T1;stage ib;2007;No;1297;Squamous cell carcinoma, NOS;N0;4c02d738-88a4-5364-aabe-b3ae1bb6512a;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;30379;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;28;NA;dfee467a-f358-5ebd-a096-15a2e8d702cf;7;NA;0.383561643835616;NA;Not Reported;NA;white;f26be288-ee00-5cff-9bbf-b673c7d68aa8;female;83;not hispanic or latino;Alive;-30379;NA;1924;NA;NA;no;NA;dd92b2a4-090e-5adf-8b22-051a9b490bdc;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;265e2d71-4d0b-58a0-984e-f4e7a9aad1d6;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2719;LUSC
TCGA-51-4081;C34.1;not reported;M0;T2a;stage iib;2009;No;911;Squamous cell carcinoma, NOS;N1;84b42b4d-ccd5-59e5-8a11-d11855990d2a;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20261;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;e8ce0b13-3330-5879-8619-99f4eb7f25f3;80;NA;438.356.164.383.562;NA;Not Reported;NA;white;73dbdf4f-96e1-5e11-bd6d-0fb1307490d0;male;55;not hispanic or latino;Alive;-20261;NA;1954;NA;NA;yes;NA;296fa6d4-862b-53c5-8de0-f79c6531023e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;bf46d516-c0af-5571-a527-c7b8801a3df3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-51-4081;LUSC
TCGA-NC-A5HM;C34.1;not reported;M0;T2a;stage ib;2010;Yes;1212;Squamous cell carcinoma, NOS;N0;0e9bcd16-fc07-5817-afb6-cc821e28878e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27938;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;99052c8b-17fb-50da-a5ca-fb060cbe33ff;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;ef1ea9b7-d83a-5892-a87b-ed8c8d4bac25;male;76;not reported;Alive;-27938;NA;1934;NA;NA;no;NA;1117b05f-4e4b-5033-8913-4921a5927f6a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;d7b72914-9fd4-55f2-b2b4-fe0b1069b816;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HM;LUSC
TCGA-77-7337;C34.9;not reported;M0;T2;stage iib;2000;No;NA;Squamous cell carcinoma, NOS;N1;7f55cd6f-a4ab-5fb5-99a9-dc83bac3a373;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;24065;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:35.084062-05:00;54;NA;2c40e647-8006-59da-93f4-187a371f72e5;79.5;NA;435.616.438.356.164;NA;Not Reported;NA;white;0469d932-6b85-597d-90a8-81c413d15437;male;65;not reported;Dead;-24065;2008;1935;3253;NA;no;NA;54439c17-228a-52e2-9bb7-b9ba1e6cf043;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c6c90070-2afa-5e18-867a-c4470ade2a18;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-7337;LUSC
TCGA-77-A5GA;C34.1;not reported;M0;T2a;stage ib;2010;No;1280;Squamous cell carcinoma, NOS;N0;8cf0007e-1371-5dc8-8215-e6e7e0ad2273;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27762;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;33;NA;f81719e4-66e2-5f07-aea2-1c9c2ddf652e;99;NA;542.465.753.424.658;NA;Not Reported;NA;not reported;863f5e88-ad46-52d8-aba3-dcc335d7931f;male;76;not reported;Alive;-27762;NA;1934;NA;NA;no;NA;12d3f412-0ac8-5a03-8de5-9bcfdfc05ac5;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;65b6bf50-5d9d-5fb9-88f3-dbdffb72de79;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-A5GA;LUSC
TCGA-XC-AA0X;C34.3;not reported;M0;T1a;stage ia;2013;No;NA;Squamous cell carcinoma, NOS;N0;6d08bc81-3828-51ab-afb0-6f15cfa01e95;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28211;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:58.925606-05:00;60;NA;cfb3357b-10cd-542d-b4c9-66fd681d44e8;30;NA;164.383.561.643.836;NA;Not Reported;NA;black or african american;170487c3-952f-5d3a-9706-9c5d29e120ed;female;77;not hispanic or latino;Dead;-28211;2013;1936;6;NA;no;NA;cc6a3c9a-6d53-57d4-bad2-dc759db66229;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;2895d62a-2d10-5477-ad93-7e44e8575214;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-XC-AA0X;LUSC
TCGA-85-8479;C34.3;not reported;M0;T1a;stage ia;2012;No;468;Papillary squamous cell carcinoma;N0;11349244-edd6-5289-94d0-6d69ea199bb3;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24350;not reported;NA;8052/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;10068e1e-c936-5199-b3aa-5cf1066279e9;90;NA;493.150.684.931.507;NA;Not Reported;NA;white;b5cd66e0-fa43-5b7f-9e12-cd01cf5eb928;male;66;not hispanic or latino;Alive;-24350;NA;1946;NA;NA;not reported;NA;40616936-70f5-5865-aa48-e3b1175be935;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;d9c6ce60-9b03-5a74-a621-09e974b098ed;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8479;LUSC
TCGA-56-7221;C34.3;not reported;M0;T2;stage ib;2011;Not Reported;608;Squamous cell carcinoma, NOS;N0;0b7ddb6a-df45-54d8-b04c-f7642c7b333b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28873;not reported;NA;8070/3;yes;NA;7th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;f9327101-faa3-5b11-852b-993e8462381e;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;b84bcee8-5f51-5326-aa0a-2ef1e87cf631;male;79;not reported;Alive;-28873;NA;1932;NA;NA;no;NA;c2ba1b26-3820-52aa-8124-4d68117c2c60;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4d60a787-b755-5947-a7e0-60aea949c0c6;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-7221;LUSC
TCGA-77-A5GB;C34.1;not reported;M0;T2a;stage ib;2010;No;NA;Squamous cell carcinoma, keratinizing, NOS;NX;965756d6-6f5b-5f99-86ba-4c0a430d4fd2;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;32872;not reported;NA;8071/3;yes;NA;7th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;4ef0aced-1799-5446-b13a-54a4ce883d9d;52;NA;284.931.506.849.315;NA;Not Reported;NA;not reported;7d0b8460-4524-5c05-ab36-4fc9aec1c4eb;male;90;not reported;Dead;-32872;2012;1920;0;NA;no;NA;01d2f392-3946-5f5e-8958-b37135f170df;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;2ef11720-575f-5f11-bfbb-04ac71ed25fc;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-A5GB;LUSC
TCGA-77-8138;C34.1;not reported;M0;T2;stage ib;2003;No;NA;Squamous cell carcinoma, NOS;N0;86a987e2-1e6a-572b-be23-f7b7b072177c;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27225;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;54;NA;a758211f-fd11-5a01-a9ae-77bdf6fa610e;54;NA;295.890.410.958.904;NA;Not Reported;NA;not reported;8424aca5-a2e7-5675-b6d6-cff538286d6f;male;74;not reported;Dead;-27225;2004;1929;539;NA;no;NA;4ce5ce3e-dfba-5f25-ae84-f41b1b4f37bc;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e6206e28-048d-5970-b425-dff4d507c8d6;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8138;LUSC
TCGA-68-8250;C34.1;not reported;MX;T1a;stage ia;2011;Yes;244;Squamous cell carcinoma, NOS;N0;75e4f33f-110a-5c98-a663-5d9b66dbb2f8;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24118;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:13:35.084062-05:00;NA;NA;7120dc5b-00d9-571e-bb9f-4dcdf03f2625;50;NA;273.972.602.739.726;NA;Not Reported;NA;black or african american;e8cdaea3-6cd3-51ec-8f49-620bcccc08fc;male;66;not hispanic or latino;Alive;-24118;NA;1945;NA;NA;no;NA;f2cd4466-1166-5a94-951e-05028fb7ca35;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;222d2b95-c4d1-5837-9523-d6759b0ea661;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-68-8250;LUSC
TCGA-58-A46J;C34.3;not reported;M0;T2;stage iib;2006;No;2589;Squamous cell carcinoma, NOS;N1;3bf937fd-c3ba-586a-97aa-c7147d9416e8;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;23653;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;05dce67a-c53f-5ea7-bb3c-74fc614d4f3b;NA;NA;NA;NA;Not Reported;NA;white;976e6a54-341f-5756-8a88-edd63da4d5a4;male;64;not hispanic or latino;Alive;-23653;NA;1942;NA;NA;yes;NA;cddea852-f981-5a27-8244-150f37546f81;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;dbd3fbd8-e282-5169-94f9-b038cb721940;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-58-A46J;LUSC
TCGA-98-A53H;C34.1;not reported;M0;T1a;stage ia;2012;No;618;Squamous cell carcinoma, NOS;N0;419bb95a-d086-587d-8751-c3bbb985bf1e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27928;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;4d02fced-98c6-5728-bdd1-a46c42c5f1d9;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;2f5f42e6-b024-5b8e-8265-933867050fc3;female;76;not hispanic or latino;Alive;-27928;NA;1936;NA;NA;no;NA;fedcbf4b-817c-5bd3-80ec-f5f0cf0f0d12;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;dc3787d1-a9bd-545c-bea9-39268eb76712;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-A53H;LUSC
TCGA-18-3414;C34.3;not reported;M1;T4;stage iv;2005;No;NA;Squamous cell carcinoma, NOS;N1;183c01b6-56cc-5f30-9b1a-b7056f5da4bb;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26938;not reported;NA;8070/3;no;NA;NA;Stage IV;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;bc43be15-59e7-5581-9a90-89afecd6ed84;25;NA;136.986.301.369.863;NA;Not Reported;NA;asian;7e36ac08-c66b-5edd-99f6-53122fcfa677;male;73;not hispanic or latino;Dead;-26938;2006;1932;716;NA;no;NA;cc9ed58e-9f40-523a-8c24-ca7d72f064c0;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;b6289b54-66a9-5eef-8a97-f6811f38d5d4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3414;LUSC
TCGA-34-2609;C34.3;not reported;M0;T2;stage iib;2004;Not Reported;951;Squamous cell carcinoma, NOS;N1;cf1067a9-fe18-5e5d-be4c-dea338e7232d;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;29871;not reported;NA;8070/3;yes;NA;NA;Stage IIB;not reported;2019-08-08T17:11:47.463501-05:00;63;NA;f6812864-92fb-5a05-85b4-62d82ac499a2;60;NA;328.767.123.287.671;NA;Not Reported;NA;black or african american;b2b32008-d978-510e-9b49-e123ea340b25;male;81;not hispanic or latino;Dead;-29871;2006;1923;951;NA;yes;NA;1e75ad04-c0f7-5eed-a2cd-3ced68f6dcce;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;9acc966c-01d1-589a-b001-3ffbb10baec8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-2609;LUSC
TCGA-34-2608;C34.1;not reported;M0;T2;stage ib;1999;No;1000;Squamous cell carcinoma, NOS;N0;4a7ea4c3-5e4b-5005-939f-75c162c9d9ef;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;30958;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;385aae36-f98c-5200-a978-196ba82b4f5c;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;ba1a5139-70df-5ebb-a02b-25283a015288;male;84;not hispanic or latino;Dead;-30958;2001;1915;1000;NA;no;NA;504b34dc-bd62-5c31-9b4a-bab44c8bc492;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;5ee46257-3886-5d22-9e2a-874cefdbb97b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-2608;LUSC
TCGA-85-A4CN;C34.3;not reported;M0;T2b;stage iib;2012;No;1038;Squamous cell carcinoma, NOS;N1;65bcf55c-6818-5723-bc03-9801eec8e466;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;20490;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;36e096f2-f110-5a48-9987-7df1b8db485a;NA;NA;NA;NA;Not Reported;NA;white;47aed786-7ebc-5166-be5f-01f3266d5696;female;56;not hispanic or latino;Alive;-20490;NA;1956;NA;NA;yes;NA;abca97df-6964-54f9-bbbc-5a26af131c7e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;de258a19-e4e8-5637-900d-16a20e8430b4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A4CN;LUSC
TCGA-56-7579;C34.1;not reported;M0;T3;stage iiia;2011;No;44;Squamous cell carcinoma, NOS;N1;f7421b5f-fb49-5d8e-a33c-9de11102aa45;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22632;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:12:31.795062-05:00;17;NA;baca539f-2fad-5a9f-bba9-7051d70c75b3;2;NA;0.10958904109589;NA;Not Reported;NA;white;d149aec5-40de-5116-9c52-1da54d7fe0a9;male;61;not hispanic or latino;Dead;-22632;NA;1950;951;NA;yes;NA;d81326b8-be18-5d62-b74b-a1d476bdb518;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;5c4eaca3-4669-5da9-9e4d-d350c6efedce;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-7579;LUSC
TCGA-51-4080;C34.1;not reported;NA;T4;stage iiib;2009;No;NA;Basaloid squamous cell carcinoma;N1;22919aaa-752a-5c38-8562-17783206a3eb;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24054;not reported;NA;8083/3;no;NA;NA;Stage IIIB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;89445867-3fce-56c9-ba77-38f3008ba5c8;NA;NA;NA;NA;Not Reported;NA;black or african american;27d01452-d091-5351-aed2-43540d95f44f;male;65;not hispanic or latino;Dead;-24054;2009;1944;12;NA;no;NA;d4b685ee-da00-5484-a0da-1b925552efa7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7ef60b0c-591b-5014-b99f-6a0c2b5dce89;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-51-4080;LUSC
TCGA-63-A5MY;C34.3;not reported;M0;T1b;stage ia;NA;No;1052;Squamous cell carcinoma, NOS;N0;fe764792-d3e2-585e-b46c-3ffa4a43259b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;NA;23276;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:13:13.079700-05:00;44;NA;ca77d876-f19c-550c-856e-d52c6da935e3;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;7382143c-eaed-558c-87cf-7f80e0b02ff4;male;63;not reported;Alive;-23276;NA;NA;NA;NA;no;NA;51a3dfce-bf7b-5fb6-9ffb-15f4c016b93b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c9784aa7-6e70-5b1c-a6e2-ddc41e260ff9;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MY;LUSC
TCGA-56-7822;C34.1;not reported;M0;T2b;stage iib;2011;No;1;Squamous cell carcinoma, NOS;N1;f49a7ba8-23a4-554e-a7b6-6d52accf3b06;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27755;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;fc66a1b9-e704-59d8-8dce-200cbf06b8a1;60;NA;328.767.123.287.671;NA;Not Reported;NA;black or african american;bd4fc044-ec86-5070-967b-daac0253d611;male;75;not hispanic or latino;Dead;-27755;NA;1936;532;NA;not reported;NA;fff8b1cf-7d3a-5a68-832f-145199130202;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;4ee38ec1-4225-59f8-8aa9-0bfe68dcc9af;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-7822;LUSC
TCGA-18-3416;C34.1;not reported;M0;T2;stage iib;2006;Not Reported;956;Squamous cell carcinoma, NOS;N1;b7f06d27-bc07-50d1-b756-404f82c2937e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;30435;not reported;NA;8070/3;yes;NA;NA;Stage IIB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;4e3838da-445d-5875-9bb5-cefb6b129066;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;cc31ad82-0182-5a46-8fc8-5d46af2642cd;male;83;not reported;Dead;-30435;NA;1923;973;NA;no;NA;b78e6274-b087-5f0d-869b-8a4f50d8f1bd;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;970df841-b1a7-5a29-b6c4-cc0111d7a4c8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3416;LUSC
TCGA-56-8308;C34.1;not reported;MX;T3;stage iib;2012;No;517;Squamous cell carcinoma, NOS;N0;71aae0ae-f909-5f11-9920-73c43113e809;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;29139;not reported;NA;8070/3;yes;NA;7th;Stage IIB;not reported;2019-08-08T17:12:53.407315-05:00;25;NA;9b13c5da-4a3c-51ff-8428-4554e19f891b;63;NA;345.205.479.452.055;NA;Not Reported;NA;white;0b0527db-7ae8-54d9-9a43-8d45bac94704;male;79;not hispanic or latino;Alive;-29139;NA;1933;NA;NA;yes;NA;fe677410-f749-502c-b262-e3eda2a95a08;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;e0bb1f46-c26f-5bc7-9bb9-84a83bbceda7;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8308;LUSC
TCGA-18-3417;C34.9;not reported;M1;T2;stage iv;2006;No;758;Squamous cell carcinoma, NOS;N1;105da122-3f8b-5a57-b53c-efc14f093a37;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;24019;not reported;NA;8070/3;no;NA;NA;Stage IV;not reported;2019-08-08T17:11:26.507214-05:00;26;NA;4bb3cd30-c7a1-5653-81fa-80600a503654;25;NA;136.986.301.369.863;NA;Not Reported;NA;not reported;5f869529-d1f1-5d49-a246-9b5be7c49366;male;65;not reported;Dead;-24019;NA;1941;1097;NA;yes;NA;5fb8af12-e6e1-518e-9fac-a60027e822af;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;9869861d-52f9-588e-b1ab-53cea0954fe2;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3417;LUSC
TCGA-21-1070;C34.1;not reported;M0;T3;stage iiia;2000;Not Reported;3636;Squamous cell carcinoma, NOS;N0;466247f5-8917-5188-9efc-ac24ce9b2c9b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22273;not reported;NA;8070/3;yes;NA;NA;Stage IIIA;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;c6cf67a8-7f28-5776-8ab6-c631738be675;15;NA;0.821917808219178;NA;Not Reported;NA;black or african american;5c341cd2-f81c-5627-8195-21123b488517;female;60;not hispanic or latino;Alive;-22273;NA;1940;NA;NA;no;NA;b1083069-652d-5d31-9273-4e44b363b51d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3a78380d-c806-56b2-96fa-74b11bd90337;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-1070;LUSC
TCGA-21-1082;C34.3;not reported;M0;T2;stage ib;1997;No;3644;Squamous cell carcinoma, NOS;N0;06d8485d-4fe0-5abe-bae6-8317cce73626;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22492;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;1c28c8a8-0f74-50fd-8c4b-b3655943f0f7;NA;NA;NA;NA;Not Reported;NA;white;96878d1b-1132-55dd-a55e-3429588e8f62;male;61;not hispanic or latino;Alive;-22492;NA;1936;NA;NA;no;NA;60dcef91-6b19-57da-bb1a-addffa5ba738;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;dd9ae27e-958a-5050-a02a-a1a30e447a25;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-1082;LUSC
TCGA-22-5474;C34.1;not reported;M0;T2a;stage ib;2005;No;445;Squamous cell carcinoma, NOS;N0;0e8f7058-4909-5a01-bb58-75e3ea902240;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27271;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;50;NA;4f1f20aa-2ac2-5aef-ae2b-12c65f2ea443;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;dc592951-e9f8-5e05-8b6a-c4e5ef7a94a4;male;74;not reported;Dead;-27271;2006;1931;445;NA;no;NA;4c6b075f-b7ec-5c33-8bff-b3396342615e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;f4d1b7bf-4ef5-5cac-8bcc-752e3ac6d6c5;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5474;LUSC
TCGA-56-A4BY;C34.1;not reported;MX;T2a;stage ib;2012;No;31;Squamous cell carcinoma, keratinizing, NOS;N0;a4eec63a-7926-57a9-ae78-f8dcf710c1ad;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24445;not reported;NA;8071/3;yes;NA;7th;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;43;NA;3f95e46b-87e6-58e5-8207-f89c3951da3f;65;NA;356.164.383.561.644;NA;Not Reported;NA;white;825a21ad-7e82-5904-8dfc-19f8158c8a60;male;66;not hispanic or latino;Dead;-24445;NA;1946;543;NA;no;NA;f08815b6-afcb-583b-a057-5ed8ca3ed339;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;a862284a-d92d-5289-bc1a-a37ad47e77b6;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-A4BY;LUSC
TCGA-66-2770;C34.3;not reported;M0;T2;stage ib;2007;No;700;Squamous cell carcinoma, NOS;N0;45a2d73a-f980-581b-8669-c03353d64078;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28945;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;25;NA;4593e7fd-e296-5f1d-9841-32d315390558;25;NA;136.986.301.369.863;NA;Not Reported;NA;not reported;4dd39b41-56a4-518b-8ed5-091268dda81f;male;79;not reported;Alive;-28945;NA;1928;NA;NA;not reported;NA;02087031-7fde-5d13-aa12-5564efd366ff;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;facc4a11-0017-5147-92db-9efc2f3e8b6d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2770;LUSC
TCGA-43-3920;C34.1;not reported;M0;T2;stage ib;2009;No;1007;Squamous cell carcinoma, NOS;N0;522cf5e4-f97f-5df0-8454-4707260d0727;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26059;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:11.623943-05:00;50;NA;1552a761-bf99-5ba5-a33a-6ab242982b6e;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;68d4e85c-cfd4-5c1c-bf6f-4199c9eccb3e;male;71;not hispanic or latino;Alive;-26059;NA;1938;NA;NA;no;NA;73034513-22ae-50cf-ad25-6fadedac030f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;8c4fd7cf-c8c0-50e0-bf94-4c8f3f9edb4f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-3920;LUSC
TCGA-60-2707;C34.1;not reported;M0;T2;stage ib;2003;No;NA;Squamous cell carcinoma, NOS;N0;f9202b69-5013-53c0-851c-02e5ace5e6dc;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25758;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;33;NA;81128ed0-74f0-5e59-b999-69cd19fa0ea0;49;NA;268.493.150.684.932;NA;Not Reported;NA;not reported;80eb0cd2-495d-5664-b2ba-a5c9b2299eef;male;70;hispanic or latino;Dead;-25758;2004;1933;667;NA;no;NA;975f338b-e7a8-50be-8235-1749f365217b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;999d1795-0d6f-535c-bdf7-e8ec52c1535e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2707;LUSC
TCGA-66-2767;C34.3;not reported;M0;T2;stage iiib;2007;No;61;Squamous cell carcinoma, NOS;N3;d65d0c35-f8e1-5c85-a435-163ff1fba774;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22888;not reported;NA;8070/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:13.079700-05:00;43;NA;8375a08b-4886-5cdb-8ac9-440a4f49d045;43;NA;235.616.438.356.164;NA;Not Reported;NA;not reported;5bb6fcea-9483-5961-9dab-36642423125b;male;62;not reported;Alive;-22888;NA;1945;NA;NA;not reported;NA;55565a3b-5a60-5352-873c-c68dd1166d24;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;ad61c63f-498a-5ebf-ad68-18603c02c7c2;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2767;LUSC
TCGA-58-8386;C34.1;not reported;M1;T3;stage iv;2008;No;NA;Squamous cell carcinoma, NOS;NX;911886c6-6bbd-5bc5-bf9a-8b24b60d1b06;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27455;not reported;NA;8070/3;no;NA;6th;Stage IV;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;1928691f-9a96-5343-81dd-66bf1bd7f322;65;NA;356.164.383.561.644;NA;Not Reported;NA;not reported;7cd1ed08-7ce6-5bb9-9943-857a824f6860;male;75;not reported;Dead;-27455;2008;1933;1;NA;no;NA;edd4c6e4-4678-5259-91bf-d017eaef211e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;33b69b18-25df-5d3b-922d-33ad909b7fbc;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-58-8386;LUSC
TCGA-56-8503;C34.3;not reported;M0;T3;stage iib;2012;No;41;Squamous cell carcinoma, NOS;N0;b7aa72a5-2c77-5331-8464-cdcf4bcdde75;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28095;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;5ffd68bb-49e3-57f3-9049-f9c568a1f4b9;91;NA;498.630.136.986.301;NA;Not Reported;NA;white;b45b9314-55f7-5c31-a50f-f92a261cbaf4;female;76;not hispanic or latino;Alive;-28095;NA;1936;NA;NA;not reported;NA;3b86726b-43d7-5377-82d9-3c574d4c35cc;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;f8f4b562-dc43-53be-a7ac-5b9e7f676b53;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8503;LUSC
TCGA-46-3767;C34.3;not reported;M0;T1a;stage ia;2009;No;396;Squamous cell carcinoma, NOS;N0;e4d5ff97-0e97-5ca9-8d2d-98d626982818;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27912;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;d59cb459-37d5-5657-ad6e-2bd14bc1cdda;NA;NA;NA;NA;Not Reported;NA;white;ca10d4e0-91ba-5b7d-91d4-bc8fe806fa37;male;76;not hispanic or latino;Alive;-27912;NA;1933;NA;NA;not reported;NA;c7b55e1c-bb68-5a6a-bafa-208ff10aef48;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;12917eb6-c10e-5f53-b80e-37bfb4441792;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-46-3767;LUSC
TCGA-22-5472;C34.3;not reported;M0;T2a;stage ib;2005;Not Reported;NA;Squamous cell carcinoma, NOS;N0;28ac3145-6531-5b5a-8488-f67941544f0f;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24482;not reported;NA;8070/3;yes;NA;NA;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;35;NA;b7e70ca0-cc0b-5d8a-9035-0d4848d36ee4;35;NA;191.780.821.917.808;NA;Not Reported;NA;white;4ffb3dc6-172b-53c2-8e26-cfae302c5d9d;male;67;not hispanic or latino;Dead;-24482;2010;1938;1975;NA;no;NA;a51eaa4a-088a-5306-bb68-bfc9741928b8;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;408cdd9b-6d09-5a33-b253-bc137addb9b6;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5472;LUSC
TCGA-LA-A7SW;C34.3;not reported;MX;T3;stage iiia;2013;No;146;Squamous cell carcinoma, NOS;N1;5a603a15-85af-5cd1-ac05-cd4aa64c1d78;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26116;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:14:36.542202-05:00;50;NA;a69740fa-989a-508b-b9a1-361a696b7256;37;NA;202.739.726.027.397;NA;Not Reported;NA;black or african american;02a99620-6c87-51cc-8769-ef3322239b52;male;71;not hispanic or latino;Dead;-26116;NA;1942;408;NA;yes;NA;77a7b4c7-399e-5837-8846-b5e1f88cfee7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;53e56272-6349-5e97-9fbd-c4fd7703f7d6;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-LA-A7SW;LUSC
TCGA-77-7138;C34.3;not reported;M0;T2;stage ib;1999;No;NA;Squamous cell carcinoma, NOS;N0;618232ba-50db-538c-9ffd-a3fa1129608b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24594;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;20;NA;5f17c5c3-c897-5433-b700-939bca677108;20;NA;10.958.904.109.589;NA;Not Reported;NA;not reported;68f54ed5-e48f-57ff-9c96-3a435d210e73;male;67;not reported;Dead;-24594;1999;1932;340;NA;no;NA;b316d4c3-a53a-5364-8afe-5900656e3734;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;1ce0abb0-1091-553e-bf8d-180238b43807;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-7138;LUSC
TCGA-56-7730;C34.1;not reported;M0;T2b;stage iia;2011;No;6;Squamous cell carcinoma, NOS;N0;2572c219-0f65-5e03-8371-e1b013747f1f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26699;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;a0647c9a-b31d-58bc-97f0-c3fbde8d5e35;NA;NA;NA;NA;Not Reported;NA;white;f90a268b-0340-5c30-9730-b848f5a35db4;male;73;not hispanic or latino;Dead;-26699;NA;1938;198;NA;yes;NA;fda84844-9174-5ea7-972b-fc32c9c9b02b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;7b382b87-a9c5-5046-b5e9-f3c1b4cd8eac;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-7730;LUSC
TCGA-37-4132;C34.3;not reported;M1;T2;stage iv;2010;No;227;Squamous cell carcinoma, NOS;N0;1535826f-1fde-586c-8406-36494594324a;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22520;not reported;NA;8070/3;no;NA;7th;Stage IV;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;79b66e49-8936-5ec1-8c2f-6e5cb165f3ca;NA;NA;NA;NA;Not Reported;NA;white;d579017e-dc3a-5edd-b22e-651a95956edd;female;61;not hispanic or latino;Alive;-22520;NA;1949;NA;NA;no;NA;e4ad5b57-7392-565e-866f-793fa8515aeb;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;0a4af257-7a48-5e72-9cfc-95905f1ee1da;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-4132;LUSC
TCGA-O2-A52V;C34.1;not reported;MX;T3;stage ii;2006;No;NA;Squamous cell carcinoma, NOS;N0;7aad9b7c-45ba-5011-960c-19fb755067cb;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27449;not reported;NA;8070/3;no;NA;6th;Stage II;not reported;2019-08-08T17:14:58.925606-05:00;20;NA;68a235df-9ce3-57bf-b80d-e7ef52df3f46;1;NA;0.0547945205479452;NA;Not Reported;NA;black or african american;3c124a69-db21-5ebe-b7e5-267d17cbbb8d;female;75;not hispanic or latino;Dead;-27449;2009;1931;1335;NA;no;NA;96144cea-ad03-5f65-8f7f-0a6857dc4ce4;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;a169f001-dcde-5392-b0ff-d6b4ad1285e2;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-O2-A52V;LUSC
TCGA-56-7580;C34.3;not reported;M0;T2a;stage ib;2011;No;925;Squamous cell carcinoma, NOS;N0;f671f8e1-b2d6-5be6-b355-dc585cd6ad14;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;30740;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;38;NA;e649aadc-c76f-563c-abd1-2409d3ea9e16;NA;NA;NA;NA;Not Reported;NA;white;a1c61f34-8b07-5375-aae5-59adbdae95e0;male;84;not hispanic or latino;Alive;-30740;NA;1927;NA;NA;no;NA;98dddc94-9765-5f4f-a7f0-4d9cd7ba2125;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;55291d06-0035-5480-9f3a-515c2ad90a5a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-7580;LUSC
TCGA-18-3408;C34.3;not reported;M0;T2;stage ib;2004;No;2099;Squamous cell carcinoma, NOS;N0;ac94a1ac-de25-5131-b355-3bb9e7d47839;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28171;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;bc9c21d2-671e-5690-b2bf-4c80cdfffa41;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;97f72156-675d-5a16-89e9-94296a9aea85;female;77;not hispanic or latino;Dead;-28171;NA;1927;2304;NA;no;NA;9ee22f4c-ae9e-53e9-bda6-61026731957e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;17aae413-8687-5b63-8848-7ab003b59d3e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3408;LUSC
TCGA-98-7454;C34.1;not reported;M0;T2a;stage ib;2011;No;652;Squamous cell carcinoma, NOS;N0;0ebaf3bf-106f-5b83-8837-93ddbba9e58c;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26827;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:36.542202-05:00;40;NA;9f0402d9-bbc0-5a42-bcfb-a502edfab68f;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;e08368f7-a216-5f09-85fd-70a6e391227a;male;73;not hispanic or latino;Alive;-26827;NA;1938;NA;NA;no;NA;ed2e15ed-c981-575d-ae51-69584c29073a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6bc626ac-8723-5455-a348-e3a049f6cb11;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-7454;LUSC
TCGA-37-3789;C34.1;not reported;NA;T2;stage ib;2006;No;13;Squamous cell carcinoma, NOS;N0;096aea1c-c5c1-5c4f-bbb2-f1081642a590;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23782;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;2073b4c7-3922-507c-8649-26d56f617659;NA;NA;NA;NA;Not Reported;NA;white;e4abf2f5-828c-561d-99d3-f8002e3d3b3f;male;65;not hispanic or latino;Alive;-23782;NA;1941;NA;NA;not reported;NA;5932f1b0-50a7-56e1-9994-98951dddfafd;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;f051420f-8413-5f52-a6e0-95a595a10529;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-3789;LUSC
TCGA-96-8170;C34.3;not reported;M0;T1a;stage iia;2011;No;531;Squamous cell carcinoma, NOS;N1;a043fa2a-04ea-5278-9e92-fcf5484bced6;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27558;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:36.542202-05:00;50;NA;3912ef7d-9bbc-5e83-bdd4-b739e2fd52fc;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;c790225f-f0b5-5653-bf5f-dd1eac4387be;female;75;not hispanic or latino;Alive;-27558;NA;1936;NA;NA;no;NA;4b5ffc0d-800e-588a-a671-73a84e148145;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;2a56df5b-7570-522e-9b97-994685c9cc2e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-96-8170;LUSC
TCGA-66-2753;C34.3;not reported;M0;T2;stage ib;2007;No;31;Squamous cell carcinoma, NOS;N0;84ac9223-fef3-5b1f-ac7d-c97cfe3280f8;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25506;not reported;NA;8070/3;no;NA;5th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;54;NA;0d171a5e-8503-5610-b7a0-81a24d2861ac;162;NA;887.671.232.876.712;NA;Not Reported;NA;not reported;82ba646b-f01d-515e-a1c6-a201507847a2;male;69;not reported;Alive;-25506;NA;1938;NA;NA;not reported;NA;ea7ffd6d-1932-5a76-ba3d-4de11b3fbe26;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;a741e64b-623f-513e-a255-6b3efa30295b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2753;LUSC
TCGA-66-2763;C34.1;not reported;M0;T2;stage ib;2007;No;30;Squamous cell carcinoma, NOS;N0;b0376645-1ef6-5a26-8757-ea7b11b66cc0;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23315;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;40;NA;960d558e-b937-55d6-9611-6e3c55044b75;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;06e353dc-460a-5b61-bf82-0c98533d08e8;female;63;not reported;Alive;-23315;NA;1944;NA;NA;not reported;NA;f26ee53c-5759-59a7-b7fb-1ccfe0674a54;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;601e16f8-b99c-547b-b4ac-91bb80a77146;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2763;LUSC
TCGA-63-7023;C34.3;not reported;M0;T1;stage iia;2008;No;1682;Squamous cell carcinoma, NOS;N1;2539b94d-0375-564e-88ea-dff30170085c;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;NA;NA;not reported;NA;8070/3;no;NA;6th;Stage IIA;not reported;2019-08-08T17:13:13.079700-05:00;56;NA;639ec1a3-cfd5-58c0-ba92-5da5d6016926;55;NA;301.369.863.013.699;NA;Not Reported;NA;not reported;71ee9241-fa42-5f07-8e44-e401312176c7;male;NA;not reported;Alive;NA;NA;NA;NA;NA;yes;NA;ec0386a8-0fcb-5a09-aac4-399f9f7235ca;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;07c7d61b-ed47-5f5d-938a-a2da885ed71b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-7023;LUSC
TCGA-21-5783;C34.1;not reported;M0;T2;stage ib;2004;No;NA;Squamous cell carcinoma, NOS;N0;61e80c94-d4d4-5a1e-a13d-a7b543f77c11;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27904;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;c176835e-d22a-5bf6-a63a-4c9f05e8e6ab;NA;NA;NA;NA;Not Reported;NA;white;9fbc4198-4d2e-58f2-9475-03dc41aea558;male;76;not hispanic or latino;Dead;-27904;2011;1928;2680;NA;no;NA;652a7f80-707f-5062-a04f-94073b2c1afc;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;5a6ac6c7-8f62-5001-b0df-2ca0a36bbf28;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-5783;LUSC
TCGA-21-1083;C34.1;not reported;M0;T1;stage ia;1997;Not Reported;267;Squamous cell carcinoma, NOS;N0;4b2a5f10-fa99-5ede-9972-dbaf5948e93b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27708;not reported;NA;8070/3;yes;NA;NA;Stage IA;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;415a06a0-354f-514a-8aa5-b1f5e7dafa3d;240;NA;131.506.849.315.068;NA;Not Reported;NA;white;eba64505-46ba-5053-81f9-75f240455600;male;75;not hispanic or latino;Dead;-27708;2000;1922;1315;NA;no;NA;897896d4-973b-5191-bcc9-a81d51159f40;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;03e83cb7-c941-536d-a6a8-8f02a4e48d98;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-1083;LUSC
TCGA-22-5479;C34.3;not reported;M0;T2;stage ib;2004;No;1651;Squamous cell carcinoma, NOS;N0;c062c06e-792c-5315-b472-d5ab234d93e4;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;23563;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;35;NA;c2166cfa-6ee7-5931-853d-27b8d47a34e8;35;NA;191.780.821.917.808;NA;Not Reported;NA;white;cb5ebd44-74ba-5e3f-87a0-86367ac6cd96;male;64;not reported;Dead;-23563;NA;1940;2625;NA;yes;NA;e56d946c-b2d9-5813-9ece-14467e057232;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;0ff241cc-15ef-544f-a2fa-9e49b4ab4b38;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5479;LUSC
TCGA-33-AASI;C34.1;not reported;MX;T2;stage iib;2008;No;NA;Squamous cell carcinoma, NOS;N1;5a4e703f-a372-5cb2-9674-bb2ece00fde5;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;23965;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;a289923c-a304-5fdc-a786-d219ab3e55fe;60;NA;328.767.123.287.671;NA;Not Reported;NA;black or african american;17aa8309-fa78-5713-b1fa-5309cdb098d2;female;65;not hispanic or latino;Dead;-23965;2011;1943;1344;NA;yes;NA;c04b64be-b4d8-5a36-ae24-636b37e3eb1a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;5bd249c1-ccb1-55b8-9e78-013fa2600ce5;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-AASI;LUSC
TCGA-56-5897;C34.1;not reported;MX;T1b;stage ia;2010;No;378;Squamous cell carcinoma, NOS;N0;7fec46a3-dfd1-54f5-802d-17e133a1ad19;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27118;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;1e7ee41e-7060-5a37-a022-52820f49c8d8;NA;NA;NA;NA;Not Reported;NA;white;a31a2a7d-58ef-5ff5-9f3c-d9fde94106f0;male;74;not hispanic or latino;Alive;-27118;NA;1936;NA;NA;no;NA;270c848e-19dd-540e-8c33-6033e38df12e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7a0041e0-0463-58d9-b8de-99e385e24431;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-5897;LUSC
TCGA-22-4601;C34.1;not reported;M0;T4;stage iiia;2003;No;1057;Squamous cell carcinoma, NOS;N0;7eabe58b-6d92-5600-b128-f8df74fe4753;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26937;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;9afc9c7b-7cbb-5981-8385-6c7b0cac0c6b;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;51a2e141-6d5b-5613-abce-bfc92d8cf0cb;female;73;not reported;Dead;-26937;2005;1930;1057;NA;no;NA;18774302-7fdf-5fbc-9c65-eccf186d142f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;13f6e543-f620-5af6-b8ed-1e202ac4c351;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-4601;LUSC
TCGA-43-A56V;C34.2;not reported;M0;T2a;stage iiia;2012;Yes;366;Squamous cell carcinoma, NOS;N2;7a69aef9-91c6-59e2-a112-5cff4189830d;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;22475;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:12:31.795062-05:00;32;NA;8e9087c1-9103-5eb3-9b14-e4b9250ce4fa;48;NA;263.013.698.630.137;NA;Not Reported;NA;black or african american;c46f503e-a28c-57a6-8104-3e4ea6eeb3f0;male;61;not hispanic or latino;Alive;-22475;NA;1951;NA;NA;yes;NA;ae1c6500-a47a-55da-b11c-f24f3d733076;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;b05969ea-eb00-5cc0-820f-85ea0eef5135;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-A56V;LUSC
TCGA-58-A46N;C34.3;not reported;M0;T2a;stage ib;2011;No;910;Basaloid squamous cell carcinoma;N0;b495fce8-2c74-5518-8ba2-e5c1954fa5fa;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;19050;not reported;NA;8083/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;cc61ce73-245d-590d-9063-d028334b7a34;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;b8e36520-7be0-5e60-920f-8da4512ebae7;male;52;not hispanic or latino;Alive;-19050;NA;1959;NA;NA;no;NA;ed913641-a5fc-53b0-bc0c-028faea25c9d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;322bfd45-63a6-5fbe-95c3-ea750daaeda0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-58-A46N;LUSC
TCGA-77-A5GH;C34.3;not reported;M0;T2a;stage ib;2011;No;1182;Squamous cell carcinoma, NOS;N0;f516fe1f-9a07-5602-8ca5-4c061d4eb70b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;29843;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;41;NA;293c3b3d-86f7-5bfe-9bcc-8e8a9336c69d;11;NA;0.602739726027397;NA;Not Reported;NA;not reported;f88c2e16-d48b-5370-b5bd-497f788792c8;male;81;not reported;Alive;-29843;NA;1930;NA;NA;no;NA;67cc248c-a049-5412-953e-508263767207;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;89787a01-0568-50d3-9ada-ad7754b1ffa3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-A5GH;LUSC
TCGA-22-5482;C34.1;not reported;M0;T2a;stage ib;2005;No;357;Squamous cell carcinoma, NOS;N0;20e281a8-ceec-55d3-b71b-edb25043586b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;29657;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;60;NA;d4da69c5-1168-53af-be47-3254d81bef1e;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;5e55b0e3-843f-5f09-8656-61ec1ecc2cb2;male;81;not reported;Dead;-29657;2005;1924;357;NA;no;NA;4d30425b-542d-5f12-868d-661cd3e5f7ab;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a39d7c6a-8851-5344-adc1-87e472170a7d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5482;LUSC
TCGA-56-1622;C34.3;not reported;M0;T2;stage ib;2007;No;NA;Squamous cell carcinoma, NOS;N0;718c9618-6343-56a4-8601-5cbafdfd0d11;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;21371;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;44;NA;07e704ea-9ead-5e3b-b39a-a1f3dbc68c94;86;NA;471.232.876.712.329;NA;Not Reported;NA;white;afc10c5c-b030-5243-98e8-866bbe92eebb;male;58;not hispanic or latino;Dead;-21371;2009;1949;881;NA;no;NA;bfeead06-e5c0-5fec-a47a-c196af7e3290;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;64265d33-57e5-5055-9d45-b3ee26d80a39;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-1622;LUSC
TCGA-NC-A5HH;C34.3;not reported;M0;T1;stage ia;2009;No;37;Basaloid squamous cell carcinoma;N0;c111e9c6-13fd-57fd-9739-feca2dfbef4a;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;19485;not reported;NA;8083/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;3eab3fa5-1dec-5c70-8f6b-a2545c494515;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;3c7a5a35-dd84-5223-b4f4-d1c49c5aaea6;male;53;not reported;Alive;-19485;NA;1956;NA;NA;no;NA;d35dc292-51ee-5852-b9f9-c82f0eb89ff9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c6e964dc-ecd9-5862-8983-c2767c43a675;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HH;LUSC
TCGA-60-2723;C34.9;not reported;M0;T2;stage ib;2008;No;1092;Squamous cell carcinoma, NOS;N0;9c6a0f1b-e8ee-50a6-affb-726bc79149ca;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;27225;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;59;NA;d0575adf-de3e-5a26-ac08-1d9d8b9ee738;58;NA;317.808.219.178.082;NA;Not Reported;NA;white;fb632fec-5b52-59d8-a224-ffaa0062a552;female;74;not hispanic or latino;Alive;-27225;NA;1934;NA;NA;no;NA;2c30d7fa-fef0-54c9-9e8b-f0d4cb5c44fa;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e78bb943-5505-570d-8eb7-c7b6817184ac;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2723;LUSC
TCGA-18-4086;C34.3;not reported;M0;T2;stage ib;2009;No;NA;Squamous cell carcinoma, NOS;N0;e31c2f80-ba2a-5b22-8f8b-29c126a14933;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;23731;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;89eb1a30-ae43-5128-9330-cc518c7ccf9c;30;NA;164.383.561.643.836;NA;Not Reported;NA;not reported;5226dcf9-581e-5ce0-b202-ba3acdcf5ca7;male;64;not reported;Dead;-23731;2009;1945;85;NA;not reported;NA;4cd0ef49-9626-5cba-9c11-853986cea160;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;241a47d3-400b-5863-a812-ac116973333e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-4086;LUSC
TCGA-85-6798;C34.1;not reported;M0;T3;stage iiia;2011;No;34;Squamous cell carcinoma, NOS;N1;5ee5d105-603e-56e4-8f68-161fbc6d524c;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20837;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;bb21f1a6-ca8f-5357-8acb-0bc507539c45;35;NA;191.780.821.917.808;NA;Not Reported;NA;white;1ee66443-9d12-573f-a4f5-9cf6a319f2b0;male;57;not hispanic or latino;Dead;-20837;NA;1954;195;NA;yes;NA;fd9118e1-a209-5887-afd0-de3621434335;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;20d3d389-3b69-5245-9cfc-8f98ec0ead76;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-6798;LUSC
TCGA-68-7755;C34.3;not reported;M0;T1b;stage iia;2011;No;83;Squamous cell carcinoma, NOS;N1;ca3ea947-6069-5710-98d9-14c61691f052;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;21936;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:13:35.084062-05:00;26;NA;563ed18a-1f18-57c3-b06b-b767e2fe0cb7;78;NA;427.397.260.273.973;NA;Not Reported;NA;white;809b68bc-3beb-5df8-9049-38c6c43caa6c;female;60;not hispanic or latino;Alive;-21936;NA;1951;NA;NA;yes;NA;e569617d-f00f-52a5-a729-14d08130832d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;5404a825-5bf2-54c0-b7ce-37be3c033a68;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-68-7755;LUSC
TCGA-98-A53I;C34.1;not reported;M0;T2a;stage iia;2012;No;565;Squamous cell carcinoma, NOS;N1;a7372b6d-58d9-5b52-8d6e-eb74cc7470b5;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23502;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:36.542202-05:00;35;NA;403a9f2e-ac59-564f-9002-819ae7037df4;70;NA;383.561.643.835.616;NA;Not Reported;NA;white;0e5965a0-288c-5067-b8c3-0eba39234a4b;male;64;not hispanic or latino;Alive;-23502;NA;1948;NA;NA;yes;NA;f3998aae-ce9a-5424-bce1-bdee87b6c0bd;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3f11390b-737f-5632-890d-1f48bdeae5f1;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-A53I;LUSC
TCGA-66-2794;C34.1;not reported;M0;T4;stage iiib;2006;No;1645;Squamous cell carcinoma, NOS;N2;042017f8-d04c-554c-b6b7-847b7bc6527f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23710;not reported;NA;8070/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:35.084062-05:00;36;NA;8c5661bf-2ea0-5d57-b9fc-f78388eda48a;100;NA;547.945.205.479.452;NA;Not Reported;NA;not reported;d4e37d65-11c8-5c83-be3d-ee4bffe55b94;male;64;not reported;Alive;-23710;NA;1942;NA;NA;no;NA;93bccf25-e103-5e91-a425-283517b6b65a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;99122f4b-07f2-5f7d-907e-52d5d20485d0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2794;LUSC
TCGA-77-8145;C34.9;not reported;M0;T4;stage iiib;2000;No;NA;Squamous cell carcinoma, NOS;N1;c13afd27-b5d6-5e76-bad6-275604c5e694;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;26707;not reported;NA;8070/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;2c1ddda8-133f-529d-a755-60778104b0f2;57;NA;312.328.767.123.288;NA;Not Reported;NA;not reported;7ebcdfdb-e760-58c9-840a-4d2892f969f1;male;73;not reported;Dead;-26707;2000;1927;212;NA;no;NA;3f3a58b8-5ff8-5fce-b09f-3f809529cb7d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;888ce301-c582-5d18-923d-d6bf4cbaf4e4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8145;LUSC
TCGA-85-A510;C34.3;not reported;M0;T2b;stage iib;2012;No;482;Squamous cell carcinoma, NOS;N1;8b3d7263-cc46-576b-bc14-28bd24e752d6;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27067;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;ff84d63b-f254-5b58-a80a-1b612d959035;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;dfdafa64-92af-5a86-81e4-2e4c8a3d4785;female;74;not hispanic or latino;Alive;-27067;NA;1938;NA;NA;no;NA;4cc9492a-17bb-576d-add3-02b3ef1b1251;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;26ac377b-86bc-5444-a6ec-23a05a1ad232;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A510;LUSC
TCGA-58-8393;C34.3;not reported;M0;T2a;stage ib;2010;No;1058;Squamous cell carcinoma, NOS;N0;de9551bd-b3b4-5448-ae7f-d05fd16a7314;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25132;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;079e3f89-5adc-5107-9ef3-0d67ecc0437e;7;NA;0.383561643835616;NA;Not Reported;NA;white;2c1e86a0-4934-5dc5-bbfb-12e70507b1b1;female;68;not hispanic or latino;Alive;-25132;NA;1942;NA;NA;no;NA;68d16296-3412-51b7-abb3-c96c511aee38;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;743e75df-8474-5d62-aff1-c2ae0d0da3ab;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-58-8393;LUSC
TCGA-77-8156;C34.1;not reported;M0;T2a;stage ib;2010;No;1106;Squamous cell carcinoma, NOS;N0;d1f7a784-4eb7-51a8-8255-5b43e42c6287;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22198;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;0e5be64f-d57d-5ce4-b516-c59d6569515d;57.5;NA;315.068.493.150.685;NA;Not Reported;NA;not reported;6f0dd0b8-bd63-5ada-b151-a3aa7dea6ad4;male;60;not reported;Alive;-22198;NA;1950;NA;NA;no;NA;c1dbc35d-2c57-5470-b942-4d59cd418558;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;121061c4-cbaa-509d-9de6-a5846a0f6c81;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8156;LUSC
TCGA-NC-A5HP;C34.1;not reported;M1b;T2a;stage iv;2011;No;730;Squamous cell carcinoma, keratinizing, NOS;N0;a6ebe17b-094c-5791-8802-260aa5e42ca7;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25286;not reported;NA;8071/3;no;NA;7th;Stage IV;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;c7ff1307-85fe-57ce-82d1-877bb101c39a;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;4c9d74ef-6789-53c4-9bbc-2bfc2bd6514c;male;69;not reported;Dead;-25286;NA;1942;770;NA;yes;NA;55d1047b-3695-52c2-b89b-2c6ddb841fdf;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;2ffcdc61-5c69-52fa-89d8-65a41bd6e57f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HP;LUSC
TCGA-52-7622;C34.3;not reported;M0;T1a;stage ia;2010;No;862;Squamous cell carcinoma, NOS;N0;516ad56b-11e7-5aaf-bd1c-810a86e60fad;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22807;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:31.795062-05:00;45;NA;473c37c9-e653-5d8d-905a-4dd0ade12781;22;NA;120.547.945.205.479;NA;Not Reported;NA;white;f857ea0a-0178-5644-bd98-67cfcc85c3f6;female;62;hispanic or latino;Alive;-22807;NA;1948;NA;NA;yes;NA;93d43fe6-c122-5ceb-a032-fc829579999a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e4c0a264-0d96-56fb-9098-3f281be4f101;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-52-7622;LUSC
TCGA-60-2725;C34.1;not reported;M0;T2;stage ib;2009;No;816;Squamous cell carcinoma, NOS;N0;2978b57d-a33f-55a5-8812-e2ccb5ab9d91;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27073;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;28;NA;1867e723-a2d8-52d6-989f-3dd70b8bf9ea;56;NA;306.849.315.068.493;NA;Not Reported;NA;white;ffa6cae6-b3dd-59da-a7d5-609fb8286879;male;74;not hispanic or latino;Alive;-27073;NA;1935;NA;NA;no;NA;6fc83a7b-6677-5d0c-ba36-a6f610c0240e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;46f8caf2-939b-5bc5-8f86-e282b970a0ee;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2725;LUSC
TCGA-77-8153;C34.3;not reported;M0;T2;stage ib;2008;No;1992;Squamous cell carcinoma, NOS;N0;dd615f87-3a66-5218-b12f-313264c3aef8;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28253;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;25;NA;10fbc588-ac62-5b56-ad25-f16f86909cde;25;NA;136.986.301.369.863;NA;Not Reported;NA;not reported;dd35fc43-9af8-5d66-ba65-deb4a66451ff;female;77;not reported;Alive;-28253;NA;1931;NA;NA;no;NA;20afee5b-e372-525a-9cb7-c056e73ba742;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;cac05969-379c-5dba-a446-56e5db3da5c2;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8153;LUSC
TCGA-56-8622;C34.3;not reported;M0;T2a;stage ib;2012;No;55;Squamous cell carcinoma, NOS;N0;7d52df74-d004-5110-819c-b70c5eb83f93;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24861;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;20;NA;e824068d-a31d-5215-af21-c6821161be52;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;2062b744-cf6d-558f-845c-8547a3f937f0;male;68;not hispanic or latino;Alive;-24861;NA;1944;NA;NA;not reported;NA;fb0c102d-2944-5c11-b13c-d9d8197336d9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;7ddd19ac-889e-5210-a48d-504feccf06d2;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8622;LUSC
TCGA-18-3421;C34.3;not reported;M0;T2;stage ib;2007;No;2645;Squamous cell carcinoma, NOS;N0;91e89651-8edc-5f23-82fc-aeb3c41f622b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;23972;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;cbc14147-3b21-5058-b80d-c0addd0f7786;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;32fd23d6-5c8f-5d9d-b88b-16fd146df8b6;male;65;not hispanic or latino;Alive;-23972;NA;1942;NA;NA;no;NA;dd3ca9a3-e79d-5e16-a183-b136fb380bb2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;dd0c5f28-1d61-53b0-ba91-91c39af3fd12;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3421;LUSC
TCGA-66-2795;C34.1;not reported;M0;T4;stage iiib;2008;No;122;Squamous cell carcinoma, NOS;N1;f4bef83a-fb49-5d08-928f-c48fdbad7d99;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24897;not reported;NA;8070/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:35.084062-05:00;43;NA;ff6002cc-edef-5af3-b3ab-69c2dfa8c860;86;NA;471.232.876.712.329;NA;Not Reported;NA;not reported;c7f81768-5dab-54be-9fff-899808b6f6ae;male;68;not reported;Alive;-24897;NA;1940;NA;NA;not reported;NA;1f8c22f1-d59d-548d-9392-347714623e0c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;9658f4a5-b566-557c-9c9d-5f94b9414f3b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2795;LUSC
TCGA-85-7843;C34.1;not reported;M0;T2a;stage iia;2011;No;35;Squamous cell carcinoma, NOS;N1;ece00ee2-c837-5873-817a-5604859da1ae;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;18353;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;8f8271e6-5797-5d0d-a6b0-8dde4e38aa15;35;NA;191.780.821.917.808;NA;Not Reported;NA;white;f1a40374-a9d1-589d-87c0-bf679865a2ac;male;50;not hispanic or latino;Alive;-18353;NA;1961;NA;NA;not reported;NA;542eff57-d2fd-5edc-ba13-5f308c680c9a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;9aede428-71f7-53c6-b9dd-7340e0a6eacd;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-7843;LUSC
TCGA-85-A4JB;C34.1;not reported;M0;T3;stage iib;2012;No;942;Squamous cell carcinoma, NOS;N0;fe9d46e1-c352-59d1-9483-d289bc4b96f6;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27315;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;da851450-61d0-5f8e-8d51-e6f63f8d438f;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;a55fb867-a32f-57f5-ab47-8f7f731128c5;male;74;not hispanic or latino;Alive;-27315;NA;1938;NA;NA;yes;NA;4c7a80c7-5f18-5cb2-b720-12b956b25684;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;bc3ee485-4c39-5224-a93e-fa4e7895847a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A4JB;LUSC
TCGA-43-2581;C34.1;not reported;M0;T3;stage iiia;2009;No;1176;Squamous cell carcinoma, NOS;N1;8abc5bae-b279-5af0-8b84-554a65969a59;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;17447;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;65498b17-f877-5f6c-b21c-0edc04f8a4bc;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;6394e180-b780-57a5-86d0-3d7476748716;female;47;not hispanic or latino;Alive;-17447;NA;1962;NA;NA;yes;NA;47666386-4b49-5c2a-807c-cc065a3f1361;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;9ab2c99a-32ac-55be-96c9-116c5634dae6;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-2581;LUSC
TCGA-77-A5G8;C34.1;not reported;M0;T3;stage iib;2009;No;1884;Squamous cell carcinoma, NOS;N0;cd60bec5-4e02-555b-8b17-717057370627;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25921;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:55.903240-05:00;60;NA;d1e1e6aa-7af2-54bc-bbe4-5ea627208ab1;90;NA;493.150.684.931.507;NA;Not Reported;NA;not reported;f4f3eac6-2efa-5075-9613-a37fd44221b9;male;70;not reported;Alive;-25921;NA;1939;NA;NA;not reported;NA;bcc184c4-3571-5a30-9463-32fc7ca22ac3;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;0a123a28-2a20-50e8-b595-62f57ffbe36e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-A5G8;LUSC
TCGA-66-2782;C34.1;not reported;M0;T3;stage iib;2004;No;NA;Squamous cell carcinoma, NOS;N0;116bd219-754e-52c6-9f71-e3a6d6204289;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26237;not reported;NA;8070/3;no;NA;5th;Stage IIB;not reported;2019-08-08T17:13:35.084062-05:00;50;NA;62d71936-6235-5da0-b08a-932ed5bbad9f;50;NA;273.972.602.739.726;NA;Not Reported;NA;not reported;22ba151e-0580-57c3-9aaf-a0b73673df92;male;71;not reported;Dead;-26237;2005;1933;365;NA;yes;NA;ccbd32a5-daed-5f55-85b6-7faae9aa6cc8;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;b3a016d6-0dae-5f88-9d39-026e3991b626;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2782;LUSC
TCGA-39-5029;C34.3;not reported;M0;T1b;stage iiia;2006;No;NA;Squamous cell carcinoma, NOS;N2;c505f06b-08f1-5652-b3f1-518909c9bfcd;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24713;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:12:11.623943-05:00;48;NA;e8f758db-8c1e-51c0-8c6b-59f9d30fb640;192;NA;105.205.479.452.055;NA;Not Reported;NA;white;45469885-05b9-50ed-9cd0-0bab366d403c;male;67;hispanic or latino;Dead;-24713;2008;1939;740;NA;yes;NA;2979eff1-c418-5c10-8a7e-37466f7dc94f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;8281e007-8884-5cae-9380-7482dd87fdd0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5029;LUSC
TCGA-85-8666;C34.1;not reported;M0;T2a;stage ib;2011;No;475;Squamous cell carcinoma, NOS;N0;1047348a-4e61-50cf-b22d-2abb8b5207aa;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23906;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;a7b7af62-ef96-5353-9acf-a8d3719b1e35;55;NA;301.369.863.013.699;NA;Not Reported;NA;white;0b07bbe8-d00a-5529-a38b-431618273807;male;65;not hispanic or latino;Dead;-23906;NA;1946;687;NA;no;NA;6ccf195b-7512-5db0-8392-572f748ab49a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;f140f320-d9aa-5878-8136-a0e3309c0f4d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8666;LUSC
TCGA-96-8169;C34.3;not reported;M0;T1a;stage ia;2011;No;557;Squamous cell carcinoma, NOS;N0;a571ff64-769b-506a-ba29-adf2c9ca03c0;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24674;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:36.542202-05:00;35;NA;aee759a4-c82f-5db0-9912-80e8e723f99f;35;NA;191.780.821.917.808;NA;Not Reported;NA;white;8ad5c8e7-c55c-5cfe-8ee1-f72b93f087bf;female;67;not hispanic or latino;Alive;-24674;NA;1944;NA;NA;no;NA;1a221f3f-de1b-5220-bf77-6519a3659359;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;54830fb9-2e58-5f35-b5ab-8118af616012;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-96-8169;LUSC
TCGA-34-A5IX;C34.3;not reported;M0;T3;stage iib;2012;No;1031;Squamous cell carcinoma, NOS;N0;1bfda408-cace-5bf6-a27e-777447c94382;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;29391;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;010f8262-333d-5cce-8f82-d11d3577b572;NA;NA;NA;NA;Not Reported;NA;white;110efb79-d17d-5142-89f4-f0b484a35d6a;male;80;not hispanic or latino;Alive;-29391;NA;1932;NA;NA;no;NA;a4ec7325-08d8-5039-8385-ad510949a283;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;dc852bd3-7ba3-5fc5-8d26-4132fdec358a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-A5IX;LUSC
TCGA-52-7809;C34.1;not reported;M0;T2;stage ib;2009;No;NA;Basaloid squamous cell carcinoma;N0;399bc779-e5fa-5c50-9e58-ac0873f1c8d3;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27233;not reported;NA;8083/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;cebe9540-2911-5517-baf9-b70282318b09;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;d80b75a9-1681-51cc-8ecc-33ffe6844e04;male;74;not hispanic or latino;Dead;-27233;2009;1935;166;NA;not reported;NA;2ac23791-b147-5e4b-920e-b4f15e47fd22;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;c23d7479-6337-538b-9bc9-ebcfea714aea;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-52-7809;LUSC
TCGA-34-5927;C34.3;not reported;M0;T1;stage ia;2009;No;1361;Squamous cell carcinoma, NOS;N0;b006faa2-c7b2-5bd7-91e2-fa73aec6c8c7;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25857;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;1d76f355-ecff-5265-b420-8eb9409c6877;NA;NA;NA;NA;Not Reported;NA;white;f6b981d9-06b0-5fd8-a527-fe8fb627af61;female;70;not reported;Alive;-25857;NA;1939;NA;NA;yes;NA;269510ad-cce3-5aab-b212-623473ea1306;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4b594c4e-e031-5f11-8c45-9687c3dbe85f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-5927;LUSC
TCGA-66-2800;C34.1;not reported;M0;T4;stage iiib;2004;No;1492;Squamous cell carcinoma, NOS;N0;2349052a-0c4c-5979-b1dc-b5875ee2f34f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25810;not reported;NA;8070/3;no;NA;5th;Stage IIIB;not reported;2019-08-08T17:13:35.084062-05:00;50;NA;69e4691a-c607-58f3-8802-0ee5b0196347;75;NA;410.958.904.109.589;NA;Not Reported;NA;not reported;42024073-fa31-5d32-9ac0-1f1cfc7dffd1;male;70;not reported;Alive;-25810;NA;1934;NA;NA;no;NA;5b18678c-308b-59da-85a4-25f4bc50154c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;841fd895-92b2-5191-a145-2ae042fc374c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2800;LUSC
TCGA-98-A53A;C34.2;not reported;M0;T2a;stage ib;2012;No;274;Squamous cell carcinoma, NOS;N0;45e7d813-17a6-5323-89f6-800f88b45344;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;25662;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;ef6887d3-33c9-5357-91a1-4bc8be889526;80;NA;438.356.164.383.562;NA;Not Reported;NA;black or african american;cf7de379-e6dc-57c6-9ed9-1cbf2380a4d8;male;70;not hispanic or latino;Dead;-25662;NA;1942;552;NA;no;NA;de8e5a48-8f74-562b-a38d-450a9288b3e3;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;eed9eade-34bc-5faa-ac86-09cbe3d4b0a4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-A53A;LUSC
TCGA-85-8481;C34.1;not reported;M0;T3;stage iib;2012;No;21;Squamous cell carcinoma, NOS;N0;225c8738-2b82-511d-8794-dbb87e6af54b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25782;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;18e98658-4a72-5061-9775-ec079c97cb6d;80;NA;438.356.164.383.562;NA;Not Reported;NA;white;f8fedec1-052c-5458-bf19-c888c72eb37a;male;70;not hispanic or latino;Dead;-25782;NA;1942;236;NA;no;NA;d7bf05b6-ecaa-5263-94bc-7d8405121232;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;45ed035f-6b90-5d28-b15e-cc7249a60441;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8481;LUSC
TCGA-43-6770;C34.1;not reported;MX;T2a;stage ib;2011;No;653;Squamous cell carcinoma, NOS;N0;dcebab2e-b1f7-5278-ba26-18770b631c48;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21683;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;6755085c-5438-563e-ae0d-832006ccb1a4;34;NA;186.301.369.863.014;NA;Not Reported;NA;black or african american;463e8946-ef4d-5745-94f2-0629ccee0fde;female;59;not hispanic or latino;Alive;-21683;NA;1952;NA;NA;yes;NA;bf0f2a16-7dc4-574b-96f8-c70cb2d2b873;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;bd148b94-85e9-54f9-ac61-5de0874f234d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-6770;LUSC
TCGA-94-8490;C34.1;not reported;M0;T3;stage iib;2011;No;153;Squamous cell carcinoma, NOS;N0;643f5dba-3c3a-5a40-9960-8482fee18e8b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25588;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;8b6d5d3c-ddec-5b8f-9258-4e9f7581358d;NA;NA;NA;NA;Not Reported;NA;white;aa9f6b93-071e-50a7-bd5b-68b97bb0ff03;male;70;not hispanic or latino;Alive;-25588;NA;1941;NA;NA;not reported;NA;c533f0e4-1295-536a-a0b5-e4f872e55cbb;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;d6fdebdc-1906-58d8-aabe-157a412b1200;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-94-8490;LUSC
TCGA-43-7656;C34.3;not reported;MX;T1b;stage ia;2011;No;596;Squamous cell carcinoma, NOS;N0;36306cb6-fbd3-5f49-adb6-b50aab81c717;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25991;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;376bca93-d80a-5b60-b223-e100e46ae98d;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;60791c70-099d-5e9f-aaaa-43638d3fef49;male;71;not hispanic or latino;Alive;-25991;NA;1940;NA;NA;no;NA;69e7a8c5-6049-5575-b71f-c7193ab51bbf;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;69370c25-3ded-525f-ade5-5cedb7acad94;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-7656;LUSC
TCGA-66-2787;C34.1;not reported;M0;T1;stage ia;2004;No;1217;Squamous cell carcinoma, NOS;N0;53648454-3019-50a4-95d8-4b383fb1a7db;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21124;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:13:35.084062-05:00;40;NA;eee10c5e-c61c-566c-98f6-28ba6ef4e79b;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;d9b9bc6b-4519-5e72-8788-3cec567c7018;male;57;not reported;Alive;-21124;NA;1947;NA;NA;no;NA;0f02a532-77db-560d-9c53-9eb95aabc252;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;557e82df-298a-5984-b489-121a981ccf33;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2787;LUSC
TCGA-85-A4JC;C34.1;not reported;M0;T2b;stage iia;2012;No;455;Squamous cell carcinoma, NOS;N0;03bba57b-a141-5d7b-9259-d1452a8d7803;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;30942;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;287997cb-7cb8-50c4-8e19-4b4666b93707;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;e095008f-4a77-5f4b-8392-252983fd26c9;male;84;not hispanic or latino;Dead;-30942;NA;1928;604;NA;yes;NA;1fab8747-2d82-5beb-9ff3-a985a47e7a66;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;edfc6f18-5b27-591b-addf-7c69157a1a18;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A4JC;LUSC
TCGA-77-6844;C34.3;not reported;M0;T3;stage iiia;2002;No;NA;Squamous cell carcinoma, NOS;N1;7e7c8ce0-f21b-5068-af6c-06f9e7ab5062;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27220;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:13:35.084062-05:00;45;NA;1faa1be8-e1c4-5e22-96d7-09b944f6476a;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;3696c249-49ad-52d5-97a5-a54e78eee7d9;male;74;not reported;Dead;-27220;2008;1928;2284;NA;no;NA;40525944-3b3c-50ba-98ae-e01c31faa168;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;47db7d6e-3ec6-53b1-8fad-9dc645348375;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-6844;LUSC
TCGA-90-7767;C34.1;not reported;MX;T2b;stage iib;2011;No;89;Squamous cell carcinoma, NOS;N1;56cd1922-3f13-5502-96e7-0c70eab755cb;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20534;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;10;NA;06b8bf41-8660-599e-bbd0-f2f2fd5f1376;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;dd58e402-9f8d-5dbf-a1fe-fbf60fd9b9ae;male;56;not hispanic or latino;Alive;-20534;NA;1955;NA;NA;not reported;NA;633cc991-6f7b-52c9-8532-e50790f78a2c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;c29e5d13-93d8-5f0b-b8ac-282f705e76d7;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-90-7767;LUSC
TCGA-33-6737;C34.1;not reported;M0;T2;stage iiia;2008;Not Reported;NA;Squamous cell carcinoma, NOS;N2;ff7823d0-4f13-5263-a6c2-839571ead76c;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26033;not reported;NA;8070/3;yes;NA;6th;Stage IIIA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;58620c99-c896-58d6-a390-781f350a01de;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;34e65006-4737-5a6f-8bf3-70483845ed3d;male;71;not reported;Dead;-26033;2009;1937;601;NA;yes;NA;b74aec4d-e893-528c-9c9b-e9fcf450ea30;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;b85098f9-e0f8-5388-92d9-4bf73cbe4c96;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-6737;LUSC
TCGA-63-A5MG;C34.3;not reported;M0;T2;stage ib;NA;No;2148;Squamous cell carcinoma, NOS;N0;fd34b9e4-b196-58c4-a391-9b5c18ae5188;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;NA;24957;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;16ff5c47-e259-5c4f-bcfb-e3495494bf88;NA;NA;NA;NA;Not Reported;NA;not reported;fff1efdd-4c27-57d1-b8a3-a61ea6910a0a;male;68;not reported;Alive;-24957;NA;NA;NA;NA;no;NA;0a2f0ea5-1645-500d-8efa-b664a6676f4f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3d88ac8f-9be9-5094-a291-6ff91477e62f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MG;LUSC
TCGA-NK-A5CT;C34.3;not reported;M0;T1;stage ia;2008;No;1997;Squamous cell carcinoma, NOS;N0;aad56f63-5aa5-5db6-aeae-0b32f3d07b69;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25726;not reported;NA;8070/3;yes;NA;6th;Stage IA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;8eeca483-d4e4-5edf-94cd-1e6931ef7a36;80;NA;438.356.164.383.562;NA;Not Reported;NA;white;f99a4281-9ab3-5823-8925-0be31435c602;male;70;not hispanic or latino;Alive;-25726;NA;1938;NA;NA;no;NA;4db97e02-2742-507f-86ba-c2957682d9b2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;bd6fef7e-8e27-5b26-b020-6ab64cd80c58;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NK-A5CT;LUSC
TCGA-58-8387;C34.3;not reported;M0;T2b;stage iia;2010;No;NA;Squamous cell carcinoma, NOS;N0;3540f6ba-fd46-50ea-b2a7-e3df4e51c6e1;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;21952;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;5bd08949-4c93-5b4c-b971-cfe4d2c26c60;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;bb4c28c9-514a-55ff-99e5-74314b13b020;male;60;not hispanic or latino;Dead;-21952;2011;1950;403;NA;yes;NA;cb725cae-0f9b-5f69-9886-fb18da9ae8ff;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7b35d0d9-551e-5e71-b0ab-eb7d377cbe76;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-58-8387;LUSC
TCGA-66-2788;C34.3;not reported;M0;T2;stage ib;2008;No;699;Squamous cell carcinoma, NOS;N0;f87cef28-8a23-51dc-9e7b-25940a9aa812;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;20637;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;40;NA;538988f5-a17a-55c9-bd42-36165765be82;80;NA;438.356.164.383.562;NA;Not Reported;NA;not reported;a1eb0d07-f1ca-599c-b1ee-4080ec57bd44;male;56;not reported;Alive;-20637;NA;1952;NA;NA;no;NA;8001e613-0002-5513-8232-b9790d57a19d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;dbad54c5-1c4d-58fc-8d72-60313f8a8921;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2788;LUSC
TCGA-46-3766;C34.3;not reported;M0;T1;stage ia;2009;No;370;Squamous cell carcinoma, NOS;N0;8161e25f-37d6-5e97-8f86-060d37b4d12c;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22707;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;d4a85844-5a1b-5c09-a11c-bb8c702070bd;NA;NA;NA;NA;Not Reported;NA;white;8ee46fe8-c0d8-5999-8775-39eee92bc921;female;62;not hispanic or latino;Alive;-22707;NA;1947;NA;NA;no;NA;930d8355-6581-57ff-92e7-42aea5a2bcbd;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4dc44b2f-94fc-5e01-8e6a-0c3ff2e59cd4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-46-3766;LUSC
TCGA-39-5036;C34.1;not reported;M0;T2;stage ib;2007;No;2165;Squamous cell carcinoma, NOS;N0;ef8e33b4-a30e-56dd-b4b4-62e066458031;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26963;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:12:11.623943-05:00;43;NA;fb6e686e-dc26-5813-afa5-53a4b4872a5b;63;NA;345.205.479.452.055;NA;Not Reported;NA;white;dc976d22-c5b1-50f2-ad73-e582b2e0fdfa;male;73;not reported;Alive;-26963;NA;1934;NA;NA;no;NA;60b99062-c0cb-5e0b-9f75-20c206825b45;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;bcb188fc-2edc-5e76-90ee-52eee78e994e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5036;LUSC
TCGA-66-2759;C34.3;not reported;M0;T2;stage iiia;2007;No;762;Squamous cell carcinoma, NOS;N2;d6b5bd39-d1d5-5900-97d4-8799637dfbd0;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24287;not reported;NA;8070/3;no;NA;5th;Stage IIIA;not reported;2019-08-08T17:13:13.079700-05:00;31;NA;e128242e-188f-5ff4-b249-25ca323abfb8;16;NA;0.876712328767123;NA;Not Reported;NA;not reported;9dc8b86e-088f-5e1d-a99c-ed941066e9ac;male;66;not reported;Alive;-24287;NA;1941;NA;NA;yes;NA;7d8904db-833a-5674-9e4c-2666ec752542;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;62664f79-63c8-5263-8006-1845092e57ca;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2759;LUSC
TCGA-34-5241;C34.3;not reported;M0;T2;stage ib;2009;No;428;Squamous cell carcinoma, NOS;N0;1fc246ac-09a1-502c-a121-64b81c31d398;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;29098;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:12:11.623943-05:00;25;NA;ce1840e5-87b4-5913-8a29-6e3f58715bc2;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;bdc0bd72-0c2c-53a4-bfaf-4b9f215c671b;male;79;not hispanic or latino;Dead;-29098;NA;1930;515;NA;no;NA;2e934da0-ee28-5a16-b9b8-e8cd568ce315;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;5bb97049-49ed-54ac-9f5b-0fc2d783d84c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-5241;LUSC
TCGA-22-4599;C34.8;not reported;M0;T2a;stage ib;2002;No;1161;Squamous cell carcinoma, NOS;N0;11e851ea-7f8f-502c-aaa5-bfd29adcc1ba;not reported;NA;Overlapping lesion of lung;No;Overlapping lesion of lung;released;0;26925;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;3ae01673-7e84-5c08-aa58-eb0d44986aec;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;dae921fe-a297-57de-aad2-4ccc6b7aba45;female;73;not reported;Dead;-26925;2005;1929;1161;NA;not reported;NA;a77891eb-9156-5758-af4a-d5d50fdee4d7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;fed1334c-db35-5eb0-9cbc-42a9667b09eb;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-4599;LUSC
TCGA-NC-A5HG;C34.3;not reported;M0;T2;stage iiia;2009;No;1963;Basaloid squamous cell carcinoma;N2;a9b72f53-3788-511c-93c7-16fd600eac2e;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;21608;not reported;NA;8083/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:14:36.542202-05:00;40;NA;57426eaf-a72f-5c62-a5fd-0169e9a3826a;80;NA;438.356.164.383.562;NA;Not Reported;NA;white;fff68e30-fbc2-5018-b415-688a8b7f6441;male;59;not reported;Alive;-21608;NA;1950;NA;NA;yes;NA;3871e70f-0277-58ab-937c-59d67d96e0e5;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;b8af5ca2-2910-5078-816d-bdcf70fabe73;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HG;LUSC
TCGA-90-7766;C34.1;not reported;MX;T1b;stage ia;2011;Not Reported;289;Squamous cell carcinoma, NOS;N0;857ae28d-ccb2-55f8-9e12-a8c7026da48b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24354;not reported;NA;8070/3;yes;NA;7th;Stage IA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;6c676ada-aaa1-520b-9706-a9a377ea45b7;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;1a0cd0b1-900c-5acf-8650-6fccd6109a18;female;66;not hispanic or latino;Alive;-24354;NA;1945;NA;NA;no;NA;382b2af1-aeaa-5241-a677-5b523210b3c2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;08a54897-9918-5e4a-bbfc-84a6d1444166;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-90-7766;LUSC
TCGA-56-8309;C34.3;not reported;MX;T1b;stage ia;2012;No;428;Squamous cell carcinoma, NOS;N0;6e5c835e-1f30-5d89-b44a-57841530eabd;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24382;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;0d7c86ef-97f1-5f57-8ca5-7afa277d3057;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;d69d7214-d3c9-5ede-9161-2cb55dfec019;male;66;not hispanic or latino;Alive;-24382;NA;1946;NA;NA;no;NA;db58dd8f-0d7e-5e59-8b8b-70459ca84803;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4d250055-e7e3-535f-beac-7be90e8ff530;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8309;LUSC
TCGA-43-2578;C34.1;not reported;M0;T1;stage ia;2009;Not Reported;684;Squamous cell carcinoma, NOS;N0;db9341a6-8a7a-5acc-805d-6354a772b8c9;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21747;not reported;NA;8070/3;yes;NA;6th;Stage IA;not reported;2019-08-08T17:12:11.623943-05:00;32;NA;dd181d9b-966a-5c0f-b61b-6c104568cc3f;64;NA;350.684.931.506.849;NA;Not Reported;NA;white;c7de9dcc-efb4-557a-982c-298f89130df5;female;59;not hispanic or latino;Dead;-21747;NA;1950;684;NA;no;NA;f5e3d935-d5d3-56cd-9cb3-3b9fdd5f2c1f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;cf5e3801-1119-51f0-900b-e27c90b630c8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-2578;LUSC
TCGA-22-4594;C34.1;not reported;M0;T3;stage iiia;2002;No;1470;Squamous cell carcinoma, NOS;N2;4a17af8b-244a-504c-ab4e-d12f427d8a51;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22115;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;87f97dff-79ab-5a12-975f-883107036c48;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;073467d4-b9ca-5967-8787-8c994df22885;female;60;not reported;Dead;-22115;2006;1942;1470;NA;not reported;NA;261169ac-442f-5ba6-8623-f9f630538ca5;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;e713605e-3f99-534b-9630-1cbe240bcd48;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-4594;LUSC
TCGA-96-A4JL;C34.3;not reported;M0;T2a;stage iia;2012;No;842;Squamous cell carcinoma, NOS;N1;ddcbf0ed-caca-57e2-9f43-a44bc18b6991;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28686;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;92e43644-dae5-5c7c-a97a-e78e7d4a0f00;NA;NA;NA;NA;Not Reported;NA;asian;382abc38-c952-5d3b-9dbb-365a32e65e7b;female;78;not hispanic or latino;Alive;-28686;NA;1934;NA;NA;yes;NA;e275ecb4-82ab-53c4-9ee2-1a3edcffa5f3;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e8aa311d-47a8-510d-b41d-7ae2cb9b8a6e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-96-A4JL;LUSC
TCGA-63-6202;C34.1;not reported;M0;T2;stage iia;2008;No;1602;Squamous cell carcinoma, NOS;N0;195bf7df-5368-5ce4-a887-eedc3231b428;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;NA;NA;not reported;NA;8070/3;no;NA;6th;Stage IIA;not reported;2019-08-08T17:13:13.079700-05:00;35;NA;187466f9-3754-588e-8f6d-dafc9c53f61b;35;NA;191.780.821.917.808;NA;Not Reported;NA;not reported;770d6c85-4e5c-5316-9578-c61fce416710;male;NA;not reported;Alive;NA;NA;NA;NA;NA;no;NA;e9d95010-1233-57c9-b59a-252ef2283f8c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;624bd8ca-318c-5058-991a-363fe94cba9f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-6202;LUSC
TCGA-21-5782;C34.3;not reported;M0;T2;stage ib;2004;No;962;Squamous cell carcinoma, NOS;N0;d9ecf172-e435-567d-88b4-63aa13850822;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24969;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;51;NA;3905ab36-0455-54e8-8412-32c2dd5cfd28;48;NA;263.013.698.630.137;NA;Not Reported;NA;white;1d45e921-c7b0-5ad4-90cb-a7aae5db93c1;female;68;not hispanic or latino;Dead;-24969;2006;1936;962;NA;no;NA;94251a68-daf3-580f-9305-783e51b025f7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ce8c83cc-4020-5cb7-a133-f88b17418b76;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-5782;LUSC
TCGA-NK-A5CR;C34.1;not reported;MX;T2;stage ib;2007;No;2542;Squamous cell carcinoma, NOS;N0;97a06edb-8d89-5eef-a44a-136e36c5bd61;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28126;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;add62681-046f-5858-94dd-e4f6937e24f9;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;35003139-1750-5ada-87f7-5df4140d54a1;male;77;not hispanic or latino;Alive;-28126;NA;1930;NA;NA;no;NA;8d48799f-7b62-53b5-927c-1cba29066f8b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;cb4260fc-dd17-5833-afe4-bccfd41ce467;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NK-A5CR;LUSC
TCGA-60-2710;C34.1;not reported;M0;T1;stage iia;2005;No;2024;Squamous cell carcinoma, NOS;N1;1ee71ae6-b93c-52f7-8e78-f646287c729c;not reported;NA;Upper lobe, lung;Yes;Upper lobe, lung;released;0;24669;not reported;NA;8070/3;no;NA;6th;Stage IIA;not reported;2019-08-08T17:12:53.407315-05:00;42;NA;90321086-0e34-539b-bfe0-2b0dea4e5941;63;NA;345.205.479.452.055;NA;Not Reported;NA;white;b68a109c-7af5-57a9-a97d-2e88c23b8674;female;67;not hispanic or latino;Alive;-24669;NA;1938;NA;NA;yes;NA;d8a37d76-751d-5826-b2ab-2cc422d54209;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a90b9847-96f5-50f3-8829-641c8592b9c9;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2710;LUSC
TCGA-66-2768;C34.3;not reported;M0;T2;stage iib;2007;No;61;Squamous cell carcinoma, NOS;N1;029f1680-0ba3-5f19-809d-43027be50ece;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;20970;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:35.084062-05:00;NA;NA;749de8a6-9ae4-5691-b8c2-840cddf31e3d;NA;NA;NA;NA;Not Reported;NA;not reported;db87cc06-9235-5c90-b5fe-75a160e4dd21;male;57;not reported;Alive;-20970;NA;1950;NA;NA;not reported;NA;267c782f-9d0c-57cb-87fe-ed7998eb2eae;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;1e738937-3c1c-5455-9d10-cd459c39a903;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2768;LUSC
TCGA-58-8391;C34.9;not reported;M0;T2;stage iiia;2006;No;2167;Squamous cell carcinoma, NOS;N2;25ed2d20-d92e-5233-9875-98c2ee933893;not reported;NA;Main bronchus;No;Main bronchus;released;0;21102;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;bb5fe104-78d6-5441-a95b-4bd3edf804c1;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;adc2f3f1-c951-558e-9166-c08867db130e;female;57;not hispanic or latino;Alive;-21102;NA;1949;NA;NA;yes;NA;07166653-404e-522d-b634-f3a61b699952;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;2dfb06b3-be0b-55c6-ba3d-d07ce1f70d1e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-58-8391;LUSC
TCGA-21-1075;C34.3;not reported;M0;T2;stage iib;2002;No;2134;Squamous cell carcinoma, NOS;N1;102af613-2a3b-51d3-92cd-b31911d6a350;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;21093;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;c96f2607-6052-5cac-8286-e13496c7ebf3;74;NA;405.479.452.054.795;NA;Not Reported;NA;white;e31cc5a5-69b0-501e-a272-1ec20c1657c9;male;57;not hispanic or latino;Alive;-21093;NA;1945;NA;NA;no;NA;22e05faf-a05c-551f-92ab-0f8c352ea67e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;5009b48a-b84d-5db6-9f08-f05974ee633c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-1075;LUSC
TCGA-94-A5I6;C34.3;not reported;M0;T3;stage iib;2012;No;538;Squamous cell carcinoma, NOS;N0;4d41b2af-eacc-5811-a3d7-37658a528352;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22949;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;40;NA;a9a45364-0bac-5e1a-b9b8-d930b1b7d9b0;80;NA;438.356.164.383.562;NA;Not Reported;NA;white;c4ddf816-a5cc-520e-bde0-a575d0073f05;male;62;not hispanic or latino;Alive;-22949;NA;1950;NA;NA;yes;NA;3971911c-b059-5052-b79d-7b699156c5fb;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;0f69607a-df3c-5439-82bf-f3633dee37d4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-94-A5I6;LUSC
TCGA-68-7756;C34.1;not reported;MX;T4;stage iiia;2011;No;202;Squamous cell carcinoma, NOS;N1;667babcc-cec9-581b-bedc-b59cfd05fe41;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;30763;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:13:35.084062-05:00;NA;NA;94a2517a-6e0a-5809-a0cd-e615cf3fb539;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;62258e67-3917-5f9e-b2fc-63924f81b647;male;84;not hispanic or latino;Alive;-30763;NA;1927;NA;NA;yes;NA;4bbc5e32-622d-5d2b-a5cd-43acfa52ddb9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;bd161b25-887f-5a05-a608-13f1e7820a52;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-68-7756;LUSC
TCGA-85-A511;C34.3;not reported;M0;T2b;stage iib;2012;No;0;Squamous cell carcinoma, NOS;N1;0e2c270d-c4e3-56f6-924d-cbbaffd7a2d7;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22759;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;6bea7713-c6d0-5940-8288-f6d5c72cd586;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;f7a2b29e-3733-5371-91c1-70e96f32c2d9;male;62;not hispanic or latino;Dead;-22759;NA;1950;455;NA;no;NA;188d16fa-1ec1-50e6-9fa8-448193765f45;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;d388f544-f787-5d78-afc8-0ca7f2c15e20;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A511;LUSC
TCGA-21-1079;C34.1;not reported;M0;T3;stage iiia;1995;No;965;Squamous cell carcinoma, NOS;N0;0f5f5579-edd1-5a73-a600-8ae7f9ff81e5;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26176;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;72b3e6b4-0e73-50a2-bf41-316c5e41264a;80;NA;438.356.164.383.562;NA;Not Reported;NA;white;658c1601-2e5b-5d74-8474-a576e101d019;male;71;not hispanic or latino;Dead;-26176;1997;1924;965;NA;no;NA;0f0f4794-286f-5317-8bb8-83390a801e67;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;329157ef-0e4a-5ddc-a27d-682d3b7e13de;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-1079;LUSC
TCGA-66-2757;C34.1;not reported;M0;T1;stage ia;2007;No;30;Squamous cell carcinoma, NOS;N0;b338c4e7-0c89-5fee-8400-8f9d5d041be9;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24014;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:13:13.079700-05:00;48;NA;d030036a-d2d0-522f-a3f8-0b9cfe8a894e;72;NA;394.520.547.945.205;NA;Not Reported;NA;not reported;96448b06-34e9-5d6e-91f6-8c19fcdeb1a4;female;65;not reported;Dead;-24014;NA;1942;1338;NA;yes;NA;c193e8b7-0f16-5b31-bdd8-4cfe169adfe4;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;dfb3f19b-c052-59dd-8b79-5790e8a3c1b0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2757;LUSC
TCGA-58-A46M;C34.3;not reported;M0;T2b;stage iib;2010;No;1072;Squamous cell carcinoma, NOS;N1;d2c1175f-0a6e-5054-8748-8593e1471188;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;22592;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;11e4cc01-3e9e-5b45-b3c4-c3af5425747b;NA;NA;NA;NA;Not Reported;NA;white;b0cac2c2-ba1f-5cc0-a71a-a74a4fb2722c;male;61;not hispanic or latino;Alive;-22592;NA;1949;NA;NA;no;NA;964321ba-5d58-5b17-8f9a-d77e11b92ec0;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e3700aa4-9190-541d-b47b-2bd3e4345d69;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-58-A46M;LUSC
TCGA-56-A4ZJ;C34.3;not reported;M0;T1a;stage ia;2012;No;640;Squamous cell carcinoma, large cell, nonkeratinizing, NOS;N0;57b9ea54-08af-5499-a83a-66d190ad4b49;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27516;not reported;NA;8072/3;yes;NA;7th;Stage IA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;b7022598-6d46-5a1d-aa11-c45cbb340c37;100;NA;547.945.205.479.452;NA;Not Reported;NA;white;a9aa366b-935c-52cc-a966-b0dec5a83001;female;75;not hispanic or latino;Alive;-27516;NA;1937;NA;NA;no;NA;78f6393a-770f-5313-99dc-5821e203df6a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;40ff4601-add7-54a6-9948-c9c2a99cd5ca;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-A4ZJ;LUSC
TCGA-37-3783;C34.1;not reported;M0;T3;stage iiia;2006;No;122;Squamous cell carcinoma, NOS;N2;d353dc61-b172-54ba-8340-e8251754eb2e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;18728;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;4f1dc6da-f957-55ff-9f44-93032701ebc6;NA;NA;NA;NA;Not Reported;NA;white;784bc330-8bf6-577e-bd98-33bd1639aa89;male;51;not hispanic or latino;Alive;-18728;NA;1955;NA;NA;not reported;NA;9a96ad02-76a5-577f-80a6-390a4802791f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;0fbdba1c-a32f-54dc-8956-d94804e7d3a7;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-3783;LUSC
TCGA-60-2708;C34.3;not reported;M0;T2;stage iib;2004;No;2447;Squamous cell carcinoma, NOS;N1;7402e4eb-e3da-5af2-b214-69ce6a68c9ad;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;23691;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:12:53.407315-05:00;40;NA;1422a66b-051e-5277-bfbd-02e824593378;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;205ebbeb-a679-5425-aa53-b46254f0c70e;female;64;not hispanic or latino;Alive;-23691;NA;1940;NA;NA;yes;NA;ea2368e2-60cb-5d73-908b-e6c25d7a45b7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c17e3f5b-2f6b-5d84-94c7-32d1b062770e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2708;LUSC
TCGA-66-2744;C34.3;not reported;M0;T2;stage iib;2006;No;30;Squamous cell carcinoma, NOS;N1;6d472c41-1b94-552e-a61c-ec5a4975b43b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26084;not reported;NA;8070/3;no;NA;5th;Stage IIB;not reported;2019-08-08T17:13:13.079700-05:00;50;NA;13fbb603-047c-5835-9a6b-7977ca627118;63;NA;345.205.479.452.055;NA;Not Reported;NA;not reported;c0d3dd3c-80d8-5eda-b24a-b3141930de1d;male;71;not reported;Alive;-26084;NA;1935;NA;NA;not reported;NA;b927dbb0-f9cb-56b9-b590-d4bcff54919b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;65afabdc-0a7c-5c2f-8d01-846b3097f2ab;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2744;LUSC
TCGA-33-4533;C34.9;not reported;M0;T2;stage ib;2001;Not Reported;4068;Squamous cell carcinoma, NOS;N0;49ae56ff-c65a-5c60-89a5-1546b33702ff;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;28001;not reported;NA;8070/3;yes;NA;5th;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;50;NA;ea374df2-869e-5e6d-93d9-9c199f6e9a83;50;NA;273.972.602.739.726;NA;Not Reported;NA;black or african american;92fe2e3c-d33a-5b84-acca-804b036194f6;female;76;not hispanic or latino;Alive;-28001;NA;1925;NA;NA;no;NA;35c567e6-f83a-5717-bdb8-675b144eefc9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ee34b031-3b56-5274-9487-ffc5fbccf7d0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-4533;LUSC
TCGA-22-0940;C34.9;not reported;M0;T1;stage iia;2000;No;608;Squamous cell carcinoma, NOS;N1;867cb4b1-3a5c-54d4-9416-333110ad92e1;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;26272;not reported;NA;8070/3;no;NA;NA;Stage IIA;not reported;2019-08-08T17:11:26.507214-05:00;24;NA;8e6c6c5d-5f3d-5961-ae0d-f37747ed32a7;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;8ec06327-4c5c-58e7-92f8-ff75fce3d8e8;male;71;not hispanic or latino;Dead;-26272;2001;1929;669;NA;no;NA;8aedcb4b-3c04-547b-a52d-2cc292b2dba2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4ad92efb-fe0c-51e1-8bee-10e8ddc0e29d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-0940;LUSC
TCGA-33-AASL;C34.1;not reported;MX;T1;stage ia;2000;No;NA;Squamous cell carcinoma, NOS;N0;2ad7ad84-64d1-5f59-b9ac-812d50a6ff5f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20940;not reported;NA;8070/3;no;NA;5th;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;5f17aad8-45a4-5548-8d35-9a9e8530e62e;60;NA;328.767.123.287.671;NA;Not Reported;NA;black or african american;20deb28f-66ff-5295-8bd5-64edb434bbc1;female;57;not hispanic or latino;Dead;-20940;2002;1943;826;NA;yes;NA;f9eb7fc5-b1d2-573e-b7bf-55bb181ebb99;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;57526f51-f925-51ca-9e08-77bff96ceb93;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-AASL;LUSC
TCGA-60-2712;C34.1;not reported;M0;T2;stage iib;2006;Not Reported;274;Squamous cell carcinoma, NOS;N1;c0a9d1eb-2c52-5bb4-8b56-94a705a038f8;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;29131;not reported;NA;8070/3;yes;NA;NA;Stage IIB;not reported;2019-08-08T17:12:53.407315-05:00;20;NA;8499e73b-6be9-5da0-b967-d19bdfe476f4;10;NA;0.547945205479452;NA;Not Reported;NA;white;48a5db01-45ca-5ca7-b86f-c8bf48dec047;female;79;not hispanic or latino;Dead;-29131;2006;1927;274;NA;no;NA;4227edb2-c5e6-5088-8138-2b4fb6598e9c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c8ad14f8-333e-508c-87ad-10c4eca8a0d6;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2712;LUSC
TCGA-21-A5DI;C34.3;not reported;M0;T1b;stage ia;2006;No;979;Squamous cell carcinoma, NOS;N0;357293a8-370c-5d2d-b701-fb59add9514f;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28374;not reported;NA;8070/3;yes;NA;6th;Stage IA;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;cc12422c-48a8-5ccc-96f6-8acde9fde138;NA;NA;NA;NA;Not Reported;NA;white;b0c0bc7e-c6b2-5a81-bc44-83aeefe549e0;male;77;not hispanic or latino;Alive;-28374;NA;1929;NA;NA;no;NA;bb262543-bc2d-5eea-8513-d4fc6236af92;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;8931f997-fbdf-5699-87da-b51931b09523;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-A5DI;LUSC
TCGA-85-8070;C34.1;not reported;M0;T2;stage ib;2011;No;960;Squamous cell carcinoma, NOS;N0;a755251a-f8dd-5385-9aa4-7d2a85c25cf1;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26183;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;4c55512c-5070-58ca-bc56-dd8886cc7b3b;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;c9a798ed-a240-5a8e-989e-3652d8ac0845;male;71;not hispanic or latino;Alive;-26183;NA;1940;NA;NA;no;NA;40bac9c4-9faa-584b-8350-050b3edeb626;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;bf54975a-f9f5-5832-9480-033512f4688b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8070;LUSC
TCGA-85-7697;C34.1;not reported;M0;T3;stage iib;2011;No;1063;Squamous cell carcinoma, NOS;N0;502578f8-87f8-519f-b44e-253ac57a53f7;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;17921;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;f3f50530-5c5b-52b6-b12b-3a1bd185aabc;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;12951ab4-aba2-5b1b-b078-b39113a9e6e1;male;49;not hispanic or latino;Alive;-17921;NA;1962;NA;NA;yes;NA;afb9b122-9724-5210-aa67-f9ee251d63b3;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;de6c305e-2d0d-5b32-b9f5-b1572ed55804;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-7697;LUSC
TCGA-56-8628;C34.1;not reported;MX;T1b;stage ia;2012;No;616;Squamous cell carcinoma, NOS;N0;2b12d044-b436-5db1-a4b5-8579681514b6;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28805;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;64270c63-3b53-50a6-bfa6-6000eccb1df3;NA;NA;NA;NA;Not Reported;NA;white;a07c7b5b-7395-53e8-9b19-bb8a6a9d6407;male;78;not hispanic or latino;Alive;-28805;NA;1934;NA;NA;no;NA;34b14536-79b2-58e1-881b-87e7dd2d416f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;efdec70c-001d-56bd-ba2a-8162c4d0a063;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8628;LUSC
TCGA-63-5131;C34.9;not reported;M0;T2;stage iib;2008;No;NA;Squamous cell carcinoma, NOS;N1;b38acade-f6ba-533d-8059-d9060aecaaed;not reported;NA;Lung, NOS;No;Lung, NOS;released;NA;NA;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;fc63b44e-d45c-52bb-bc77-8de682d366dd;50;NA;273.972.602.739.726;NA;Not Reported;NA;not reported;85ddb719-e406-5d1a-9381-ea98d164993e;male;NA;not reported;Dead;NA;NA;NA;NA;NA;no;NA;66c70e16-2155-567a-8c20-830b95116713;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e27f5101-8017-5f85-92ff-98ca175f2316;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-5131;LUSC
TCGA-77-7142;C34.1;not reported;M0;T2;stage ib;2007;No;2227;Squamous cell carcinoma, NOS;N0;e891e60f-9a80-5f24-bc40-9296fae4cdff;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21796;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;45;NA;ae8152f8-ddee-571b-a197-845e5da3339a;52.5;NA;287.671.232.876.712;NA;Not Reported;NA;white;48b56430-3475-5825-95b1-b81dcadd5021;female;59;not reported;Alive;-21796;NA;1948;NA;NA;no;NA;e9cf71d2-27f2-575e-8ce8-38d0de441d4c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;d18d8e6c-3c91-5509-9c8f-1f1d32e186f1;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-7142;LUSC
TCGA-NK-A5D1;C34.1;not reported;M0;T2a;stage iia;2011;No;511;Squamous cell carcinoma, NOS;N1;d038b36f-75c1-577e-a543-88785bf7cf27;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20909;not reported;NA;8070/3;yes;NA;7th;Stage IIA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;5512d720-3b3f-5237-bb2e-4d9ec88067a7;90;NA;493.150.684.931.507;NA;Not Reported;NA;white;9798a470-64f4-56bf-a8c2-fa839b5c5381;male;57;not hispanic or latino;Alive;-20909;NA;1954;NA;NA;yes;NA;086de0de-40f3-5f62-bf93-f8a071baf8b3;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;de7099a7-8c5e-5cce-9371-8508b72356b8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NK-A5D1;LUSC
TCGA-22-5491;C34.3;not reported;M0;T1a;stage ia;2003;No;1713;Squamous cell carcinoma, NOS;N0;9673bc62-3a8d-5c7f-8635-ceb94452e883;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;27145;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;712ee74a-1c84-57d2-9ac8-37635094ac81;57;NA;312.328.767.123.288;NA;Not Reported;NA;white;fc7b7dc6-8f61-5bce-aaf4-7a7184a9749f;male;74;not reported;Dead;-27145;2007;1929;1713;NA;not reported;NA;879d0722-fc34-5e70-8284-e778b7618b55;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;221416a2-fae4-5fbd-9f9d-8f6a3922dce6;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5491;LUSC
TCGA-63-A5MB;C34.1;not reported;M0;T2;stage ib;NA;No;3123;Squamous cell carcinoma, NOS;N0;f954caf6-4ddf-5f91-baed-b47f44003ad1;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;NA;22930;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;3dbf2f1b-13f6-56f9-926c-f33b7f866f1b;25;NA;136.986.301.369.863;NA;Not Reported;NA;not reported;80dd72bc-f5e7-58e4-b08d-009614480bd9;male;62;not reported;Alive;-22930;NA;NA;NA;NA;yes;NA;efcb71a1-5c61-58fc-b636-7a36d5eaecb8;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c4561ccd-0f2a-5f96-bce6-17f03fa90635;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MB;LUSC
TCGA-21-1072;C34.9;not reported;M0;T2;stage ib;2001;No;3016;Squamous cell carcinoma, NOS;N0;c1564d8b-5faf-5461-88fe-d9be44537a96;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;27397;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;39f3b3c9-5fb4-5c19-85cc-53c67dbccc55;NA;NA;NA;NA;Not Reported;NA;white;ce19c2f5-2e5b-5f99-8b5c-cb39669dc406;male;75;not hispanic or latino;Alive;-27397;NA;1926;NA;NA;no;NA;382a6b6e-283f-556f-907c-6543c64cb595;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;56f7566e-b35a-587a-8642-fb5750f70646;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-1072;LUSC
TCGA-56-6546;C34.1;not reported;MX;T2b;stage iia;2011;No;NA;Squamous cell carcinoma, NOS;N0;4dc5a798-65a9-51ec-b25b-4d59c4be826a;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24594;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:12:31.795062-05:00;57;NA;9672733c-3426-53f5-92b5-a0451c733562;NA;NA;NA;NA;Not Reported;NA;white;d955f984-6278-536b-8bc3-b2aa645e6ca9;male;67;not hispanic or latino;Dead;-24594;NA;1944;NA;NA;no;NA;8547a077-08e9-5552-b2f1-7b19f03ab87d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;21b6225e-5880-570c-8da6-b38a62d4bdca;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-6546;LUSC
TCGA-85-8071;C34.1;not reported;M0;T1a;stage iia;2011;No;815;Squamous cell carcinoma, NOS;N1;dcfc14a6-5bad-52e1-819f-672abc13c53a;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;19158;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;b79ab0e9-f852-5703-a7c6-d19255840ffc;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;382e9eb9-441d-5330-bd82-c9f51575a3a2;male;52;not hispanic or latino;Alive;-19158;NA;1959;NA;NA;no;NA;de3342a4-3b91-5c25-99d1-d4803442985a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;bb7f6409-f098-50dc-b3b3-2b802305701e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8071;LUSC
TCGA-77-8131;C34.3;not reported;M0;T2;stage ib;2000;No;NA;Squamous cell carcinoma, NOS;NX;5b1cf6ab-90e4-5bd0-9d71-35f439301334;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26611;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;46;NA;a84070bb-1f91-5b90-91c3-d7de4fa4a9ba;69;NA;378.082.191.780.822;NA;Not Reported;NA;not reported;0b6ae36c-9edf-5fc2-a5cf-d8a9d34ed5f0;male;72;not reported;Dead;-26611;2001;1928;383;NA;not reported;NA;04e17b70-b301-5aac-b675-27bfd3fe4977;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;c38e0892-6d6d-5143-8408-9c66a0ff9bae;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8131;LUSC
TCGA-85-A512;C34.3;not reported;M0;T1b;stage iia;2012;No;465;Squamous cell carcinoma, NOS;N1;c19ff937-c25a-54cc-86bb-be754d19bd59;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;16811;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;53a3f2f6-da53-5418-acf5-d7e369db8226;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;b835d4d3-2440-532f-9bed-58d889de2cca;male;46;not hispanic or latino;Alive;-16811;NA;1966;NA;NA;yes;NA;684f1e1d-c653-5ef5-8256-e024c365e1e5;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;74060ab3-f311-5d69-97a2-3343f7a628d9;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A512;LUSC
TCGA-33-A5GW;C34.3;not reported;MX;T1a;stage iia;2012;No;9;Squamous cell carcinoma, NOS;N1;04a34408-fd8b-5eb3-b5ca-9ea0a8ba953d;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24586;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;4a7991f4-cfb3-5b12-baae-273786adbb73;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;9003e636-80a2-5225-b97d-6ea1869c26d6;male;67;not hispanic or latino;Dead;-24586;NA;1945;9;NA;no;NA;bb30659a-2f3d-5c7b-aee1-23402645adca;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;2dadc685-28fa-5164-856a-eecb34b8f058;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-A5GW;LUSC
TCGA-33-A4WN;C34.1;not reported;MX;T2a;stage ib;2011;No;NA;Squamous cell carcinoma, NOS;N0;3ee6bb57-2d39-55e4-859c-62602073f38e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22268;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;018ee0ae-f3b7-52d6-a343-db39f1738033;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;a29ce34d-90a6-5592-ae5c-6ab37163aee5;male;60;not hispanic or latino;Dead;-22268;2011;1951;143;NA;not reported;NA;ae24880b-ae4a-53a8-abf0-7de39d5cabc4;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;7534b7a9-168b-56eb-884a-01181968447d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-A4WN;LUSC
TCGA-56-7731;C34.1;not reported;MX;T2a;stage ib;2011;No;0;Squamous cell carcinoma, NOS;N0;4eb7a035-cb07-5cc8-990f-06daa0fe5ee4;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24441;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;50;NA;f2fea8ca-6630-50d5-bc58-665c2a81f011;100;NA;547.945.205.479.452;NA;Not Reported;NA;white;93bbffdf-30ab-56fa-9361-ad4f29fb88ef;female;66;not hispanic or latino;Dead;-24441;NA;1945;3;NA;no;NA;10aac030-fdf8-5dd7-8689-ba96a923a712;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a05c2046-2dce-5654-9077-b7cebffa07e7;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-7731;LUSC
TCGA-43-5668;C34.1;not reported;M0;T1b;stage iia;2010;Not Reported;349;Squamous cell carcinoma, NOS;N1;4ad29871-b0c8-5ecd-ba89-4f62d41747d0;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28635;not reported;NA;8070/3;yes;NA;7th;Stage IIA;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;46903183-99d7-5759-8863-659f7ad2cb0f;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;973a0248-b49f-530a-ae9f-cc9a218fc478;male;78;not hispanic or latino;Dead;-28635;NA;1932;559;NA;yes;NA;b7542f53-543a-524b-99d0-fad870f97f81;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;dbf26982-97b4-59f7-b165-d3889623bc21;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-5668;LUSC
TCGA-60-2709;C34.1;not reported;MX;T2;stage ib;2004;No;1505;Squamous cell carcinoma, NOS;N0;9b2c3c61-f8ea-51d0-93f1-5da6f1f3902a;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25453;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;e864899d-c852-59d2-8899-fed1f2b93230;157.5;NA;863.013.698.630.137;NA;Not Reported;NA;black or african american;781e077d-55fb-5c1f-a3cf-31335cf4468a;male;69;not hispanic or latino;Alive;-25453;NA;1935;NA;NA;no;NA;bd07d282-b16b-5767-b743-24147403a978;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;cd43a523-51d4-5267-b05b-8cfcd704ba72;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2709;LUSC
TCGA-85-7844;C34.1;not reported;M0;T2a;stage ib;2011;No;911;Squamous cell carcinoma, NOS;N0;dd86c96a-89b5-51bd-96df-b1615a3fed6d;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26141;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;9f5b2b71-506a-5cc2-8731-eba1f5d6d89e;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;ab1296a1-1f03-5942-82c8-a2515a53f54c;male;71;not hispanic or latino;Alive;-26141;NA;1940;NA;NA;no;NA;7abf0624-0b84-5f69-98fa-2cbc8a82dccc;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;fee900b5-4073-5747-b01e-35e2bec294fe;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-7844;LUSC
TCGA-43-8118;C34.1;not reported;M0;T1b;stage ia;2011;Yes;NA;Squamous cell carcinoma, NOS;N0;a7d0697f-32ec-5029-a02d-380d59d14c41;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20224;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;28c645f1-3143-560c-b6ca-30e28df54639;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;cab9fc5b-2187-506b-93cc-183a884fbabb;female;55;not hispanic or latino;Dead;-20224;2011;1956;89;NA;yes;NA;5d4a573b-e281-5801-96e5-17c8da72210d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e760b939-956d-51c9-b9c0-72c07663f30b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-8118;LUSC
TCGA-56-A4ZK;C34.3;not reported;M0;T2;stage ib;2012;No;570;Squamous cell carcinoma, NOS;N0;78ce22e7-bcfe-502a-bad8-c8309b456b8f;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28039;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;52;NA;3674bb45-3430-524b-b78c-5337ff7d1344;NA;NA;NA;NA;Not Reported;NA;white;d596b68f-dd1e-5f20-96b2-01ef96e3c8dd;female;76;not hispanic or latino;Alive;-28039;NA;1936;NA;NA;no;NA;8c42bee7-ec3f-5573-963a-29b414d9ef23;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ed7bdfb2-003a-52e3-a22e-bb4944afef8d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-A4ZK;LUSC
TCGA-52-7810;C34.8;not reported;M0;T3;stage iib;2008;No;923;Squamous cell carcinoma, NOS;N0;2d80e870-2c0e-5c68-81db-78c6d9865bbf;not reported;NA;Overlapping lesion of lung;No;Overlapping lesion of lung;released;0;22241;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:12:31.795062-05:00;20;NA;872af6de-58da-5748-ad7c-7b54cb9c669c;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;8aa48614-04fe-5a4b-96bb-e9dbb4b16205;female;60;not hispanic or latino;Alive;-22241;NA;1948;NA;NA;yes;NA;1a9a25af-a765-5e3e-8181-d919a381b5d6;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;13b7d1d3-f0ac-50cb-858a-f70e8a97eefc;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-52-7810;LUSC
TCGA-60-2695;C34.1;not reported;M0;T2;stage ib;2009;No;642;Basaloid squamous cell carcinoma;N0;26b0875c-c5c7-5253-8647-6154860c2640;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27211;not reported;NA;8083/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;32;NA;d2b8b938-792f-54ff-a26c-b4f40ccf210c;64;NA;350.684.931.506.849;NA;Not Reported;NA;white;2fcc373d-44de-5980-8f90-4cbecf76622d;female;74;not hispanic or latino;Alive;-27211;NA;1935;NA;NA;no;NA;780b747e-780b-5fd2-bfe0-444bc35993e9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;56f33fa8-aee4-520b-898d-763970792279;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2695;LUSC
TCGA-85-8352;C34.1;not reported;M0;T3;stage iiia;2011;No;67;Squamous cell carcinoma, NOS;N1;0a4144e3-a9aa-55c3-b653-02813235be43;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24788;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;e0b82f54-0bfd-548a-a99e-a46a3e9d3979;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;008339c9-8305-5fc6-8c44-dde0fcb3b4ad;male;67;not hispanic or latino;Dead;-24788;NA;1944;161;NA;no;NA;1aea6cbd-83c8-5f42-8388-eb58341e2953;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;0f0f42c6-44d8-5b4e-83f1-0bda87c40e43;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8352;LUSC
TCGA-NC-A5HE;C34.1;not reported;M0;T2;stage iib;2008;No;2336;Squamous cell carcinoma, NOS;N1;e35bb137-b21c-5a14-b66c-2ca8b8ccfc65;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22179;not reported;NA;8070/3;yes;NA;6th;Stage IIB;not reported;2019-08-08T17:14:36.542202-05:00;20;NA;9737f0b6-855b-551f-994b-07340db8e883;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;6248a8b6-5fe1-5397-8f11-39cfe8394c9f;male;60;not reported;Alive;-22179;NA;1948;NA;NA;yes;NA;46e73443-236f-59dd-937b-548d03dfaa67;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;cc378121-5dc1-5110-b244-957ea4e76be7;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HE;LUSC
TCGA-85-8350;C34.1;not reported;M0;T1b;stage ia;2011;No;683;Squamous cell carcinoma, NOS;N0;672133f2-dc67-519f-8122-132e299e332f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22526;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;f917b7e7-f47c-525f-bdd2-ddfd8c20dd63;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;82c80c91-2e0e-5c8a-b8c1-172b50494075;male;61;not hispanic or latino;Alive;-22526;NA;1950;NA;NA;no;NA;38cf06ba-0b0c-5845-889c-7642b4352ed0;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;4ff3c876-189f-56a3-868b-6dab7301b311;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8350;LUSC
TCGA-63-7021;C34.1;not reported;M0;T1;stage ia;2007;No;2142;Squamous cell carcinoma, NOS;N0;c9488c9d-1f29-535d-922f-746288f9dc6d;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;NA;NA;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:13:13.079700-05:00;52;NA;a45dbf3e-34b0-5f64-b211-27556207c64c;21;NA;115.068.493.150.685;NA;Not Reported;NA;not reported;6ad8c691-b1a3-59eb-a323-1a293bb82fbf;male;NA;not reported;Alive;NA;NA;NA;NA;NA;no;NA;98b7dcd7-5010-5029-9117-42f6b453c728;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ddc9acbb-b6e3-5c05-8797-5a51f93499d1;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-7021;LUSC
TCGA-37-A5EM;C34.1;not reported;M0;T2;stage ii;2011;No;867;Squamous cell carcinoma, NOS;N0;ae33d0b3-e1a6-5b17-b002-2432978a539c;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;18011;not reported;NA;8070/3;no;NA;7th;Stage II;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;fdf27c64-6c97-519a-81c0-eb3ab595a594;NA;NA;NA;NA;Not Reported;NA;white;10de2742-1650-589d-b9c5-44e19aa25f7b;male;49;not hispanic or latino;Alive;-18011;NA;1962;NA;NA;no;NA;37981233-308e-5430-8875-81603e4b12c3;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3328070b-c2b6-5945-a570-6d6d7611e489;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-A5EM;LUSC
TCGA-NC-A5HJ;C34.2;not reported;M0;T3;stage iib;2009;No;NA;Squamous cell carcinoma, NOS;N0;34713833-c250-53c9-917e-24cd025e5f50;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;21730;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;a2e53211-d646-5d18-bab2-a8601f7840d7;78;NA;427.397.260.273.973;NA;Not Reported;NA;white;4c053b53-b0c4-5599-889a-84d4c8be2cf1;male;59;not reported;Dead;-21730;2010;1950;418;NA;no;NA;ca431acc-202b-5f95-b667-76cdfce7929d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ba5937ef-7df6-505f-873b-6894b16db30f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HJ;LUSC
TCGA-77-7140;C34.1;not reported;M0;T2;stage iib;2002;Not Reported;NA;Squamous cell carcinoma, NOS;N1;7af77760-e2d3-587a-a083-1c6f236f3566;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25303;not reported;NA;8070/3;yes;NA;6th;Stage IIB;not reported;2019-08-08T17:13:35.084062-05:00;NA;NA;b720b9c5-e6e5-5e63-9a15-d8b688cecbce;NA;NA;NA;NA;Not Reported;NA;white;7d9cf916-e029-569f-accd-dde1e5cb0f81;female;69;not reported;Dead;-25303;2003;1933;632;NA;no;NA;38b5ddb8-5026-5e6d-a60d-460046652b05;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;8fe5db85-d6bf-53de-821f-2f36f04e7540;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-7140;LUSC
TCGA-22-0944;C34.9;not reported;M0;T2;stage ib;2000;No;223;Squamous cell carcinoma, NOS;N0;1064cd72-43ee-55f8-ae24-7f717debee82;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;22329;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;fc92dfb3-e6b0-5d36-9d1e-95afa6de4bc3;38;NA;208.219.178.082.192;NA;Not Reported;NA;white;ac02340f-7e54-5124-83e8-db3e6250a8f4;male;61;not hispanic or latino;Dead;-22329;2000;1939;223;NA;not reported;NA;b32f85f2-22a1-5704-9482-2360886ec460;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;55e0c187-7a3b-58e6-9cdc-1e11af7875b3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-0944;LUSC
TCGA-56-7582;C34.3;not reported;M0;T2a;stage ib;2011;No;601;Squamous cell carcinoma, NOS;N0;b27e64b1-55b7-55c8-860d-85e89f0aa603;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;30678;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;e22ac73d-50ce-5357-97a2-ec7c852b2f27;NA;NA;NA;NA;Not Reported;NA;white;fa43f0fc-827c-5679-9b94-477770778c5a;male;83;not hispanic or latino;Alive;-30678;NA;1928;NA;NA;no;NA;8d94a7f8-176f-5edc-9fb6-48b38e068a32;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;70dc1273-1ba4-5fb1-9438-fc34d4b4cb95;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-7582;LUSC
TCGA-60-2713;C34.3;not reported;M0;T2;stage ib;2006;No;1731;Squamous cell carcinoma, NOS;N0;cdd3e28c-4d42-5bee-8603-00888403fe95;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;23630;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;21032b0f-8520-5ee6-ac42-526b08f3aaa0;110;NA;602.739.726.027.397;NA;Not Reported;NA;white;1dbae3ea-9e24-50e4-8933-accca8ae4972;male;64;not hispanic or latino;Alive;-23630;NA;1942;NA;NA;no;NA;0b86a073-7037-58b6-8ece-1dd32290ae90;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;8eb51977-8d05-5056-abcd-62bcbb022240;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2713;LUSC
TCGA-O2-A52Q;C34.1;not reported;MX;T3;stage iii;2005;No;NA;Squamous cell carcinoma, NOS;N1;3fdeea72-22db-5773-b6b9-9fbd75a43aca;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;16429;not reported;NA;8070/3;no;NA;6th;Stage III;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;7201d68e-b0e7-599e-bf24-ed2ea83e4497;1;NA;0.0547945205479452;NA;Not Reported;NA;white;25c6a4e1-b613-5a8f-9aa5-d700ae9d6123;female;44;not hispanic or latino;Dead;-16429;2005;1961;113;NA;no;NA;e9dfd916-1ad1-52ed-b917-6358adae3da4;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;59771b25-f95d-5f82-9762-30ec983f6946;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-O2-A52Q;LUSC
TCGA-77-A5G3;C34.1;not reported;M0;T2;stage iib;2002;No;4570;Squamous cell carcinoma, NOS;N1;f6298658-c6cc-5401-8fbc-c794cffe064c;not reported;NA;Main bronchus;No;Main bronchus;released;0;23171;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:55.903240-05:00;40;NA;fd038555-7c92-5508-8b4f-1c0b8617bc07;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;d8fbf030-9e61-54ed-93d8-aad5b23743c9;male;63;not reported;Alive;-23171;NA;1939;NA;NA;no;NA;36106abf-bea1-522d-93dc-f4bd842c475e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;df31e790-c10c-58b6-a9c7-726b22d0be4c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-A5G3;LUSC
TCGA-90-A59Q;C34.1;not reported;MX;T2a;stage iia;2012;No;269;Squamous cell carcinoma, NOS;N1;82088090-5739-50b3-9990-8750c36f8b8f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22420;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;cf290544-0592-5f7f-bb3f-048d124e1528;80;NA;438.356.164.383.562;NA;Not Reported;NA;white;ade4f3ba-8336-5f03-b515-51591ff3e28c;female;61;not hispanic or latino;Dead;-22420;NA;1951;322;NA;yes;NA;1431df4b-56d6-582b-bf58-d60da97d659f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;be87bcf9-9880-561a-b6b2-9ec4be529685;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-90-A59Q;LUSC
TCGA-22-5483;C34.1;not reported;M0;T1a;stage iia;2005;No;573;Squamous cell carcinoma, NOS;N1;7b55e170-b3bf-50d1-a244-a75e4cfa150e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27109;not reported;NA;8070/3;no;NA;NA;Stage IIA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;3d9eb4a2-01c4-5315-ae1a-cdb931ace22d;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;56838732-9bc0-5601-a8e1-82eccfd10e3c;male;74;not reported;Dead;-27109;2006;1931;573;NA;yes;NA;122be7ba-a90e-5f3d-9260-b445a9773ab7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;56157ed5-cbaf-5619-b89d-06dc549dd963;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-5483;LUSC
TCGA-94-7033;C34.3;not reported;MX;T2;stage ib;2011;Not Reported;640;Squamous cell carcinoma, NOS;N0;77ea1741-a49d-52b2-90aa-5e311d5e0d8b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26948;not reported;NA;8070/3;yes;NA;7th;Stage IB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;09b4b0ab-4c4d-5a1e-a17e-77641a0532ad;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;518899fe-c4fc-5d46-a92b-39cef32811e0;male;73;not hispanic or latino;Alive;-26948;NA;1938;NA;NA;yes;NA;3cf6d77e-7ff8-5d4b-ab71-57508f83aa0d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;9fb38364-c3cb-591a-9bbd-6c2a9d740d6d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-94-7033;LUSC
TCGA-85-7696;C34.1;not reported;M0;T1;stage ia;2011;No;1111;Squamous cell carcinoma, NOS;N0;59cc5fb3-9548-54dc-8459-4228bf928b06;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23413;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:13:55.903240-05:00;40;NA;49180924-bb1a-5c82-9cfb-9cb75b276554;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;6b733e0b-b27a-59a4-b19c-ddcdaee04454;male;64;not hispanic or latino;Alive;-23413;NA;1947;NA;NA;no;NA;f90677fc-20f0-586a-a964-ab8287b117d9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ba1151b2-59c3-5a15-b332-e74222ead202;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-7696;LUSC
TCGA-39-5030;C34.3;not reported;M0;T2a;stage iiia;2006;No;59;Squamous cell carcinoma, NOS;N2;f086b768-cec5-5afe-8421-d0d195c57e87;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;29893;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:12:11.623943-05:00;11;NA;e6b7554a-df52-5a58-b6b3-620be34471b3;8;NA;0.438356164383562;NA;Not Reported;NA;asian;bc8659c2-7c93-5e68-a089-48c26aabcce6;female;81;not reported;Dead;-29893;2006;1925;59;NA;no;NA;12ab1cd1-e3c9-57de-ab39-59f7a23c06c0;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6e9a78a8-203f-5c40-8c87-238cd5613271;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5030;LUSC
TCGA-77-8130;C34.1;not reported;M0;T2;stage iib;2000;No;4765;Squamous cell carcinoma, NOS;N1;a57c3e0c-09fa-5fb4-9ecb-0ed98841a701;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25260;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:55.903240-05:00;51;NA;83e443f7-fd24-53e5-8bcd-854a9bf977e5;32.25;NA;176.712.328.767.123;NA;Not Reported;NA;not reported;ed66130c-e14d-5a6c-a98c-75b78a91a475;male;69;not reported;Alive;-25260;NA;1931;NA;NA;no;NA;cf0df015-83f0-526d-8ae6-b74f5cee9a1c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c48db1e0-4e84-5a10-b754-29332c54ced0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8130;LUSC
TCGA-94-A4VJ;C34.9;not reported;M0;T1b;stage ia;2012;No;430;Squamous cell carcinoma, NOS;N0;236626f8-fa9c-5b80-874e-0cf2a75b292e;not reported;NA;Main bronchus;No;Main bronchus;released;0;25991;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:16.559953-05:00;50;NA;d02365c0-53fe-5cb1-9c6f-61548b849eac;37.5;NA;205.479.452.054.795;NA;Not Reported;NA;white;bc2ba22d-e5d4-5e5b-a094-87e86ec6374d;female;71;not hispanic or latino;Alive;-25991;NA;1941;NA;NA;no;NA;7e1d5523-ba49-57a2-b9f7-ff316ec22934;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3b0f2528-b44a-52ab-8cdf-e145103a3d05;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-94-A4VJ;LUSC
TCGA-60-2714;C34.9;not reported;M0;T2;stage iib;2006;No;1531;Squamous cell carcinoma, NOS;N1;2e25b0bb-523b-561b-b306-2d66b7d993c7;not reported;NA;Lung, NOS;Yes;Lung, NOS;released;0;24169;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:12:53.407315-05:00;45;NA;8acb528e-5ccc-5bfa-a28e-6023c949a4fa;90;NA;493.150.684.931.507;NA;Not Reported;NA;white;214eb0ec-555b-5b9a-9865-626214e1f9c9;female;66;not hispanic or latino;Alive;-24169;NA;1940;NA;NA;yes;NA;2473a3d0-fe5d-5513-877c-3932f4daa4d7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c6670b09-dbbe-535b-86e6-c1ba71662980;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2714;LUSC
TCGA-94-7557;C34.1;not reported;M0;T2;stage ib;2011;Not Reported;NA;Squamous cell carcinoma, NOS;N0;07d362a5-d403-5803-99bc-d0991fc89b88;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26802;not reported;NA;8070/3;yes;NA;7th;Stage IB;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;56d86642-9239-579d-9f4c-f13557e4548c;NA;NA;NA;NA;Not Reported;NA;black or african american;3a9b3cdb-2328-5eb7-951d-587060b3f1fa;male;73;not hispanic or latino;Dead;-26802;2011;1938;5;NA;no;NA;eef8a233-fd2e-529a-88a6-0e697e8c2660;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e65bfab1-c823-585c-a24f-ed3ff11909d7;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-94-7557;LUSC
TCGA-77-6842;C34.8;not reported;M0;T2;stage iib;2000;No;NA;Squamous cell carcinoma, NOS;N1;626dc505-a0de-5043-8d92-5ba96e525df1;not reported;NA;Overlapping lesion of lung;No;Overlapping lesion of lung;released;0;28861;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:35.084062-05:00;50;NA;c5bfcdcb-71ad-5d2b-b918-8005a5632e38;22.5;NA;123.287.671.232.877;NA;Not Reported;NA;white;d24ce3f2-00fd-58f4-a0b9-c64c3dd61345;male;79;not reported;Dead;-28861;2002;1921;899;NA;no;NA;139da5bf-b9f8-560e-b711-c0bcd4eaa052;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;72b49510-49fe-5337-b9a8-cbced4771728;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-6842;LUSC
TCGA-NC-A5HK;C34.8;not reported;M0;T3;stage iib;2010;No;128;Squamous cell carcinoma, NOS;N0;c09db9c9-42c1-5663-b222-d13a7aa0593c;not reported;NA;Overlapping lesion of lung;No;Overlapping lesion of lung;released;0;21531;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;46b63503-2976-5c37-915a-2cc41464893f;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;ef4116a0-5ea1-5ab0-a2f7-3404d285df49;female;58;not reported;Alive;-21531;NA;1952;NA;NA;yes;NA;69850d66-d72a-554e-a728-8876a0b03aa3;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;f03f0deb-9bbb-555a-8fb3-80c067ef3c42;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HK;LUSC
TCGA-34-5928;C34.3;not reported;M0;T2;stage iib;2010;No;1196;Squamous cell carcinoma, NOS;N1;527fa1eb-b8de-5892-9a30-6c663ebf5770;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;30334;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;6a575875-1d09-5d37-9047-5bbbfd31f467;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;0bb467ff-e09f-5924-b094-5f3e7bf92ccb;female;83;not hispanic or latino;Alive;-30334;NA;1927;NA;NA;no;NA;85cdf513-62ca-5c4f-8e42-4fc0e478e0bd;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a35a329b-a4b4-5a4f-b009-c45db33ef2c3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-5928;LUSC
TCGA-NC-A5HQ;C34.2;not reported;M0;T3;stage iiia;2011;No;NA;Squamous cell carcinoma, keratinizing, NOS;N2;2248f120-c7c1-5ac9-a217-23ec757a7504;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;25781;not reported;NA;8071/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;afdf2041-5658-5024-856c-179983560b6d;NA;NA;NA;NA;Not Reported;NA;white;8b796836-b989-5030-a63b-945481af9ca6;male;70;not reported;Dead;-25781;2012;1941;448;NA;yes;NA;6dc61453-d271-5d79-ae11-529554c4ef2f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;2b64d613-4d1b-576d-93c2-ffc87c9294bd;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HQ;LUSC
TCGA-34-5240;C34.1;not reported;M0;T2;stage iib;2009;No;1541;Basaloid squamous cell carcinoma;N1;f6a10066-0a74-5363-840f-5fa66f80ec39;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26735;not reported;NA;8083/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;c8b7809b-474f-5fc0-aebf-970ac86b1ee2;56;NA;306.849.315.068.493;NA;Not Reported;NA;white;00b798ab-3977-58ff-ae2a-fceac37cc7f3;female;73;not hispanic or latino;Alive;-26735;NA;1936;NA;NA;yes;NA;d3e02051-6241-5280-8d91-7258cf942b3e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;2cca6c57-84f9-5388-88d9-1252edecd3f4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-5240;LUSC
TCGA-34-5929;C34.1;not reported;M0;T2;stage ib;2010;No;NA;Squamous cell carcinoma, NOS;N0;441f0094-2385-57ec-a564-c6eb5651a030;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28844;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;2085b6f5-5467-5469-8e0c-c5bf05ddac91;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;2c6f553c-7ace-5f77-9e5a-05a4b8a3b625;female;78;not hispanic or latino;Dead;-28844;2010;1932;151;NA;no;NA;1dec3a31-2991-5e7e-a896-368e1d9ce161;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6ea79c3f-316a-58e9-b4e2-2e75a603386e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-5929;LUSC
TCGA-85-8287;C34.1;not reported;M0;T1b;stage ia;2011;No;13;Squamous cell carcinoma, NOS;N0;26257847-0691-5f5a-90e6-4cbd86c8937d;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26401;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;37eeade4-a7f6-5b3e-81d6-c6cdc3e28073;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;9a9cb74c-3344-5aa0-93f9-39ba0c1b89b9;male;72;not hispanic or latino;Dead;-26401;NA;1939;23;NA;no;NA;4f9d8c22-cb58-5ed1-9339-71db4efd258e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7b759edb-4bc6-5f53-850d-583688b31d19;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8287;LUSC
TCGA-85-8049;C34.3;not reported;M0;T2a;stage ib;2011;No;579;Squamous cell carcinoma, NOS;N0;d91d0560-a5f7-5724-b714-dfcee4caef63;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;20995;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;fd83be63-8d06-5032-aa9b-36029b4ce7fd;NA;NA;NA;NA;Not Reported;NA;white;f66ffd6e-1c16-5db7-9d47-79f13090cff5;male;57;not hispanic or latino;Alive;-20995;NA;1954;NA;NA;no;NA;1f6d4538-b0ce-5874-bae8-dbd9df71b48f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;f1c929fe-caa4-5c5f-a191-126df8a6c6d1;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8049;LUSC
TCGA-22-1011;C34.9;not reported;M0;T2;stage ib;2001;No;53;Squamous cell carcinoma, NOS;N0;f9f54689-5d19-5893-ae3a-577377937274;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;26732;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;eaa3c6bd-db11-56f1-ba6d-17770c9137e0;83;NA;454.794.520.547.945;NA;Not Reported;NA;white;39dae89d-fd02-5ebb-912a-d3279c78fffb;male;73;not hispanic or latino;Dead;-26732;2001;1928;53;NA;no;NA;af4b9296-331a-51eb-bb36-c61d54f257c5;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7d0a33aa-3149-5848-b735-f5b52e491ace;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-1011;LUSC
TCGA-68-8251;C34.1;not reported;M0;T2a;stage ib;2012;No;406;Squamous cell carcinoma, NOS;N0;36f71d03-6eec-5a28-9c22-634c28379713;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28739;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;35;NA;54bf0be3-d94c-5b2d-a2b4-0bbfc51c6fd2;52;NA;284.931.506.849.315;NA;Not Reported;NA;white;b29dcaa8-3c13-5830-9721-4eb0d742e403;male;78;hispanic or latino;Alive;-28739;NA;1934;NA;NA;yes;NA;89499d26-4716-5df5-b739-8c31ab689511;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;0301ca45-d4a1-5670-908d-cc8547ad0d34;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-68-8251;LUSC
TCGA-52-7811;C34.3;not reported;M0;T2;stage ib;2009;No;NA;Squamous cell carcinoma, NOS;N0;625fad1e-04ff-501b-a9ad-659571fc42a5;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24782;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;b1f44c16-9a14-55ab-9e47-d73f39ea28ce;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;090a1112-5d92-5d08-a3bc-f0599b2576aa;male;67;hispanic or latino;Dead;-24782;2009;1942;266;NA;no;NA;00ae00b9-37bd-5f1a-a370-104232a54080;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;49c3ce68-310a-5a7f-a30b-8832aa185bb1;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-52-7811;LUSC
TCGA-37-4129;C34.2;not reported;M0;T1b;stage ia;2010;No;242;Squamous cell carcinoma, NOS;N0;51cb20e3-8156-5ae3-a15e-ea20950536a9;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;19154;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:11.623943-05:00;30;NA;a549ee9e-d95c-5b3e-bb10-bb7deff2de81;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;a33b6f83-b436-5a0d-853c-2515446a393a;female;52;not hispanic or latino;Alive;-19154;NA;1958;NA;NA;no;NA;90ccdd9c-c515-5783-aa47-80bdf4f09609;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;96f4b800-c9cd-504e-bbe1-7c5a1314d84a;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-4129;LUSC
TCGA-37-4130;C34.1;not reported;M0;T1b;stage ia;2010;No;247;Squamous cell carcinoma, NOS;N0;6c5bc4bd-c294-5052-bb59-9fe1e84cbb83;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;20652;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:11.623943-05:00;25;NA;fea0673e-c544-56c8-964e-e359aee84812;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;7dfba375-1b74-5133-85d4-7a932f930d87;male;56;not hispanic or latino;Alive;-20652;NA;1954;NA;NA;not reported;NA;c6bbd93b-96be-533d-8997-d2902bbc3314;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;b91aa06e-f42c-5db9-b18b-8f160b7e74fa;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-4130;LUSC
TCGA-NC-A5HD;C34.1;not reported;M0;T3;stage iib;2008;No;NA;Squamous cell carcinoma, NOS;N0;52ea80a1-2fa6-52d4-902b-c2f3c2ff0bb0;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28916;not reported;NA;8070/3;yes;NA;6th;Stage IIB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;8c016a0d-49cc-57cd-a783-2760ba8cdbab;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;8e4a0b7c-6291-5ea7-8daf-393fa105a822;male;79;not reported;Dead;-28916;2008;1929;2;NA;no;NA;29ada365-9bcc-5bae-a234-1dc883ad5e2d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c253c4cd-9593-58ff-afa5-dd9e17c8431b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HD;LUSC
TCGA-58-8388;C34.1;not reported;M0;T2a;stage ib;2010;No;378;Basaloid squamous cell carcinoma;N0;0c91a6b1-8138-535e-88d7-1c86db194d18;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21949;not reported;NA;8083/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;df12c49d-2392-586f-aaa8-0c8da75f009a;80;NA;438.356.164.383.562;NA;Not Reported;NA;white;3df7a5d9-831f-524c-9310-e0a22f682036;male;60;not hispanic or latino;Dead;-21949;NA;1950;412;NA;no;NA;0b2e9613-2f5d-5eec-acc2-aaf57d7c23c2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;aa19f053-ebbc-58ed-b510-a7b74213f59e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-58-8388;LUSC
TCGA-77-8128;C34.9;not reported;M0;T2;stage iiia;1999;No;NA;Squamous cell carcinoma, NOS;N2;738a8c28-448a-5c5d-a4c3-f9db1873aa6f;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;21986;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;ef512e83-c4cb-554e-b289-22ede845be4c;113;NA;619.178.082.191.781;NA;Not Reported;NA;not reported;1646f3f4-6603-5c94-8d00-490ba172ab47;male;60;not reported;Dead;-21986;2002;1939;1150;NA;no;NA;cf329c2f-b0fb-5892-9327-4f45f8b71107;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;5168c4b1-cfae-55ec-be35-df59cfd380a3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8128;LUSC
TCGA-43-6647;C34.3;not reported;MX;T2b;stage iib;2010;No;757;Squamous cell carcinoma, NOS;N1;72111d22-c35d-58cf-8fe9-4584aa7668aa;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25378;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:12:31.795062-05:00;36;NA;8c22012f-8edf-5716-86b6-629c490a7edb;36;NA;197.260.273.972.603;NA;Not Reported;NA;white;b2e3fa90-73db-5a38-a7aa-c08a1fe89805;female;69;not hispanic or latino;Alive;-25378;NA;1941;NA;NA;yes;NA;8dbbdc56-115d-597c-bf0a-53d5f35b43d4;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;d254af27-d4a2-59d2-aeae-f54db4994ffc;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-6647;LUSC
TCGA-58-8392;C34.1;not reported;M0;T2a;stage ib;2010;No;NA;Squamous cell carcinoma, NOS;N0;e0705ef4-cb9a-5faf-9dfc-88523f442999;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25710;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;d509d5e5-03a9-5964-80e2-12b7d1ab1efb;80;NA;438.356.164.383.562;NA;Not Reported;NA;white;cb3f61bc-b593-5466-99cb-5ad4bb60d372;male;70;not hispanic or latino;Dead;-25710;2011;1940;501;NA;yes;NA;abd8c844-4699-5d17-823f-ce423d279224;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;d94a33b1-def0-5350-addb-2ebe7795c5ed;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-58-8392;LUSC
TCGA-22-1002;C34.9;not reported;M0;T1;stage ia;2001;No;131;Squamous cell carcinoma, NOS;N0;e5b91887-4f22-5180-8704-1e2a8b29321b;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;25359;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:11:26.507214-05:00;49;NA;9f513bdd-89d8-5edd-a162-6605e7a883b5;85;NA;465.753.424.657.534;NA;Not Reported;NA;white;6051df34-01e9-55a8-b1dc-91d1ed29153b;male;69;not hispanic or latino;Dead;-25359;2001;1932;131;NA;no;NA;5ef46d91-7b78-5289-8fb9-49a612467c31;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;69fbe135-f42e-59bd-993c-50a273d3ee69;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-1002;LUSC
TCGA-90-7964;C34.1;not reported;MX;T2a;stage ib;2011;Not Reported;428;Squamous cell carcinoma, NOS;N0;decc1dd4-a080-56a1-8a87-364cfc7a0936;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25646;not reported;NA;8070/3;yes;NA;7th;Stage IB;not reported;2019-08-08T17:14:16.559953-05:00;60;NA;81255b50-ce96-5f7d-bca1-bb949726fabc;180;NA;986.301.369.863.014;NA;Not Reported;NA;white;fd1e7f1f-94aa-518a-a6a3-787fd32e2dcf;male;70;not hispanic or latino;Alive;-25646;NA;1941;NA;NA;no;NA;14132bad-6559-5c77-8dd2-d80e0b507b9b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;b9a533ff-91f9-5f78-a3b6-7f3563ece5f3;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-90-7964;LUSC
TCGA-NC-A5HI;C34.3;not reported;M0;T2;stage ib;2009;No;1743;Squamous cell carcinoma, NOS;N0;eaf70c94-5b41-522f-aa6e-e367be3d3b8e;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24981;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:14:36.542202-05:00;NA;NA;72a7063c-d7a7-5f15-aff0-b27f63595d0f;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;22e8b0d0-52c9-5157-bc0c-d08c62141624;female;68;not reported;Alive;-24981;NA;1941;NA;NA;yes;NA;5a66809c-86e6-53eb-9be1-c824c3e4d202;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7bcbcdc5-9b7f-50c8-9403-6df2e985fa8b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HI;LUSC
TCGA-77-A5G6;C34.1;not reported;M0;T2;stage iiia;2009;No;NA;Squamous cell carcinoma, NOS;N2;4bc0575d-e6a9-513e-b8da-4b77482b64b4;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24215;not reported;NA;8070/3;no;NA;6th;Stage IIIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;9bd4c40f-55f6-5e2e-87db-2cfdeceaa537;74;NA;405.479.452.054.795;NA;Not Reported;NA;not reported;0855d56e-cadd-5691-b9fe-d695194cf57f;male;66;not reported;Dead;-24215;2010;1943;678;NA;no;NA;5dc03097-02a3-5489-b7cc-c23ede19e553;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;2ab1ea14-840e-58fd-92d9-3cdf0cea502f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-A5G6;LUSC
TCGA-60-2715;C34.1;not reported;M0;T1;stage ia;2008;Not Reported;NA;Squamous cell carcinoma, NOS;N0;2d77ff54-6b50-5468-bf90-5e18b85df5e9;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;18990;not reported;NA;8070/3;yes;NA;6th;Stage IA;not reported;2019-08-08T17:13:13.079700-05:00;23;NA;edb6d63b-99b0-51f2-acbb-5c8919d91228;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;58fcb699-fe93-5bac-8c27-b743c9895e43;male;51;not hispanic or latino;Dead;-18990;2010;1957;1075;NA;yes;NA;6157a0b2-1686-5222-85d0-d634ba2cf0d1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;93df3593-1123-585e-9fea-827adb585239;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2715;LUSC
TCGA-85-8288;C34.2;not reported;M0;T1b;stage iia;2011;No;54;Squamous cell carcinoma, NOS;N1;30f5dd84-b554-5657-b3e5-e1b292962e1f;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;25629;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;08339c06-3a64-514c-9891-79ee9d5ce72e;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;81acf61c-0834-533e-992f-4ecf963febea;male;70;not hispanic or latino;Dead;-25629;NA;1941;402;NA;no;NA;96bf0132-2793-5955-90ab-473a8121877b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;43dff9b8-d9bd-5791-afe9-b0cee4c98062;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8288;LUSC
TCGA-18-3406;C34.1;not reported;M0;T1;stage ia;2003;Not Reported;NA;Squamous cell carcinoma, NOS;N0;227169f8-714a-580f-a5be-e0f9d71e25f0;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24477;not reported;NA;8070/3;yes;NA;NA;Stage IA;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;472d2035-4aaf-5c6c-a301-dc77b503066e;200;NA;10.958.904.109.589;NA;Not Reported;NA;white;f21bd65e-44be-5803-8728-3098780be5e6;male;67;not hispanic or latino;Dead;-24477;2004;1936;371;NA;no;NA;227bdf85-0710-5366-8bf6-8837c49ae9a1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;a2ce9f32-7938-5dfe-aa08-af77dfa1769d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3406;LUSC
TCGA-98-A53C;C34.3;not reported;M0;T1a;stage ia;2012;No;822;Squamous cell carcinoma, NOS;N0;35a707ea-636e-5368-9260-f115887d4234;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28146;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:36.542202-05:00;45;NA;961a1ccd-7910-57ed-a14d-c3e1549af363;112.5;NA;616.438.356.164.384;NA;Not Reported;NA;white;1828fb9d-d1c1-545c-a7e1-448d141b5da7;female;77;not hispanic or latino;Alive;-28146;NA;1935;NA;NA;no;NA;f805d105-ca2c-508d-afe0-af93817bdba2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;b063d3da-0661-5644-86f2-e9e477e9b7c5;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-A53C;LUSC
TCGA-33-4547;C34.1;not reported;M0;T2;stage ib;2007;No;2419;Squamous cell carcinoma, NOS;N0;a0afaf10-7287-549e-94fd-da7f6b314f35;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25056;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;20;NA;b747f478-c034-547c-bce7-2578d438023a;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;5dff9454-8bdc-56b3-857b-b9d2f6bb976c;male;68;not hispanic or latino;Alive;-25056;NA;1939;NA;NA;no;NA;79508560-9da9-59ab-a7fd-5b2b0182b5c4;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;cd32dda1-00da-505a-bd33-0461b9ccc09d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-4547;LUSC
TCGA-66-2742;C34.1;not reported;M1;T2;stage iv;2006;No;641;Squamous cell carcinoma, NOS;N1;fff716b1-b1e7-53f3-9890-3a576ed148a3;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25688;not reported;NA;8070/3;no;NA;5th;Stage IV;not reported;2019-08-08T17:13:13.079700-05:00;35;NA;ff832b2c-e58d-594f-be92-396891e2d706;44;NA;241.095.890.410.959;NA;Not Reported;NA;not reported;30d165a5-eb94-501a-8a04-3cbbfae291ed;male;70;not reported;Alive;-25688;NA;1936;NA;NA;no;NA;c349b082-0b66-5a40-b8e3-46c3a9577301;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c373f85c-57df-577e-9609-9c75273ba197;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2742;LUSC
TCGA-37-3792;C34.1;not reported;M0;T2;stage ib;2006;No;12;Squamous cell carcinoma, NOS;N0;2d81fdf0-3d04-55d7-8187-a478dc6d3cf9;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25502;not reported;NA;8070/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;e43cf608-2b0c-5018-ad3a-11ec038bfc8f;NA;NA;NA;NA;Not Reported;NA;white;559b129f-e7aa-5299-bd92-baa8573c4f23;male;69;not hispanic or latino;Alive;-25502;NA;1937;NA;NA;not reported;NA;c635b225-276d-58ce-a495-b39293fc2caf;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;2602d01d-b104-528f-b753-40e56cb73241;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-3792;LUSC
TCGA-56-8305;C34.1;not reported;M0;T2a;stage ib;2011;No;105;Squamous cell carcinoma, NOS;N0;2fd1031c-640b-5109-bf0d-c092724c42f9;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26428;not reported;NA;8070/3;yes;NA;7th;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;50;NA;86ce4462-ddb7-5eec-a203-ac23f3749a84;100;NA;547.945.205.479.452;NA;Not Reported;NA;white;73f78f90-919e-5b5c-aa5f-6d13ace6ce03;male;72;not hispanic or latino;Alive;-26428;NA;1939;NA;NA;not reported;NA;6cd11bb8-6a69-593c-aaef-b9f64dc3661c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;8c114c78-c85e-5241-b107-e6b35c682e0c;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8305;LUSC
TCGA-18-5592;C34.1;not reported;M0;T3;stage iib;2010;No;1519;Squamous cell carcinoma, NOS;N0;c7099c8a-4d06-5b60-a244-62e3733ab8e3;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21020;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;61b3755d-75c6-5dc5-89e0-61fd5380f59a;40;NA;219.178.082.191.781;NA;Not Reported;NA;not reported;911491f3-5a54-5039-ade9-240c675ab1d4;male;57;not reported;Alive;-21020;NA;1953;NA;NA;yes;NA;5ca611bf-ba6e-5616-9ede-eb121c2762f8;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;0c4c6edb-f667-50e8-bb1a-3a91fa58aee8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-5592;LUSC
TCGA-33-AASB;C34.1;not reported;MX;T2;stage ib;2002;No;NA;Squamous cell carcinoma, NOS;N0;027a7483-c620-5836-b938-e83b2645f07a;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24183;not reported;NA;8070/3;no;NA;5th;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;472523f7-bed2-52ac-8999-2a4c36fbe6bb;40;NA;219.178.082.191.781;NA;Not Reported;NA;black or african american;40513342-fb8b-5d14-b021-c59668116f6f;male;66;not hispanic or latino;Dead;-24183;2002;1936;211;NA;yes;NA;8db10013-9c9b-56e2-adba-a94cbc4239b7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;3e609429-2481-53e3-afcb-52025350056d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-AASB;LUSC
TCGA-85-7699;C34.1;not reported;M0;T4;stage iiia;2011;No;1;Squamous cell carcinoma, NOS;N0;3aac29d0-24bd-554e-a57b-4dd6c79bfd99;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26965;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:13:55.903240-05:00;37;NA;8bc61190-f442-5497-a482-aaa8cd15a3f6;74;NA;405.479.452.054.795;NA;Not Reported;NA;white;907cf7eb-e194-5a68-971b-4931a070a5d2;male;73;not hispanic or latino;Dead;-26965;NA;1938;1001;NA;yes;NA;543f9286-fe91-5fe2-a219-527824b02da7;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e26a2df6-1b30-5a30-8a2d-76e862d6ee85;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-7699;LUSC
TCGA-21-5787;C34.1;not reported;M0;T2;stage iiia;2009;No;329;Squamous cell carcinoma, NOS;N2;e7ebef41-76b7-5d26-8805-455fe744e380;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24071;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:11:26.507214-05:00;53;NA;726971c8-a309-5752-8369-c5210668d8a9;100;NA;547.945.205.479.452;NA;Not Reported;NA;black or african american;ec5b31ae-6f49-56f5-9079-bb6b89c2234b;male;65;not hispanic or latino;Dead;-24071;2009;1944;329;NA;no;NA;a7c3f59d-883a-56b7-9b90-953d40e10d73;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;401cb601-7324-57d4-b2e5-da68b879ad94;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-21-5787;LUSC
TCGA-60-2721;C34.1;not reported;M0;T2;stage ib;2008;Not Reported;983;Squamous cell carcinoma, NOS;N0;b389df4c-037d-5508-b29d-9e860978bfe0;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27007;not reported;NA;8070/3;yes;NA;NA;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;62;NA;cf81a8f2-43d3-5740-91e4-5874e6b3d9ea;93;NA;50.958.904.109.589;NA;Not Reported;NA;white;a42e595e-e83e-5de7-85bf-2649f3f0333f;male;73;not hispanic or latino;Alive;-27007;NA;1935;NA;NA;no;NA;aba862d3-867d-5686-8ff4-1cb7c6454c73;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;1c1b27c7-8e61-57a5-a8cb-fdeef3f9f31d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2721;LUSC
TCGA-66-2773;C34.3;not reported;M0;T2;stage ib;2007;No;NA;Squamous cell carcinoma, NOS;N0;b64c1304-f9de-5d36-bc47-8bdf19f55896;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25355;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:35.084062-05:00;23;NA;8ba23632-f535-5763-8476-4f68b65ad7b0;58;NA;317.808.219.178.082;NA;Not Reported;NA;not reported;a04ed323-443c-5a00-ac26-5cff64e47ee6;male;69;not reported;Dead;-25355;2007;1938;92;NA;not reported;NA;b81c9d0e-e84a-5b81-a638-4883c21c3aee;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;d0310796-32f5-55ad-a1e4-f4074d757e52;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2773;LUSC
TCGA-18-3409;C34.1;not reported;M0;T1;stage ia;2004;Not Reported;3747;Basaloid squamous cell carcinoma;N0;a1576373-57c7-5677-9f20-428e68a6f8b5;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27154;not reported;NA;8083/3;yes;NA;6th;Stage IA;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;4f5c700f-122b-516a-a962-732605dee8c9;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;276fefa4-778e-52fc-b57c-757da0761d85;male;74;not hispanic or latino;Alive;-27154;NA;1930;NA;NA;no;NA;3ab6fc09-8da9-5da8-90e0-8bb87185b934;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;fc7d21c6-1999-5093-84a4-5121b866f447;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3409;LUSC
TCGA-46-3765;C34.1;not reported;M0;T1;stage ia;2009;No;405;Squamous cell carcinoma, NOS;N0;7b795311-cfa8-5318-a9fc-c42c96d37b0f;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;21762;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;750258e8-3f72-5304-a49e-6d78cb8fdf5c;NA;NA;NA;NA;Not Reported;NA;white;0aed79fa-1048-59c4-b6e5-da410896844e;female;59;not hispanic or latino;Alive;-21762;NA;1950;NA;NA;no;NA;6320de2a-5ce3-5963-8506-b24732c38591;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;77805249-09bf-5fbc-a3e6-eb9558a09e84;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-46-3765;LUSC
TCGA-77-6845;C34.2;not reported;M0;T3;stage iib;2003;No;NA;Squamous cell carcinoma, NOS;N0;a540bd33-9a8a-5eee-aef5-67daf2512383;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;25321;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:35.084062-05:00;51;NA;522cc1fe-5ab1-5793-81ff-d349b416eb8f;51;NA;279.452.054.794.521;NA;Not Reported;NA;white;f95ddad9-a3cb-5c5a-a103-0e194e8d2ffd;male;69;not reported;Dead;-25321;2004;1934;708;NA;no;NA;49da7aff-19a4-59a5-a7b2-6145b8bdee71;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e688d5b2-299c-58e8-85a2-ecf3f552ca8e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-6845;LUSC
TCGA-37-4141;C34.1;not reported;M0;T1b;stage ia;2010;No;12;Squamous cell carcinoma, NOS;N0;7b5c968b-fe91-551f-ba75-8b875ea5548e;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24048;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;e3f643bf-b8ec-58fe-97c3-c5a439086bde;NA;NA;NA;NA;Not Reported;NA;white;faf737a7-340b-5599-b542-92c3b957f5d0;female;65;not hispanic or latino;Alive;-24048;NA;1945;NA;NA;not reported;NA;052a19b3-ba83-584b-8470-f6afbda88953;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;31da8485-8bfe-533e-940b-7a32484fe116;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-4141;LUSC
TCGA-63-7022;C34.1;not reported;M0;T1;stage ia;2007;No;2073;Squamous cell carcinoma, NOS;N0;ce6a9d7e-977c-51a0-8503-6a9f53df7829;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;NA;NA;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:13:13.079700-05:00;60;NA;9d086f8a-fac3-5f07-a61a-8d50a5f74ea3;30;NA;164.383.561.643.836;NA;Not Reported;NA;not reported;c839f429-0aa2-5b2b-98f8-dd0e745dc053;female;NA;not reported;Alive;NA;NA;NA;NA;NA;no;NA;44eb4f51-a1bb-5ebc-a5fe-65edcf8d3075;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;543107f6-e365-50ca-9358-8fe5a596470f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-7022;LUSC
TCGA-34-5231;C34.1;not reported;M0;T1;stage ia;2006;No;1528;Squamous cell carcinoma, NOS;N0;82597651-b143-511a-8c9c-bb89710353f7;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26525;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;ee601b74-829d-503f-800d-70e9cedc37a1;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;68900fc6-7df8-56d3-9fd8-710d7f8dae99;male;72;not hispanic or latino;Dead;-26525;NA;1934;1984;NA;no;NA;84afc2a4-4dd9-5b1e-afb8-02523e813d8e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;ce29ac3a-fe0f-5795-af26-2dc6e00c2bdf;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-34-5231;LUSC
TCGA-56-7223;C34.8;not reported;MX;T3;stage iiia;2011;No;30;Squamous cell carcinoma, NOS;N1;bf9b8b7a-881a-509f-a7a0-886ae0d53a9b;not reported;NA;Overlapping lesion of lung;No;Overlapping lesion of lung;released;0;24288;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;db21dea3-7486-5138-9a5d-943863302df6;NA;NA;NA;NA;Not Reported;NA;white;4eb7c75f-2c8d-5fdf-aff2-5e7969d9c5cc;male;66;not hispanic or latino;Dead;-24288;NA;1945;442;NA;yes;NA;8f4b319c-ca52-5357-a99a-eacb743c9684;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e293a58d-0f02-5513-88c9-d49896ac2ecc;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-7223;LUSC
TCGA-33-4532;C34.3;not reported;M0;T2;stage ib;2001;Not Reported;2524;Squamous cell carcinoma, NOS;N0;f1207955-f463-570c-b29c-7577ec63f8c2;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25169;not reported;NA;8070/3;yes;NA;5th;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;4653ac5b-8cf4-5bc1-be2d-20911471e903;53;NA;29.041.095.890.411;NA;Not Reported;NA;white;763af29e-d176-5398-8caf-53da5d365147;male;68;not hispanic or latino;Dead;-25169;NA;1933;3924;NA;no;NA;5b241182-76fe-55b3-b720-4761f36ca9e9;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7a761afc-8438-59b4-b1df-9b82e0d95105;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-4532;LUSC
TCGA-33-AASD;C34.3;not reported;MX;T1;stage ia;2001;No;NA;Squamous cell carcinoma, NOS;N0;b8d4b2a7-95f8-53ce-9a05-a036d8fd14fc;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;30623;not reported;NA;8070/3;no;NA;5th;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;d5a05c5f-eaa3-5255-8ab5-5c96f33e68b3;84;NA;46.027.397.260.274;NA;Not Reported;NA;black or african american;44198d03-00df-5790-9fe7-398854b20057;male;83;not hispanic or latino;Dead;-30623;2010;1918;2249;NA;no;NA;b9541bb7-c76c-5c80-bbd0-f31224e7d57c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;1f1bd2ae-0b5a-5485-8ed8-374ca06cf534;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-AASD;LUSC
TCGA-39-5039;C34.1;not reported;M0;T2b;stage iia;2008;Not Reported;544;Squamous cell carcinoma, NOS;N0;fcae638b-0aec-5405-a777-4627aa38635a;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27781;not reported;NA;8070/3;yes;NA;NA;Stage IIA;not reported;2019-08-08T17:12:11.623943-05:00;34;NA;12daf616-3ea5-5d3a-b8f4-2459da3bedab;64;NA;350.684.931.506.849;NA;Not Reported;NA;white;1b488d1a-7855-5a20-b574-edbbe2c36c21;male;76;not reported;Dead;-27781;2009;1932;544;NA;no;NA;b64a1000-c875-5504-8b13-4f065163ea27;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e96e16a9-a59c-5f0f-a4f9-9e7e0bce2ad8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5039;LUSC
TCGA-85-8351;C34.3;not reported;M0;T2a;stage iia;2011;No;510;Squamous cell carcinoma, NOS;N1;c1e552f8-d752-5dea-8f69-840fe93fccf4;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;26437;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;3756f913-9cd9-5a77-9b06-06a26077324b;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;f42cfc6c-d59a-5339-8b28-c78a6f5afddc;male;72;not hispanic or latino;Alive;-26437;NA;1939;NA;NA;yes;NA;593187e5-5759-537c-b2bd-ca4c3ab9af45;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e489f5fc-a502-5198-aead-a48a72dce210;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8351;LUSC
TCGA-22-1017;C34.9;not reported;M0;T1;stage ia;1999;Not Reported;NA;Squamous cell carcinoma, NOS;N0;28c2c1e1-b717-5d3a-b4bd-d68d6478910e;not reported;NA;Lung, NOS;Yes;Lung, NOS;released;0;22880;not reported;NA;8070/3;yes;NA;5th;Stage IA;not reported;2019-08-08T17:11:26.507214-05:00;40;NA;24e4fa4b-6f8e-5588-88e8-6d313fb562bb;NA;NA;NA;NA;Not Reported;NA;white;91f8bedd-35ee-51a3-bf4d-30eb397b748e;male;62;not hispanic or latino;Dead;-22880;2003;1937;1485;NA;yes;NA;40dc78ed-dbaa-5449-8504-60a681ddf0f5;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;c021ac9f-059e-50c2-99e2-07c20058d495;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-1017;LUSC
TCGA-NC-A5HN;C34.3;not reported;M0;T2a;stage iia;2010;No;1499;Squamous cell carcinoma, NOS;N1;f327c50f-f4e7-5a1f-a433-dda7a5f8d4fc;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;28151;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:36.542202-05:00;48;NA;6de4b5bd-2152-542a-9a44-7b4254b314f2;100;NA;547.945.205.479.452;NA;Not Reported;NA;white;86e114ec-6abe-5a84-8d72-e8ee5b89e297;male;77;not reported;Alive;-28151;NA;1933;NA;NA;no;NA;c9325326-cb3b-5dc2-85e3-d76da824afac;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c3c93bd8-f0c5-536c-a0c6-cbc701f3a1e1;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-NC-A5HN;LUSC
TCGA-22-1000;C34.9;not reported;M0;T2;stage ib;2000;Not Reported;NA;Squamous cell carcinoma, NOS;N0;7551fd77-6d66-5cb3-b2c1-ba46d287ff5e;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;27901;not reported;NA;8070/3;yes;NA;7th;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;45;NA;036f1464-7257-56f5-9500-80ae02d70b1e;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;9a101103-319c-5793-b17b-6617f73d7520;male;76;not hispanic or latino;Dead;-27901;2001;1924;454;NA;no;NA;3960ebc1-9c38-5823-844d-da3cc7134bd1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;abd42020-6e86-5a69-941e-0e2bd4cd7369;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-1000;LUSC
TCGA-56-5898;C34.1;not reported;M0;T1b;stage ia;2010;No;555;Squamous cell carcinoma, NOS;N0;25db3b75-ad00-503a-a4e2-5aca7f9d378b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25441;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;68b24f15-a812-5855-bbd6-761dfe38b874;NA;NA;NA;NA;Not Reported;NA;white;0567aa96-093a-5d9b-b8f7-8340f637961c;male;69;not hispanic or latino;Alive;-25441;NA;1941;NA;NA;no;NA;0d76cc59-f89b-5473-9031-cb9c6a15fd1f;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;81f7da81-81bb-57ca-8485-7546ae177bc4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-5898;LUSC
TCGA-60-2711;C34.9;not reported;M0;T2;stage ib;2007;Not Reported;1260;Squamous cell carcinoma, NOS;N0;0e0985ca-ffca-5fba-8120-3c229a89f4de;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;23651;not reported;NA;8070/3;yes;NA;NA;Stage IB;not reported;2019-08-08T17:12:53.407315-05:00;39;NA;befe3a22-da7c-56ab-98ad-e8953953efe7;39;NA;213.698.630.136.986;NA;Not Reported;NA;white;a95d152a-ef0c-5b48-8528-086f2f50def5;female;64;not hispanic or latino;Alive;-23651;NA;1943;NA;NA;no;NA;6f7b2499-b1d5-58cb-a201-6ce0d5b9ca89;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;652fed8d-b5bd-5f0d-ada7-ee1f96aebe09;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2711;LUSC
TCGA-85-8052;C34.1;not reported;M0;T3;stage iib;2011;No;734;Squamous cell carcinoma, NOS;N0;0218adcd-914b-5e49-a74c-9b6490b65f6b;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;19671;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;f6e098f1-ba92-57a6-ac08-a17e2c1bb2eb;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;517762d7-e9e7-5b47-adf6-2bb3ce809bae;male;53;not hispanic or latino;Alive;-19671;NA;1958;NA;NA;no;NA;500b9c48-808f-50d3-83ee-5b20047dc3cb;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6a12902e-daba-5979-a494-b8c2a731ac81;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8052;LUSC
TCGA-18-3412;C34.3;not reported;M0;T2;stage ib;2005;No;NA;Squamous cell carcinoma, NOS;N0;7bcd2b49-c4a1-5e60-8067-3f659e885af8;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;19025;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;30614122-575d-5fb5-89fd-f27d44d2553f;25;NA;136.986.301.369.863;NA;Not Reported;NA;white;a39ff622-8d10-5ce8-ac87-e526d1f77f5c;male;52;not hispanic or latino;Dead;-19025;2005;1953;345;NA;yes;NA;af04c404-5dca-50b8-a0b6-901647c823ff;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e6d05ed7-697c-5408-b1ae-ec3407aca472;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3412;LUSC
TCGA-63-A5MW;C34.1;not reported;M0;T2;stage ib;NA;No;1639;Squamous cell carcinoma, NOS;N0;891bcbfa-ec3c-5588-a549-df608652e526;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;NA;27892;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;b758d988-fe97-52eb-a595-b81c0abc50e3;60;NA;328.767.123.287.671;NA;Not Reported;NA;not reported;cd68cc33-a1ab-52b3-a682-3f1a208fb625;male;76;not reported;Alive;-27892;NA;NA;NA;NA;no;NA;f06047a5-9cc3-5f1a-9f36-2dbca83e6e7a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;00610350-a6b3-54d2-acc1-affaccf77ad1;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-A5MW;LUSC
TCGA-85-8072;C34.1;not reported;M0;T1a;stage ia;2011;No;932;Squamous cell carcinoma, NOS;N0;a50466d9-f348-59a8-8138-c0fe3d2d2ab1;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;22069;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;9cffcab6-1c35-58ed-9e2a-ebed1e0f2c11;15;NA;0.821917808219178;NA;Not Reported;NA;white;27dda0de-b3b2-5ee4-be7b-7281634bbfa5;male;60;not hispanic or latino;Alive;-22069;NA;1951;NA;NA;no;NA;29074486-29ef-534d-89a6-06d119a966b5;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;fae44250-0ed2-5ef0-b16a-57cf339e1e96;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8072;LUSC
TCGA-O2-A52N;C34.1;not reported;MX;T2;stage i;2005;No;NA;Squamous cell carcinoma, NOS;N0;81cefb1f-3984-5346-925e-1818f0123176;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;28520;not reported;NA;8070/3;no;NA;6th;Stage I;not reported;2019-08-08T17:14:36.542202-05:00;55;NA;576fdc05-6fc7-558f-9763-5c092169f191;4.125;NA;0.226027397260274;NA;Not Reported;NA;white;352c2cd0-19cd-5ea7-990c-a3ef1bb0b6de;male;78;not hispanic or latino;Dead;-28520;2007;1927;1006;NA;no;NA;6673b44a-5af1-521b-bb98-b1877d4cf9f2;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6ffb8d77-0f47-57a4-bde4-8bcd00c1fdb0;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-O2-A52N;LUSC
TCGA-60-2716;C34.9;not reported;M0;T2;stage iib;2007;No;1475;Squamous cell carcinoma, NOS;N1;7433683b-2a30-56cd-8d54-8f1d777f2238;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;14345;not reported;NA;8070/3;no;NA;NA;Stage IIB;not reported;2019-08-08T17:13:13.079700-05:00;NA;NA;f632e65b-b52e-506f-a219-ae0bc2166b93;NA;NA;NA;NA;Not Reported;NA;not reported;32815718-de7a-5516-8695-19298314cac9;male;39;not hispanic or latino;Alive;-14345;NA;1968;NA;NA;yes;NA;554b4f60-b566-5bd2-94a7-fbeeb913c333;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;79227b86-d694-51ef-bc99-53cf82871a3b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2716;LUSC
TCGA-43-6143;C34.3;not reported;M0;T2;stage ib;2010;No;699;Basaloid squamous cell carcinoma;N0;324b5de9-d80a-5379-865f-15960e855ce9;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;25820;not reported;NA;8083/3;no;NA;7th;Stage IB;not reported;2019-08-08T17:12:31.795062-05:00;57;NA;da3eccc5-d60c-5e2f-bfa3-65d2d2caf593;114;NA;624.657.534.246.575;NA;Not Reported;NA;white;9062b651-b0f7-5d72-9e18-aac8f50e53f4;male;70;not hispanic or latino;Alive;-25820;NA;1940;NA;NA;yes;NA;6b85a75c-b84c-5ac9-ace5-c0e6ac839625;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;e28a6e49-021e-557d-9ee1-19eccf9e80e8;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-6143;LUSC
TCGA-63-7020;C34.1;not reported;M0;T1;stage ia;2007;No;2133;Squamous cell carcinoma, NOS;N0;46311239-6c75-52dd-ba97-1b341b8f9512;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;NA;NA;not reported;NA;8070/3;no;NA;6th;Stage IA;not reported;2019-08-08T17:13:13.079700-05:00;53;NA;62f9c2c2-11dd-5f0f-aa3b-3d395959ddc9;50;NA;273.972.602.739.726;NA;Not Reported;NA;not reported;1c0435cc-adb1-58ed-9baa-0850ca1f4c9f;male;NA;not reported;Alive;NA;NA;NA;NA;NA;no;NA;43e28173-a20b-5c86-9bf0-264253de7be8;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;eef266bb-c969-58ab-ba45-05e065756f5f;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-63-7020;LUSC
TCGA-18-4083;C34.3;not reported;M0;T2;stage iib;2005;Not Reported;NA;Squamous cell carcinoma, NOS;N1;4e83e83b-316a-5216-b060-4df0b2ae519f;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;23125;not reported;NA;8070/3;yes;NA;NA;Stage IIB;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;ba81070a-cd51-5c20-8bbc-57a87335cf80;45;NA;246.575.342.465.753;NA;Not Reported;NA;white;ba5a90f8-684b-50f2-9aca-9aaa33a1e23e;male;63;not hispanic or latino;Dead;-23125;2005;1942;188;NA;yes;NA;88c45300-32eb-53cd-946d-14bd2c87ae02;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;76d2852e-4abb-54f8-901a-ed5aac0e516d;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-4083;LUSC
TCGA-56-8304;C34.1;not reported;MX;T1b;stage ia;2011;No;106;Squamous cell carcinoma, NOS;N0;d817cd5e-5450-527b-ae76-6555ef95e0c2;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26803;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:12:53.407315-05:00;NA;NA;d9f1558a-4797-58d9-a36c-09e6ff897bbf;58;NA;317.808.219.178.082;NA;Not Reported;NA;white;1157cde8-2d77-51bb-9ef0-98fe0b6c9cc7;female;73;not reported;Alive;-26803;NA;1938;NA;NA;not reported;NA;f3b21c26-f68f-50e1-8163-1290b58d290c;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;205cfc9e-af68-5d74-bbfb-3cffbfea4960;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8304;LUSC
TCGA-33-4566;C34.1;not reported;M0;T2;stage ib;1996;No;NA;Squamous cell carcinoma, NOS;N0;f990d0cd-5459-535a-adf7-4cfc029eaef7;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;14643;not reported;NA;8070/3;no;NA;4th;Stage IB;not reported;2019-08-08T17:11:47.463501-05:00;NA;NA;d78eaab9-0aca-5cb5-8f9b-515a15fe2479;20;NA;10.958.904.109.589;NA;Not Reported;NA;white;5be503e3-f174-59f7-ac0d-bce79707ab1b;male;40;not hispanic or latino;Dead;-14643;2010;1956;5287;NA;not reported;NA;36b22073-5207-54a5-8946-66b54923aa16;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;9f99e5fc-77d4-52fb-890c-a7d5e70e0edd;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-33-4566;LUSC
TCGA-39-5021;C34.1;not reported;M0;T2a;stage ib;2004;No;2086;Squamous cell carcinoma, NOS;N0;d55da6f7-27d3-5a52-8130-7165d1b652ea;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25895;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:12:11.623943-05:00;57;NA;12d69734-d018-530e-b261-1bedb39e6700;114;NA;624.657.534.246.575;NA;Not Reported;NA;white;224ae73c-cc8b-5bc3-bc11-87346bb5da71;male;70;not hispanic or latino;Dead;-25895;2009;1934;2086;NA;no;NA;f5f46c26-8f73-5bd0-ab21-0260ea8b9747;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;6b0e8440-8e71-5bc4-b1e8-b6413161d9c1;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-39-5021;LUSC
TCGA-22-4596;C34.1;not reported;M0;T1b;stage ib;2002;No;17;Squamous cell carcinoma, NOS;N0;adfd134c-b0c7-5533-bf7c-58e0e1ad4128;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25448;not reported;NA;8070/3;no;NA;NA;Stage IB;not reported;2019-08-08T17:11:26.507214-05:00;40;NA;cb82db9f-c29f-53fc-bc6c-e178a3ef5956;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;7e4039c0-ce5e-5b43-bfcb-8a14a27e7daf;female;69;not reported;Dead;-25448;2002;1933;17;NA;no;NA;763310a8-6ee8-5283-a7a3-6188cca1507d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;412d5db9-4718-54d8-84bb-17eac7340f64;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-4596;LUSC
TCGA-56-8201;C34.1;not reported;MX;T3;stage iib;2011;No;28;Squamous cell carcinoma, NOS;N0;cd56f329-5cbd-550f-acca-d34a652902ee;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27211;not reported;NA;8070/3;yes;NA;7th;Stage IIB;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;d8bd0a0a-5e02-572e-9564-1492a8a0a0fb;NA;NA;NA;NA;Not Reported;NA;white;50969ab0-d027-57b3-99ff-ac2fd3e1d0cc;male;74;not hispanic or latino;Dead;-27211;NA;1937;397;NA;no;NA;f8b46733-3874-569a-970e-7c1d79c5ab3d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;cc88b7ce-9759-5f62-87cc-4ec2f44daaa6;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-56-8201;LUSC
TCGA-51-6867;C34.1;not reported;M0;T1;stage i;2003;Not Reported;NA;Squamous cell carcinoma, NOS;N0;394ab265-8cbe-54a3-b19d-356c1b69632d;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26523;not reported;NA;8070/3;yes;NA;6th;Stage I;not reported;2019-08-08T17:12:31.795062-05:00;NA;NA;777546e9-eff3-5cf0-99ef-975cf56c388e;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;0694b748-b37d-5699-be6f-fd78f8291484;female;72;not hispanic or latino;Dead;-26523;2008;1931;1856;NA;no;NA;f4e5e261-146c-5eb9-a385-fce18d153d2b;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;62db1b9d-e0a1-583a-89ce-8d86594a5489;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-51-6867;LUSC
TCGA-66-2783;C34.3;not reported;M0;T2;stage iiib;2008;No;759;Squamous cell carcinoma, NOS;N3;67a5f144-b3a1-5ded-9798-b7ff02add24f;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24686;not reported;NA;8070/3;no;NA;6th;Stage IIIB;not reported;2019-08-08T17:13:35.084062-05:00;43;NA;2e214980-14f8-5a02-80cd-74eb92cc09bf;65;NA;356.164.383.561.644;NA;Not Reported;NA;not reported;b8e87036-bee8-5359-967a-c61b6bebe11b;male;67;not reported;Alive;-24686;NA;1941;NA;NA;yes;NA;9e567147-e270-5767-a0be-f4376afbac67;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;c5c122a0-b76d-5445-868d-1ec8fc4e4853;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2783;LUSC
TCGA-77-8007;C34.1;not reported;M0;T2;stage iib;2001;No;NA;Squamous cell carcinoma, NOS;N1;8df45c17-8d7b-53ff-847c-2a6f190ce128;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;25102;not reported;NA;8070/3;no;NA;6th;Stage IIB;not reported;2019-08-08T17:13:35.084062-05:00;NA;NA;ec316ce9-d46a-5800-ae75-e5772219323a;100;NA;547.945.205.479.452;NA;Not Reported;NA;not reported;26f60de3-b9c7-5692-bb67-70be44b4ce4a;male;68;not reported;Dead;-25102;2001;1933;198;NA;not reported;NA;6cdb75f2-3fe1-5130-98be-5ab1d736f44a;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;931acc9b-4f2a-5574-b387-2c7b6c563be2;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-77-8007;LUSC
TCGA-98-8021;C34.1;not reported;M0;T1a;stage ia;2011;No;937;Squamous cell carcinoma, NOS;N0;1c997622-443b-5301-9d03-6c1d7f6198eb;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;27738;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:36.542202-05:00;60;NA;943afddf-0c72-550a-b061-222085bf6ae3;60;NA;328.767.123.287.671;NA;Not Reported;NA;white;4287fad5-a9c7-5748-a1eb-f508fc163bcf;female;75;not hispanic or latino;Alive;-27738;NA;1936;NA;NA;no;NA;50bcf755-024b-5e7e-b63d-51c9b100dd22;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;9d6fb0a3-d777-5471-8a88-1943d30833dd;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-98-8021;LUSC
TCGA-22-4613;C34.1;not reported;M0;T1b;stage ia;2004;No;358;Squamous cell carcinoma, NOS;N0;fd6a72e8-83ec-54f9-aa78-8c9d2ff1eba5;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26722;not reported;NA;8070/3;no;NA;NA;Stage IA;not reported;2019-08-08T17:11:47.463501-05:00;30;NA;8922340d-052a-5fb6-bb71-fae4188da0f4;30;NA;164.383.561.643.836;NA;Not Reported;NA;white;03741f01-6fe4-50b5-89bd-fd08dd15ca3d;female;73;not reported;Dead;-26722;2004;1931;358;NA;no;NA;81bf193f-f4c5-5142-81b5-42b74028cc89;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;acf657a2-7d43-5cbb-a727-f1bd4bd5ce69;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-22-4613;LUSC
TCGA-18-3411;C34.1;not reported;M0;T2;stage iiia;2005;No;3576;Squamous cell carcinoma, NOS;N2;cde088fb-07f2-5333-8950-e90dbfe4c933;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23370;not reported;NA;8070/3;no;NA;NA;Stage IIIA;not reported;2019-08-08T17:11:26.507214-05:00;NA;NA;7b6ec1eb-c43c-542f-8a57-7928fb253088;50;NA;273.972.602.739.726;NA;Not Reported;NA;not reported;9132adc9-2ca0-5980-a54f-32cae28a9528;female;63;not reported;Alive;-23370;NA;1942;NA;NA;yes;NA;4e4ed885-a9bd-58b9-b958-fb2d5ad5828e;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;085220f1-0ae8-5535-a978-1690524e16d4;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-18-3411;LUSC
TCGA-85-A4CL;C34.3;not reported;M0;T1b;stage ia;2012;No;781;Squamous cell carcinoma, NOS;N0;33a78729-6bee-5c0f-b70a-11452b964882;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;24005;not reported;NA;8070/3;no;NA;7th;Stage IA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;83b34cf2-092a-57fa-9671-0a4413e11114;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;73bf462b-279e-5acd-a271-a270ced7f5a7;male;65;not hispanic or latino;Dead;-24005;NA;1947;921;NA;no;NA;17bfad90-7c6c-5aca-8903-61a49fff69b0;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;48e683d1-5ce0-5565-8d46-390e97f3fd00;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A4CL;LUSC
TCGA-43-3394;C34.3;not reported;M0;T2a;stage ib;2009;No;822;Squamous cell carcinoma, NOS;N0;ebb21717-aa2b-5703-9cc0-f2d532140fb5;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;19310;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:12:11.623943-05:00;NA;NA;b6adfff2-a387-5f69-90b6-07397af1dad6;15;NA;0.821917808219178;NA;Not Reported;NA;black or african american;84a63aa6-c83b-56c7-9fd5-10aafd575614;male;52;not hispanic or latino;Dead;-19310;NA;1957;1190;NA;yes;NA;02d1b995-d497-5207-b4cf-26a0a67204a0;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;2498b4a3-64c1-5279-88f3-2c5c87412574;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-43-3394;LUSC
TCGA-66-2765;C34.3;not reported;M0;T2;stage ib;2007;No;61;Squamous cell carcinoma, NOS;N0;318eb79a-c005-511d-8113-3914c2fc094b;not reported;NA;Lower lobe, lung;No;Lower lobe, lung;released;0;23465;not reported;NA;8070/3;no;NA;6th;Stage IB;not reported;2019-08-08T17:13:13.079700-05:00;54;NA;f847affd-f150-52f8-9aa7-345cfdf91372;108;NA;591.780.821.917.808;NA;Not Reported;NA;not reported;6f38b000-d687-5d1b-9094-1ccb3edc5f71;male;64;not reported;Alive;-23465;NA;1943;NA;NA;not reported;NA;9094d172-d538-562a-9869-21084d65bdce;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;4dbc72d2-002c-575b-a232-685f05c8a434;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-66-2765;LUSC
TCGA-85-8584;C34.1;not reported;M0;T2a;stage iia;2012;No;0;Papillary squamous cell carcinoma;N1;3ea9bdb0-7574-52f8-8068-890e64ba2a50;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;26081;not reported;NA;8052/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:16.559953-05:00;NA;NA;9aa25a74-45b2-5f68-b505-6d2e929a45eb;50;NA;273.972.602.739.726;NA;Not Reported;NA;white;729a72a8-823a-546d-b0b6-7e972fe0e061;male;71;not hispanic or latino;Dead;-26081;NA;1941;383;NA;not reported;NA;f5e24c79-961d-5468-b1b3-2b4999c4bece;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;1f3059d6-310c-5117-be7f-22928c9c369e;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-8584;LUSC
TCGA-60-2726;C34.2;not reported;M0;T2;stage iia;2009;No;358;Squamous cell carcinoma, NOS;N1;c4597b19-aff3-5180-a53e-5e167da9ce7a;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;20618;not reported;NA;8070/3;no;NA;NA;Stage IIA;not reported;2019-08-08T17:13:13.079700-05:00;42;NA;a4217d92-bf14-561e-863e-c43355b3df2a;42;NA;23.013.698.630.137;NA;Not Reported;NA;white;6013f23e-a5b4-599f-887f-23bbc6df1e12;male;56;not hispanic or latino;Dead;-20618;2009;1953;358;NA;no;NA;15b7165b-5828-569c-81d3-1e00f046f55d;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;29154f3a-fd20-5d8c-9b70-34b274714bf1;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-60-2726;LUSC
TCGA-37-4133;C34.9;not reported;M0;T4;stage iiia;2010;No;238;Squamous cell carcinoma, NOS;N0;b63c394d-8933-5538-8840-ca24775a5404;not reported;NA;Lung, NOS;No;Lung, NOS;released;0;23083;not reported;NA;8070/3;no;NA;7th;Stage IIIA;not reported;2019-08-08T17:12:11.623943-05:00;40;NA;6ffd01dc-c293-5afb-ab92-2a5fdf89ba42;40;NA;219.178.082.191.781;NA;Not Reported;NA;white;b439081f-05ac-50be-ba19-ce5809329603;male;63;not hispanic or latino;Alive;-23083;NA;1947;NA;NA;not reported;NA;b5718518-2a1c-5bf7-b1f3-ad36a1869bbf;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;not reported;NA;ef9a73e8-f305-5620-a1de-e93e2647b264;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-37-4133;LUSC
TCGA-85-A53L;C34.2;not reported;M0;T2b;stage iia;2012;No;377;Squamous cell carcinoma, NOS;N0;8b07482f-0053-5ef9-9590-929982876976;not reported;NA;Middle lobe, lung;No;Middle lobe, lung;released;0;23065;not reported;NA;8070/3;no;NA;7th;Stage IIA;not reported;2019-08-08T17:14:16.559953-05:00;30;NA;3450c37f-3c9d-5731-95f9-0261dd8e3a1e;30;NA;164.383.561.643.836;NA;Not Reported;NA;asian;b3a90371-af9a-571b-a340-60366906abba;male;63;not hispanic or latino;Alive;-23065;NA;1949;NA;NA;no;NA;441e2903-2e40-5f04-aab0-80e86e168e93;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;c2a38c30-a733-5e09-b17c-fb68cecf7f31;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-A53L;LUSC
TCGA-85-6175;C34.1;not reported;M0;T3;stage iib;2010;No;0;Squamous cell carcinoma, NOS;N0;5608de1f-0c69-59a7-8c85-98d3a2405784;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;23228;not reported;NA;8070/3;no;NA;7th;Stage IIB;not reported;2019-08-08T17:13:55.903240-05:00;NA;NA;67e13e3d-6e03-5819-aa4d-2516cad04745;NA;NA;NA;NA;Not Reported;NA;white;a8a6308e-a94e-515d-b777-a02355754f24;female;63;not hispanic or latino;Dead;-23228;NA;1947;294;NA;no;NA;fb28b323-a71d-5a85-a5c8-cb59717b4ee1;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;no;NA;7403d9a5-8f17-5231-818f-e42a14af4f76;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-85-6175;LUSC
TCGA-70-6723;C34.1;not reported;M0;T3;stage iia;2010;No;375;Papillary squamous cell carcinoma;N0;50910b7d-b3f7-547d-aefd-8b8dda3628bb;not reported;NA;Upper lobe, lung;No;Upper lobe, lung;released;0;24035;not reported;NA;8052/3;no;NA;6th;Stage IIA;not reported;2019-08-08T17:13:35.084062-05:00;NA;NA;dcee0259-964b-5a18-9a0e-e615c4ea8d4a;NA;NA;NA;NA;Not Reported;NA;asian;640b2334-1fec-5681-8bbb-f879afe03aa2;male;65;not hispanic or latino;Alive;-24035;NA;1945;NA;NA;no;NA;5b91498e-d6d2-5488-88c2-e3274920d4e3;NA;NA;NA;NA;Pharmaceutical Therapy, NOS;NA;NA;NA;NA;yes;NA;7e4f6d9e-3b8c-5649-b035-80711dc35e9b;NA;NA;NA;NA;Radiation Therapy, NOS;NA;NA;NA;TCGA-70-6723;LUSC